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  Zusammenfassung 
I 
Zusammenfassung 
Spalt Proteine bilden eine Familie von Transkriptionsfaktoren, die von Caenorhabdits 
elegans über Drosophila melanogaster bis hin zu Vertebraten konserviert sind. In 
Säugetiergenomen findet man jeweils vier Gene, die als Spalt-like (SALL1 bis SALL4) 
bezeichnet werden. Mutationen in SALL1 und SALL4 verursachen im Menschen Townes-
Brocks-Syndrom (TBS) beziehungsweise Okihiro-/Duane Radial Ray-Syndrom (DRRS). 
Beide Syndrome variieren stark in ihrem klinischen Befund, beschrieben sind unter anderem 
Verdopplung oder Fehlen von Fingern und Zehen, Schäden im zentralen Nervensystem sowie 
Missbildungen im Urogenitalsystem. Wie es zu diesen multiplen Fehlbildungen kommt ist 
nicht verstanden. Aufbauend auf eine systematische, vergleichende Untersuchung der 
Expressionsmuster wurden in der vorliegenden Arbeit die Auswirkungen von Mutationen in 
Sall1 bis Sall4 auf die Embryonalentwicklung von Mäusen einzeln oder in Kombination 
untersucht. Bisher wurde nur gezeigt, dass Verlust von Sall1 zur Nierenagenese führt. Das 
Ziel war deshalb, durch Untersuchung der verschiedenen Sall Mutationen in unterschiedlichen 
Organsystemen zugrunde liegende Gemeinsamkeiten herauszuarbeiten, die eine generelle 
Rolle von Sall Genen während der Embryonalentwicklung aufzeigen.  
 
Sall4 ist der erste Sall Transkriptionsfaktor, der während der Embryonalentwicklung 
exprimiert wird. Die innere Zellmasse (IZM) der Blastula, aus der die embryonalen 
Stammzellen und das Extraembryonale Endoderm hervorgehen, exprimiert Sall4 besonders 
stark. Im Trophoblast hingegen wird die Transkription von Sall4 ab dem Tag e5.5 vollständig 
reprimiert. Die Deletion von Sall4 aus dem Mausgenom führt bei homozygoten Tieren zum 
Fehlen der beiden IZM Zellinien und damit zum Absterben des Embryos direkt nach der 
Einnistung in die Gebärmutter. Das Studium dieses Prozesses in einem Kultursystem 
bestätigte den sukzessiven Verlust der IZM und führte zu der Aussage, dass Sall4 für den 
Erhalt der embryonalen Stammzellen und des primitiven Endoderms notwendig ist. In 
Abwesenheit von Sall4 kommt es jedoch nicht zum Zelltod sondern zu reduzierter Zellteilung 
dieser Zellinien und zu deren Differenzierung. Auch embryonale Stammzellen verlieren in 
Kultur die Fähigkeit zur Zellteilung, wenn Sall4 deletiert wird. 
Um zu testen, ob Sall4 die Identität von Zellen zellautonom steuert, wurden chimäre 
Mäuse aus Zellen mit und ohne Sall4 hergestellt. Dabei wurde festgestellt, dass Zellen, deren 
Sall4 Gen entfernt ist, auch im Verband mit Wildtyp-Zellen nicht zum Embryo beitragen 
können. Dies lässt die Schlussfolgerung zu, dass die Funktion von Sall4 zellautonom ist. 
  Zusammenfassung 
II 
Im Gegensatz zum frühen Embryo werden in Vorläuferzellen des zentralen 
Nervensystems alle vier Sall Gene abgelesen. Es konnte gezeigt werden, dass die Mutation 
einzelner Gene nur milde Effekte auf die Entwicklung hat wohingegen das Entfernen 
mehrerer Sall Faktoren zu Verlust, Verkleinerung oder mangelnder Organisation 
verschiedener Bereiche des Nervensystems führt. Dies wurde auf die Beobachtung 
zurückgeführt, dass die Zellteilungsrate verringert ist. Beispiele hierfür sind die 
Grosshirnrinde und der Bulbus olfactorius. In Sall1/Sall2 Doppelmutanten kommt es so zum 
kompletten Verlust des Geruchssinns. Auch die wachsende Extremitätenknospe aktiviert 
mehrere Sall Gene, in späteren Stadien vor allem Sall1 und Sall3. Hier konnte gezeigt werden, 
dass die vollständige Ausbildung aller Elemente des Skeletts von der Dosis der Sall Aktivität 
abhängt und totale Abwesenheit von Sall1 und Sall3 Oligodaktylie zur Folge hat.  
 
Mutation mehrerer Gene führt in Mäusen demnach zu Entwicklungsschäden 
vergleichbar denen, wie sie in Menschen, für TBS und DRRS beschrieben sind. Funktionen 
von Sall Faktoren überlappen stark. In allen untersuchten Entwicklungsprozessen kommt es in 
Abwesenheit aller hier exprimierten Sall Transkriptionsfaktoren zum Fehlen von 
differenzierten Zellen in den betroffenen Geweben, das sich nicht durch Zelltod sondern 
durch den Verlust der Vorläuferpopulation erklärt. Da Sall Proteine immer in Vorläufer- und 
Stammzellen aktiv sind lässt sich also ein allgemeines Modell postulieren, nachdem Sall 
Proteine für den Erhalt dieser nicht differenzierten Zellen nötig sind. Dieser Blickwinkel 
eröffnet neue Interpretationsmöglichkeiten für das Zustandekommen der Vielzahl an 
Missbildungen in TBS und DRRS. 
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  Introduction 
1 
Introduction 
In development, a single, totipotent cell undergoes multiple rounds of division 
accompanied by a determination and differentiation process. Differentiation occurs at the 
expense of a loss of developmental potential in almost all daughter cells of a progenitor cell. 
While several cell types remain competent to differentiate into multiple others as well as to 
self-renew, the only truly totipotent cells constitute the germline of an adult animal. Loss of 
totipotency is tightly linked to differentiation and controlled by multiple cellular signalling 
pathways. As a consequence to the signals received, much of the developmental state of a cell 
is defined by the genes expressed, facilitating the cell to carry out the designated functions. To 
translate the proper set of proteins, cells evolved a complex circuitry of transcriptional 
regulators. Control of transcription will reflect on the level of messenger RNA and ultimately 
contribute to the regulation of protein abundance. Many transcription factors themselves are 
thus expressed in a tightly controlled fashion in space and time. One such transcriptional 
regulator family that plays a crucial role in multiple developmental processes is founded by 
the Drosophila gene spalt. The mutation was initially described in Drosophila melanogaster 
(Tsonis and Goetinck, 1988). Subsequently, cloning revealed that the observed phenotypes 
are caused by mutations of a Zn-finger transcription factor (Kuhnlein et al., 1994). 
 
1. The Spalt-like Transcription Factor Family 
1.1. Orthologs and Similarities 
Spalt (sal) like proteins are transcription factors that are described for nematodes, 
shrimp, insects and multiple chordata analyzed till date. 175 members of the Spalt family of 
proteins have been annotated in different sequenced organisms (ensembl). The simplest 
organism described to contain a Spalt homolog is C. elegans. Only one spalt like gene is 
found in C. elegans, the genome of Drosophila melanogaster harbours two paralogs and in 
vertebrates typically four genes are present. These paralogs seem to have arisen by several 
duplication events of the spalt locus and are called Sall for spalt-like. Figure 1 shows the 
relative homology of a selection of 23 spalt-like genes based on protein conservation. Judged 
by sequence homology, the vertebrate spalt genes evolved from one ancestor more closely 
related to the Drosophila spalt major (salm) ortholog than to spalt-related (salr). Sem-4 of C. 
elegans and spalt-related form a distant subgroup (figure 1) with the two Drosophila spalt  
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Figure 01: Relative sequence similarity of Spalt proteins
Sequence comparison of Spalt proteins in human (hSALL1-4), chimpanzee (pSALL1-4), mouse (mSALL1-4), chicken 
(cSALL1-2), Fugu, Drosophila (Dm Salm, Dm Salr) and C. elegans (Sem-4). Sequence was compared in ClustalX, similarity 
is illustrated by the length of arms separating genes from junctions or junctions from one another.
While completed genomes for human and mouse allow precise alignment, other vertebrate genomes still miss informa-
tion. For some fugu orthologs, only fragments  are known till date and therefore final alignment will have to await 
completion of the sequencing projects.
Underlaying colores emphasize the four groups of vertebrate spalt genes as well as a distant group of Spalt homologuos 
genes. In accordance with phylogenetic distances known for human, chimpanzee, mouse and chicken, SALL proteins 
relate in the subgroup for  each paralog. It can therefore be assumed that  the four SALL proteins found in mammals were 
present already before separation into different lineages and that homolog genes can directly be assigned for mamma-
lian genomes.
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paralogs being less similar to one another than any of the vertebrate alleles are to each other. 
The presence of four paralog genes was established very early in vertebrate development 
judging from the presence of closely related orthologs for most Sall genes in fish. The 
presence of two Fugu paralogs in subgroup two and four represents recent duplications in fish 
genomes. In Danio rerio, Medaka and Fugu the number of paralogs will also exceed the four 
found in higher vertebrates, once the genome sequencing projects are completed. Already six 
spalt like genes are annotated in the Fugu genome.  
Based on sequence homology, Sall1 and Sall3 derive from one common ancestor while 
Sall4 is more distant. Sall2 shares the least homology with the other three orthologs. 
Nevertheless, all four SALL paralogs are almost identical in protein sequence level within the 
functional domains. 
In support of the sequence comparison, close relationship between all four SALL/Sall 
orthologs is also seen in the organization of the mRNA in humans and mice. All four genes 
are encoded by a small first exon harbouring the translational start followed by a big intron 
and a second large exon with most of the coding sequence followed by small 3´exons 
(figure2). 
 
1.2. Protein Structure and Subcellular Localization 
Spalt proteins are large proteins of 1000 to 1300 amino acids. Typical for Spalt proteins 
is the presence of a double zinc finger domain of the C2H2 type, in which two zinc fingers are 
located directly adjacent to one another. Zinc finger motifs form a distinct three dimensional 
structure stabilized by the complexation of a zinc ion between cysteine and histidine residues. 
They are known to bind DNA with the alpha-helical part of the loop between the first two and 
second two zinc binding sites (Kuhnlein et al., 1994; Pavletich and Pabo, 1991). The double 
zinc finger motif is repeated three to four times within the protein structure of all Spalt 
proteins with high similarity even on sequence level. Next to the second double Zn-finger 
domain, a single Zn-finger is found in all Spalt-like proteins. Moreover, all vertebrate SALL 
proteins contain an additional N-terminal zinc finger of the C2HC class (Kohlhase et al., 
2002b). The N-terminus including the C2HC zinc finger motif had been shown to facilitate 
repression of target genes by binding and recruiting histone deacetylase (HDAC) (Kiefer et 
al., 2002), suggesting that Spalt proteins act as transcriptional repressors. However, fusion 
experiments of XsalF and VP16 in a Xenopus oocyte system indicate that Spalt proteins can 
also act as transcriptional activators in some contexts (Onai et al., 2004) .  
Intron 1 Intron 2
SALL1
Intron 1
SALL2
Intron 1 Intron 2
SALL3
Intron 1 Intron 2
SALL4
Intron 3
Figure 02: Protein structure of vertebrate SALL genes 
A) SALL proteins are transcription factors of 1000-1300 aminoacid length. The most prominent sequence structure found 
in all spalt genes is a double zinc-finger domain which is repeated several times within the coding sequence with the 
second repeat being accompained by an additional Zn-finger. The N-terminal Zn-finger scetched in black has been 
shown to bind histone deacetylase and mediate transcriptional repression. SALL proteins are believed to act as dimers 
with the glutamine rich stretch serving as dimerzation domain. Human (shown here) and murine Sall genes even show 
conservation in mRNA structure, as seen by conserved positions of intronic sequence.
B) multiple sequence alignment with ClustalW shows a close to complete conservation of primary sequence between 
mouse and human homologues within the glutamine rich as well as the Zn-finger domains. These domains are also 
highly conserved between paralog genes.  An asterisk indicates the postions of cystine and histidine chelating the 
Zn-ion to form Zn-fingers.
A
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B
mSall1 438 AKSTSDEAFFKHKCRFCAKVFGSDSALQIHLRS HTGERPFKCNICGNRFSTKGNLKVHFQRHKEKYPHIQMNPYPVPEHLDNVPTSTGI 
hSALL1 437 AKSTSDEAFFKHKCRFCAKVFGSDSALQIHLRS HTGERPFKCNICGNRFSTKGNLKVHFQRHKEKYPHIQMNPYPVPEHLDNIPTSTGI 
mSall3 386 PKASAEDPFFKHKCRFCAKVFGSDSALQIHLRS HTGERPFKCNICGNRFSTKGNLKVHFQRHKEKYPHIQMNPYPVPEYLDNVPTCSGI 
hSALL3 408 PKASAEDPFFKHKCRFCAKVFGSDSALQIHLRS HTGERPFKCNICGNRFSTKGNLKVHFQRHKEKYPHIQMNPYPVPEYLDNVPTCSGI 
mSall4 375 VKAKDEVVLGKHKCRYCPKVFGTDSSLQIHLRS HTGERPYVCPICGHRFTTKGNLKVHLQRH----PEVKANPQLLAEFQDKGAVSAAS 
hSALL4 370 VKPKDEAALYKHKCKYCSKVFGTDSSLQIHLRS HTGERPFVCSVCGHRFTTKGNLKVHFHRH----PQVKANPQLFAEFQDKVAAGNGI 
mSall2 360 VISSLEKPGGRHKCRFCAKVFGSDSALQIHLRS HTGERPYKCNVCGNRFTTRGNLKVHFHRHREKYPHVQMNPHPVPEHLDYVITSSGL 
hSALL2 361 VMGPLEKPGGRHKCRFCAKVFGSDSALQIHLRS HTGERPYKCNVCGNRFTTRGNLKVHFHRHREKYPHVQMNPHPVPEHLDYVITSSGL 
 
B
 
mSall1  173 KVAVAQF 210SQEARCGGASGG-----KLLISTLMEQLLALQQQQIHQLQLIEQIRHQI LLLASQSADLP 
hSALL1  173 KVAVAQF 210SQEARCGGASGG-----KLAVPALMEQLLALQQQQIHQLQLIEQIRHQI LLLASQNADLP 
mSall3  140 KVAVAQF 157SQGARAGGTTGAGGSVGAVAIPMILEQLVALQQQQIHQLQLIEQIRSQV ALMSRQ----P 
hSALL3  135 KVAVAQF 181SQGARAAGGSGAGGGVAAAAVPLILEQLMALQQQQIHQLQLIEQIRSQV ALMQRP----P 
mSall4  129 KVAVNQR 191GAEAPMAPMPAAQ------GIPWVLEQILCLQQQQLQQIQLTEQIRVQV NMWAAH----- 
hSALL4  130 KVAVNQR 196SADALPAPVPGAN------SIPWVLEQILCLQQQQLQQIQLTEQIRIQV NMWASH----- 
mSall2  134 STPAPPP 162PPPPPPPPGVGSG----HLNIPLILEELRVLQQRQIHQMQMTVQICRQV LLLGSLG---- 
hSALL2  134 STPAPPP 162PPPPPPPPGVGSG----HLNIPLILEELRVLQQRQIHQMQMTEQICRQV LLLGSLG---- 
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Introduction
4
  Introduction 
5 
In addition to zinc fingers, the only other domain recognizable on primary structure 
level is a glutamine rich region prior to the first double zinc finger motif. In chicken it has 
been shown that this domain is necessary for dimerization of Spalt proteins. It is therefore 
proposed that Spalt proteins function as homo- or heterodimers (Sweetman et al., 2003). 
Figure 2B illustrates the high level of sequence identity in functional domains of Sall genes 
exemplified by the glutamate rich domain as well as the first double zinc finger motif for 
human and mouse spalt homologous genes.  
Zinc finger domains show a very high degree of homology and in Drosophila, salm and 
salr show strong genetic interaction arguing for redundancy of protein function (Mollereau et 
al., 2001). Taken together with relative protein homologies, functional redundancy of Sall 
genes in mouse might also be expected. 
Studies in cell culture revealed the subcellular localization of SALL proteins. By 
tagging full length Csal1 and Csal3 it could be shown that Csal1 is found localized to the cell 
nucleus, while Csal3 remains in the cytoplasm (Sweetman et al., 2003). In a coexpression of 
both orthologs, Csal1 and Csal3 colocalized and Csal3 tethered Csal1 to the cytoplasm. It 
remains to be determined though whether cytosolic Csal3 localization was due to 
modification of the protein by fusion of a flag tag.  
Similarly, a study in transiently transfected NIH-3T3 cells, where human SALL1 was 
tagged with GFP, revealed localization to pericentromeric heterochromatin (Netzer et al., 
2001).  
 
2. Mutations in Spalt-like Genes Cause Inherited Diseases in 
Humans 
Mutations in genes of the spalt like transcription factor family have been shown to 
manifest in phenotypic aberrations in several model organisms. Moreover, humans carrying 
mutations in spalt like genes suffer from various developmental defects.  
Two autosomal inherited diseases have been linked to mutations in genes of the Spalt 
like transcription factor family in humans. While mutations in SALL2 (spalt-like, ortholog 2) 
and SALL3 have not been reported to result in pathologic variations, both, mutations in SALL1 
and SALL4, result in multiple developmental aberrations inherited in an autosomal dominant 
fashion. 
  Introduction 
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2.1. Townes-Brocks Syndrome (TBS) 
Patients suffering from Townes-Brocks Syndrome display a combination of anal, renal, 
limb and ear abnormalities (Townes 1972).The clinical presentation is highly variable even 
within families. Patients typically display outer ear deformities, an imperforate anus and 
sensineural hearing loss (Townes 1972) combined with several other conditions. The most 
common limb defects in TBS are preaxial polydactyly, syndactyly and club feet. Reported 
renal malformations can lead to renal failure (Rossmiller and Pasic 1994). Typically one or 
both kidneys are hypoplastic (Kohlhase et al 1999). Further rare conditions are mild mental 
retardation, a hypoplasia of the corpus callosum, coloboma as well as heart defects. Various 
genital malformations like vaginal aplasia, bifid uterus and scrotum as well as 
chryptorchidism have also been reported. The frequency of TBS could not be determined to 
date since penetrance seems incomplete but due to its dominant nature it is a rare syndrome. 
TBS is inherited in an autosomal dominant fashion. Therefore haploinsufficiency of 
SALL1 has been discussed as a likely explanation for TBS (Kohlhase et al., 1998) but 
formally a dominant negative or gain of function effect can not be excluded. 
35 independent mutations in TBS patients have been mapped and all but two cluster 
prior or in the first double zinc finger motif and found to result in truncated SALL1 protein. 
Other mutations include a variety of deletions and insertions (Botzenhart et al., 2005; 
Kohlhase et al., 1999). Taken together with the finding that SALL proteins form homo- and 
heterodimers through the glutamine rich domain which lies N-terminal to the to the cluster of 
truncation sites in TBS patients, a dominant negative effect was proposed (Sweetman et al., 
2003). Until date, no correlation between the molecular basis and site of the mutation with the 
clinical presentation could be drawn (Botzenhart et al., 2005) and high phenotypic variability 
is observed even within families. 
 
2.2. Okihiro Syndrome/Radial Ray Syndrome 
Mutations in the most recently identified member of the Spalt class of transcription 
factors, SALL4, have recently been described to result in a range of clinically overlapping 
phenotypes. The two most commonly observed effects are eye movement disorders and limb 
malformations. Patients diagnosed of Okihiro Syndrome, Radial Ray Syndrome (DRRS), 
Holt-Oram Syndrome, Acro-Renal Ocular Syndrome and Thalidomide Embryopathy have 
been found to carry mutations in SALL4 (Al-Baradie et al., 2002; Borozdin et al., 2004; 
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Kohlhase et al., 2005; Kohlhase et al., 2002b; Kohlhase et al., 2003). These patients typically 
display limitation of eye abduction associated with retraction of the eye globe as well as 
absence or dysplasias of the radius and fingers, most often the thumb. Close examination also 
reveals slight deformities of the ears, hearing loss in some cases, and kidney hypoplasia. 
Overall, a clear overlap to clinical manifestation of Townes Brocks Syndrome is apparent. 
The high variability of the expressivity is also a common feature of the syndromes described 
above. 
Initial reports (Kohlhase et al., 2002b) found a clustering of mutations in SALL4 that 
will result in premature truncation prior to the first double zinc finger motif similar to 
mutations seen in SALL1. Later reports also see large deletions of the whole SALL4 locus in 
DRRS patients (Borozdin et al., 2004), arguing that in contrast to SALL1, mutations in SALL4 
do indeed manifest in a haploinsufficient fashion. Further studies with higher numbers of 
patients analyzed will clarify this observation. 
In summary, clinical manifestations of SALL mutations are highly variable and affect 
sensory organs as well as CNS, kidney and limb development. Phenotypes in TBS and DRRS 
vary and a clear genotype-phenotype correlation is not evident (Kohlhase et al., 1999). 
The molecular effect of mapped mutations is not understood, one would for example 
expect, that oligodactyly versus polydactyly is caused by different types of mutations. 
Nevertheless, a correlation between the molecular effect of a mutation and the phenotypic 
manifestation is not clear. Due to the complicated genetics, no underlying developmental 
principal was identified till date that could account for TBS and DRRS. 
 
3. Mutations in Spalt and Sem-4 
Spalt proteins were first described in Drosophila melanogaster by virtue of its capacity 
to promote terminal structures (Tsonis and Goetinck, 1988). Spalt major (Salm), the founding 
member of this protein family, has been shown to play important roles in multiple steps of 
development (Dong et al., 2003) such as sensory organ development, the anterior-posterior 
boundary formation in the wing disc as well as determination of trunk identities. Mutations in 
spalt cause head and tail segments to develop trunk structures (Kuhnlein et al., 1994). This 
publication also is the first one to report the protein sequence and the one to identify the Zn-
finger domains since the transcriptional unit had previously been misidentified.  
Further, mutation of salm and salr in the eye indicates a requirement of spalt genes for 
development of photoreceptors R3/R4 (Domingos et al., 2004b) and R7/R8 (Domingos et al., 
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2004a). Loss of spalt genes in the developing tracheal system as well as their overexpression 
result in defects in tracheal branching and morphogenesis (Ribeiro et al., 2004).  
A null allele of the C. elegans homolog sem-4 (sex myoblast) causes a failure in sex 
myoblast differentiation and neuronal determination (Basson and Horvitz, 1996). In addition, 
several alleles exhibit vulval cell fate determination defects (Grant et al., 2000). Sem-4 
function is required for expression of lin-39, the Drosophila sex combs reduced homolog in 
C. elegans. Together with a genetic interaction of spalt and antennapedia as well as other 
studies from Drosophila and mammals, it has been proposed that spalt genes may be part of a 
bigger complex required for general transcriptional silencing (polycomb complex) and 
activation (Franch-Marro and Casanova, 2002; Toker et al., 2003). Localization of Spalt to 
heterochromatin as discussed earlier might fit this idea.  
 
4. Spalt-like Transcription Factors and Cell Signalling 
Till date, induction of spalt transcription has been linked to a number of different 
signalling pathways. While Salm is repressed by antennapedia in the leg imaginal disc 
(Wagner-Bernholz et al., 1991), expression of spalt-major and spalt-relates (salr) is induced 
in response to decapentaplegic (dpp), a BMP4 homolog, in the wing disc (Barrio R, 1996; de 
Celis and Barrio, 2000) and required for the positioning of veins in the wing disc. Spalt 
expression in the tracheal system is induced by wingless (Ribeiro et al., 2004). Wnt genes in 
Xenopus have also been reported to activate homologs to spalt that in turn will antagonize 
canonical Wnt signalling (Onai et al., 2004). Contrary to that, expression of Sall1 in cell 
culture potentiated Wnt signalling (Sato et al., 2004). In the fish Medaka, spalt is discussed as 
a target of hedgehog signalling (Koster et al., 1997). It appears from these studies that Spalt 
function can not be assigned into a single cell signalling pathway but rather is involved in a 
more general fashion to facilitate a series of developmental processes. One model generated 
in Xenopus suggests that SALL proteins facilitate general cellular responsiveness to cell 
signalling inputs (Onai et al., 2004). How responsiveness might be achieved is not 
understood. 
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5. Aim of this Study 
Mutations in genes of the spalt-like family manifest in multiple developmental 
phenotypes. Genetic interaction of Spalt proteins with known cell signalling pathways can not 
explain the observed general cellular responses. Function of Sall genes could neither be 
attributed to specific cell types nor specific cellular pathways. Especially, observations in 
mammals are too few and – in case of humans - difficult to interpret. Mutations of human 
SALL genes lead to a variety of different malformations arguing that SALL transcription 
factors are involved in multiple developmental processes in mammals. A deeper 
understanding of the role of Sall genes in mammalian development will therefore gain 
insights into general development as well as elucidate the underlying principles of Townes-
Brocks Syndrome, Duane-Radial Ray Syndrome and related diseases. 
Mouse is the closest system to humans that is accessible to reverse genetics. Therefore, I 
decided to study the effects of loss of Sall orthologous genes in Mus musculus by means of 
genetic manipulation. The fully sequenced genome and a good correlation of spalt orthologs 
between mice and men facilitate such an approach. 
Mice homozygous mutant for Sall1 do not show the phenotypes observed in patients 
suffering from TBS. Rather, Sall1 knockout mice are born without kidneys or with severe 
renal hypoplasia. Defective kidneys are supposed to lead to the perinetal lethality in these 
animals (Nishinakamura et al., 2001). No other phenotypes due to the loss of Sall1 have been 
described and heterozygous mice show no defects. The allele used for this study is believed to 
be a genetic null while mapped mutations in humans typically lead to truncations of the 
SALL1 or SALL4 proteins. This argues that humans are either more sensitive to the level of 
SALL protein or the nature of these mutations is acting in a dominant negative or gain of 
function manner. Dimerization of Spalt proteins has been reported previously (Sweetman et 
al., 2003) and could explain such effects. 
Further support that expression of a truncated Sall1 protein rather than 
haploinsufficiency causes the defects seen in TBS patients comes from the observation that 
expression of a truncated version of Sall1 in mouse results in stronger phenotypes, more 
similar to the malformations seen in humans (Kiefer et al., 2002). Like in humans, the 
expressivity of the phenotype is low, variable and difficult to study. 
If the pathology observed in humans is indeed due to expression of truncated Spalt 
protein that forms homo- or heterodimers with full length Spalt protein, genetic analysis has 
to be evaluated carefully. It is not clear if and to what extend dimerization occurs (Sweetman 
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et al., 2003), if all Sall genes heterodimerize and if or how truncated protein interferes with 
the function of full length protein. In addition, expression of Spalt proteins has never been 
studied carefully or comparatively in mouse to ask the question, which Sall genes may 
interact. 
Clean analysis of the effects of a loss of SALL activity requires a well controlled genetic 
system as well as good phenotypic penetrance. Based on the high degree of protein identity 
and limited phenotypes observed in a mouse knockout system I reasoned for possible 
redundancy in function amongst the different Sall proteins in mouse. To assess redundancy, 
expression needs to be taken in account and so I intended to study it in a precise and 
comparative manner. 
The design of this study further included the genetic disruption of each known Sall 
paralog in the mouse genome. Based on the expressional analysis, I intended to study 
phenotypic effects in murine development caused by loss of all Sall activity in the tissue 
under observation. By comparison of several independent developmental systems I intended 
to link Sall function to a general cellular attribute that would be able to interpret several of the 
observed phenotypes caused by mutations in Sall genes. 
This approach generated phenotypes with full penetrance that enables the investigation 
of cellular responses to SALL proteins. As a result, I have identified a novel function for Sall 
genes in maintenance of pluripotency within progenitor populations. 
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Results 
1. Comparison of Sall Proteins 
1.1. Comparative Expression Analysis of Sall mRNA Transcripts in 
Mouse  
In order to get a better overview of all four Spalt like proteins in mouse the decision was 
taken to compare their expression patterns. Due to the high degree of conservation of the 
protein sequence amongst the different orthologs of the spalt family, a genetic loss of function 
analysis of their role in development can only be investigated when taking precise expression 
patterns of all four orthologs into account. Spatially and temporally overlapping expression of 
two or more orthologs could mask the developmental effects of a loss of one Sall gene. 
A comprehensive expression analysis of the mouse spalt-like mRNA transcripts was 
performed by in situ hybridization at various developmental stages. To reach maximal spatial 
resolution and optimal comparability, adjacent histological sections were processed side by 
side for each paralog. Stages analyzed included e6.5 pre-gastrulation implantation sites, e9.5 
post turning embryos, e11.5, e12.5, e13.5, e15.5 and P0 as well as various adult tissues.  
Sall1 transcripts are barely detectable at e6.5 but start to be strongly transcribed shortly 
after. At e9.5, strong expression can be seen in the neuroectoderm (figure 3B). With further 
growth and differentiation of the embryo (e13.5, figure 3E), the transcript is found mainly in 
the central nervous system around the ventricles as well as in pituitary gland, thyroid gland 
and kidney (see insert e15,5 in E). Strongest expression can be seen in the developing 
telencephalon. It is interesting to note that expression within here restricts more and more to 
the ventricular and subventricular regions (figure 3C). Generally it can be said that expression 
is seen in tissues where progenitor populations are expected to reside. Adult tissues do not 
express Sall1 at high levels with exception of the olfactory bulbs. 
 
In contrast to Sall1, Sall2 is expressed more broadly in space and time. Where both 
genes are expressed, levels of Sall2 transcript are generally lower than those seen for Sall1. 
First expression can be seen in the embryo proper region of an e6.5 pre-gastrulation embryo. 
It will then remain expressed all through development within the CNS, but in other tissues 
Sall2 transcript detection fades away between e13.5 and birth. At e15.5 (J, insert), expression  
Sall1 
Sall2 
Figure 03: Comparative expression analysis of Sall1 and Sall2 
In situ hybridisation of Sall1 and Sall2 on cryostat sections. Tissues shown are e6.5 embryos including extraembryonic 
and maternal tissues (A, F), as well as sagittal sections of embryos at stages e9.5 (head region: B, G), e13.5 (E,J), e19.5 (C, H) 
as well as adult ovary (A, F). Autoradiographic staining indicating expression appears white in dark field microscopy. 
Sall1 expression was observed very weakly in the embryo proper at e6.5 as well as in the central nervous system in later 
stages restricting successively to the ventricular zones. Renal expression was observed on lateral sections (inserts in E, J 
are e15.5). Sall2 is expressed in the whole embryo proper from e6.5 onwards with exeption of the liver.
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E F
F G
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J
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Figure 04: Comparative expression analysis of Sall3 and Sall4. 
In situ hybridisation of Sall3 and Sall4 on cryostat sections. Tissues shown are e6.5 embryos including extraembryonic 
and maternal tissues (A, F), as well as sagittal sections of embryos at stages e9.5 (head region: B, G), e13.5 (E,J), e19.5 (C, H) 
as well as adult ovary (A, F). Autoradiographic staining indicating expression appears white in dark field microscopy.  
Sall3 transcript is not present in the adult ovary (D) and only weakly expressed at e 6.5 (A). At later stages, expression was 
detected in brain and spinal cord as well as heart. Kidney with high level of transcript can not be seen on the midline 
section but in the insert taken from e15.5. 
Sall4, the only spalt ortholog expressed in the maturing oocyte (I) and can be detected in all inner cell mass derivatives 
at e6.5 (F). At e9.5 (G) the transcript is still present at high levels in every tissue. from then onwards, expression declines 
and restricts mainly to the liver (J).
Sall3 
Sall4 
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is still visible in the kidney. The only tissue, that Sall2 transcript is excluded from is the liver. 
In adult mice, Sall2 can still be detected in olfactory bulb, hippocampal neurons and 
granulosa cells in the ovary (figure 3I). 
 
Sall3 expression is reminiscent of Sall1 expression (figure 4A-E). First strong 
expression was visualized e9.5. Transcription will then restrict mainly to the CNS again (C, 
E). Notably, only weak expression can be seen in the telencephalon at e13.5 while 
diencephalic and paleocortic precursor cells display active transcription. After completion of 
neurogenesis, Sall3 expression restricts to the ventricular zone of the neocortex at birth (figure 
4C). Like Sall1 and Sall2 the third family member too is expressed in the olfactory bulbs at 
high levels and remains to be also in adult animals. Expression outside the central nervous 
system localizes to heart and mesoderm derived structures in the kidney but not its cortex. 
 
Sall4 differs considerably in temporal expression. For the three other genes, 
transcription peaks around mid-gestation and generally fades out until birth. Sall4 is expressed 
much earlier. Strong expression can already be seen in post implantation embryos. Cells 
staining positive for Sall4 localize to embryo proper, extraembryonic mesoderm and 
extraembryonic endoderm. Post implantation, Sall4 transcription soon starts to be down 
regulated. E9.5 embryos still express high levels of Sall4 but already two days later at e11.5 
transcription disappears in most tissues. In e13.5 embryos expression is weak and remains 
active mainly in the liver (figure 4J). Sall4 thus expresses at high level in tissues that show no 
expression of other spalt genes like extraembryonic mesoderm and extraembryonic endoderm. 
At later stages of development, expression is neither detectable in kidney nor in CNS. In adult 
mice, strong Sall4 transcription was detected in developing oocytes (figure 4I) 
Whether conservation of phenotypes caused by loss of a gene product can be expected 
in different species depends on their expression patterns in vivo. Promoter regions change at a 
higher rate than open reading frames making predictions across species difficult. I therefore 
decided to compare expression patterns as an approximation based on unigene clusters. The 
unigene library contains a big number of expressed sequence tags (ESTs), mapped to genes 
and sorted by the tissue that they were cloned from. Information is publicly available. I 
compared the origins of expressed sequence tags mapping to Sall4 normalized to the total 
number of clones. Data were obtained from unigene webpage based on ESTs included until 
20th of September 2005. 
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Table 1 shows a list of tissues with the relative expression level for each ortholog in 
mouse and human based on EST hits in the respective tissue. A comparison of presented in 
situ data with the abundance of mouse unigene clones indicates that a tendency of expression 
is also represented in unigene cluster quantification. For example mouse Sall1-3 transcripts 
are found in kidney while mouse Sall4 is the only transcript present in liver. Therefore, a 
tendency for expression can be retrieved from this comparison. An overall similarity in 
expression levels between human and mouse can be seen, e.g. Sall4 shows especial high 
abundance in embryonic stem cells in both organisms while all other members are found in 
the brain. Sall1 in humans is not comparable due to a very high number of clones obtained 
from the liver.  
 
 Human Mouse 
Sall1 non cancerous liver tissue:      97.67 soft tissue:                      1.04 
kidney:                           0.32 
pluripotent cell line derived from 
blastocyst inner cell mass:       0.26 
cervix:                           0.18 
liver:                            0.09 
placenta:                         0.08 
other:                            0.08 
muscle:                           0.06 
brain:                            0.05 
Undifferentiated ES Cell:       27.81 
uterus:                         21.49 
unclassified:                   16.40 
Embryonic Stem Cell:            14.54 
brain:                           6.18 
pituitary gland:                 3.33 
other:                           3.23 
kidney:                          2.72 
spleen:                          2.61 
whole body:                      1.70 
Sall2 embryonic stem:                  32.51 Embryonic Stem cells:            10.05 
human embryonic stem cells:       7.34 
peripheral nervous system:        7.23 
pluripotent cell line derived from 
blastocyst inner cell mass:       6.90 
bladder:                          6.34 
thyroid:                          5.76 
small intestine:                  3.96 
pancreatic islet:                 3.83 
brain:                            3.80 
Pituitary gland:                17.08 
eye:                            14.84 
brain:                          13.93 
pancreatic islet:                7.83 
other:                           6.61 
ovary:                           5.29 
mixed:                           4.99 
Embryonic Stem Cell:             4.15 
lung:                            4.12 
lymph node:                      3.93 
Sall3 pluripotent cell line derived from blastocyst inner cell mass:      42.42 
brain:                           15.89 
eye:                              9.47 
kidney:                           7.38 
blood:                            6.80 
other:                            6.62 
prostate:                         6.42 
testis:                           2.86 
skin:                             2.14 
ES Cell:                        30.66 
brain:                          26.07 
kidney:                         22.90 
other:                          10.41 
whole body:                      5.74 
eye:                             4.22 
Sall4 Embryonic Stem cells:            67.58 human embryonic stem cells diff. to an 
early endod. cell type:          18.09 
small intestine:                  5.33 
pluripotent cell line derived from 
blastocyst inner cell mass:       3.09 
other:                            1.77 
testis:                           1.25 
ovary:                            0.97 
muscle:                           0.73 
mixed:                            0.53 
skin:                             0.47 
embryo, late gastrula:          25.73 
Undifferentiated ES Cell:       20.90 
Embryonic Stem Cell:            20.48 
unclassified:                   10.12 
Trophoblast stem cell:           9.14 
Whole body:                      4.02 
pancreatic islet:                2.58 
liver:                           1.47 
other:                           1.32 
heart:                           1.10 
Table 1: Abundance of spalt transcripts among expressed sequence tags (ESTs) in human 
and mouse: Values are normalized to total number of sequenced ESTs from each tissue. 
Data were retrieved from unigene (September 20th, 2005). 
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On a northern blot, expression of human SALL1 has been reported for the fetal brain but 
not the fetal liver. Strong expression could also be observed in adult endocrine organs like 
pituitary gland, adrenal gland and the gonads (Ma et al., 2002). These data fit well with my 
observations in mouse but they contradict the high number of clones unigene retrieved from 
the liver. 
 
1.2. Expression Domains of Spalt-like Proteins Overlap. 
The expression analysis shows, that spalt-like genes strongly overlap in their expression 
profile. At e9.5 all four spalt transcripts are very abundant and widely expressed. Especially 
in the CNS, overlapping expression is seen until birth. At e13.5 to P0 overlapping prominent 
expression is seen in ventricular zones of the central nervous system including the spinal cord. 
Strong expression in the olfactory bulb is observed only in Sall1, Sall2 and Sall3, as opposed 
to a very low abundance of Sall4 transcript in mitral cells (figure 4H) Sall1-3 will still be 
expressed in adulthood. Notably, the roof of the lateral ventricles, giving rise to the neocortex, 
shows expression of Sall1 and Sall2 while Sall3 expression is weak. A strong overlap of 
expression of Sall1-3 can also be observed in the developing kidney. 
Sall4 is expressed earlier than the other three Sall members and is detected already in 
female gametes. At e6.5 and e9.5, the expression level exceeds that of the paralogous 
transcripts.  
To understand the developmental processes, in which spalt genes are involved in vivo, 
organ systems of prominent spalt expression like the brain were studied. This approach was 
complicated by the fact that high levels of expression coincided with a high degree of 
coexpression with other members of this transcription factor family. It has been suggested 
before, that Spalt proteins have redundant functions due to the high degree of sequence 
similarity. To overcome a potential masking of the loss of function phenotype by the presence 
of other members of the spalt family it was thus necessary to have null alleles for each spalt 
gene available and to delete all Spalt activity in the tissues examined. 
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2. Generation of Mouse Lines 
Previous to the presented study, a mouse line genetically null for Sall1 had already been 
generated by our lab (Mathias Treier, unpublished). The second exon of Sall1 had been 
excised and the sequence was replaced by enhanced green fluorescent protein (EGFP) fused 
in frame to the remaining amino acids of Sall1. 3´ to that in the transcript is an internal 
ribosomal entry site (IRES) and lacZ encoding for β-galactosidase. Such a setup should 
enable me to visualize cells expressing this bicistronic construct either through GFP or an 
enzymatic colour reaction of β-galactosidase in a cellular resolution. I will herein refer to this 
allele as Sall1-lacZ. 
Mice heterozygous for Sall3 (Parrish et al., 2004) were provided by Prof. Dr. Schütz, 
DKFZ Heidelberg, as frozen blastocysts and rederived by the EMBL transgenic service. The 
lacZ fused to the Sall3 coding region only results in very weak expression of β-galactosidase. 
I will refer to this allele as Sall3-lacZ 
 
2.1. Knockout Vector Design for Sall2 
In order to obtain a Sall2 null allele, the genomic region of Sall2 was cloned. I screened 
a chromosomal mouse BAC (bacterial artificial chromosome) library with a Sall2 exon two 
probe and identified three BAC clones that contained the Sall2 genomic region, the 
identification numbers are 15P22, 137K18 and 177B13. A seven kilobase PstI fragment as 
well as a twelve kilobase XbaI fragment was subcloned and used for further assembly of the 
Sall2 knockout vector. 
The coding sequence for Sall2 is distributed on two exons with 24 amino acids being 
encoded on the first exon. It is therefore reasonable to assume that a deletion of the second 
exon will result in a genetic null allele. Facilitating an AgeI site at the 5´end of exon two, it 
was possible to generate a vector that terminates the Sall2 open reading frame (ORF) after 61 
amino acids (figure 5). The C2HC amino-terminal zinc finger is just encoded within the first 
exon and the few amino acids remaining from exon two. The glutamine rich domain and all 
double zinc-finger motifs are encoded on the second exon and will be deleted. The knockout 
vector contained a positive selection cassette conferring neomycin resistance flanked by loxP 
sites, a negative selection marker encoding diphtheria toxin A to select against random 
integration events, a 5820 base pair 5’ arm and a 4153 base pair 3’ arm, to enable homologous  
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Figure 05: Targeting strategy for Sall2-lacZ. 
A) Exon two carries the coding sequence for the glutamine repeat as well as all double zinc fingers. A replacement vector 
carried an IRES-lacZ as well as a positive selection cassette (PGK-Neo) between the two arms. Homologous recombina-
tion resulted in genetic removal of exon two and introduces a lacZ allele. Cre-mediated excision of PGK-Neo generated 
the allele termed Sall2-lacZ.
B) Screening for homologous recombination was done by digestion of genomic DNA with SpeI and subsequent south-
ern blotting and probing with a probe 5´external to the 5´arm (grey box).
C) Interbreeding mice heterozygous for Sall2-lacZ revealed that Sall2 loss does not lead to any obvious phenotype in 
an experimental environment. Genotyping done with the primers indicated in A.
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recombination. The restriction sites used to clone the 5´and 3´arm were EcoRV-AgeI and 
PstI-PvuII respectively. Inserting an IRES lacZ cassette into the remaining transcript enables 
expression analysis of the Sall2 locus.  
 
2.2. Establishment of a Mouse Line Carrying a Sall2 Null Allele 
The knockout vector was electroporated into IB10 embryonic stem cells (ES cells). 
G418 resistant clones, which had incorporated the knockout vector, were picked after 10 days 
of selection and cultured individually in a 96 well plate. To screen the ES-cell clones for 
homologous recombination at the Sall2 locus, clones were split in two replicas, expanded and 
DNA was purified from one replicate. A Southern blot strategy was devised based on a SpeI-
AseI digest followed by hybridization with a 3’ external probe as shown in figure 5. A total of 
240 ES cell colonies were picked. One clone had undergone positive homologous 
recombination at the Sall2 locus resulting in a shift of the band containing the Sall2 locus 
from 16 kilobases to 12 kilobases.  
 
Chimeric male    X  C57BL6/J, 2 females 
  
Agouti heterozygous male  X  C57BL6/J, 2 females Deleter- 
        Cre or Deleter-FlpE 
 
Agouti knockout-, Deleter-  X  C57BL6/J, 2females 
heterozygous male 
 
Knockout line after removal of selection cassette and Deleter-Cre/FlpE 
Table 2: Breeding scheme illustrating the sequence of crossings to remove selection 
cassettes used for positive selection in cell culture. To enable genetic excision, selection 
markers are located between loxP or FRT sites, recognized by recombinases Cre-
recombinase and flippase respectively. For the Sall2-lacZ and Sall4-GFP allele, cassettes 
were removed with Cre; FlpE recombination was used for Sall4-loxP. 
 
The clone was expanded, trypsinized and always twelve ES cells were injected into one 
of approximately 50 e3.5 blastocysts by the EMBL transgenic facility and all living 
blastocysts were subsequently transferred into pseudopregnant females to obtain chimeric 
animals. Male chimeras that had high contribution of the injected ES cells, which is reflected 
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by a high agouti to black coat colour ratio, were bred to black Bl-6 females. Agouti offspring 
indicates contribution of the modified ES cells to the germ line and those pups were screened 
for the presence of the engineered Sall2 allele. Heterozygous animals were then bred into a 
Deleter-Cre line (Schwenk et al., 1995), a mouse strain expressing bacterial Cre recombinase 
in the germ line.  
The positive selection cassette used for targeting Sall2 is flanked by loxP sites, which 
are 34 base pair recognition sites for Cre recombinase. In mice carrying a Sall2 allele and the 
Deleter-Cre transgene, recombinase will excise any sequence between tandemly repeated 
loxP sites in the germ line. Mice heterozygous for both engineered alleles were subsequently 
bred back to wild type to obtain the desired final genotype. Thus, a replacement of the second 
exon of Sall2 by a traceable marker with minimal further modifications in the genome was 
achieved. Successful recombination was analyzed by PCR; the allele will be called Sall2-lacZ 
from here on. 
 
2.3. Mice Mutant for Sall2 are Viable and Fertile 
Intercrossing mice heterozygous for Sall2 resulted in 25% homozygous offspring (figure 
5C). These mice were viable and showed no obvious phenotypes even at close examination, 
neither in Bl-6 nor in Bl-swiss background. The life expectancy is not altered. Furthermore, 
breeding pairs of individuals lacking the Sall2 gene had normal litter sizes. It thus had to be 
concluded that Sall2 function is not necessary for mice in the experimental environment, 
possibly due to expression of other Sall members with redundant function. 
 
2.4. EGFP Knockin of Sall4 
The exon-intron structure of Sall4 also suggested that deletion of almost the entire 
second exon would result in a null allele. Similar to the strategy used for Sall2, a BAC library 
was screened, to identify a clone containing the genomic region of Sall2. The 5´ and 3´ arms 
used for homologous recombination were subcloned with SalI-AgeI and SpeI-KpnI 
respectively and assembled to a knockout vector. Positive and negative selection was 
facilitated by the same neomycin and diphtheria toxin A cassettes. The arms used for 
homologous recombination had a length of 2646 and 4261 base pairs respectively and would 
result in a remaining open reading frame encoding for 58 amino acids thereby deleting all zinc  
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Figure 06: Targeting strategy for Sall4-GFP. 
A) Exon two carries the coding sequence for the glutamine repeat as well as the first two double zinc finger motifs. A 
replacement vector carried IRES-GFP as well as a positive selection cassette (PGK-Neo) between the two arms indicated 
in A. Homologous recombination resulted in genetic removal of exon two and introduces a GFP allele as well as a 
transcriptional stop codon preventing transcription of downstream exons. Cre-mediated excision of PGK-Neo generated 
the allele termed Sall4-GFP.
B) Screening for homologous recombination was possible by digestion of genomic DNA with XbaI and subsequent 
southern blotting and probing with a probe 5´external to the 5´arm (grey box).
C) Successful deletion of the Neoomycin resistance cassette as well as further genotyping utilized the primers indicated 
in A. The 520 basepair band is indicative of the wildtype allele, a 400 basepair band is amplified from Sall4-GFP.
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fingers including the one of the H2CH type at the N-terminus. A transcriptional stop signal 
should prevent transcription of exons three and four, thereby excluding alternative splicing. 
Knowing that Sall4 was expressed very early in development a high resolving nuclear 
labelling of Sall4 to label expressing cells seemed important. I therefore designed an IRES-
Histone2b::EGFP cassette and inserted it into the Sall4 knockout vector after testing it in cell 
culture. This resulted in enhanced green fluorescent protein incorporated in the chromatin of 
all cells expressing Sall4. 
Electroporation of embryonic stem cells resulted in 110 colonies that were picked, 
cultured and analyzed for recombination using an outside probe southern blot strategy shown 
in figure 6. DNA was digested with XbaI, separated by gel electrophoresis, blotted and the 
Sall4 locus was screened with a 5´outside probe. Seven clones that had undergone 
homologous recombination were detected and Histone2b::EGFP expression assayed. Cells of 
two independent clones were transferred into wild type blastocysts. High percentile chimeras 
were taken through the same breeding scheme as Sall2-lacZ to remove the positive selection 
cassette. PCR analysis revealed successful deletion and the engineered allele was called Sall4-
GFP. 
 
2.5. Conditional Knockout of Sall4 
As discussed before, Sall4 is expressed very early and the expression is largely not 
overlapping with other members of the spalt-like family. This raised the possibility of a very 
early lethal phenotype in mice homozygous null for Sall4. Early phenotypes are often difficult 
to analyze. It appeared indicated to account for this by the generation of a conditional allele to 
be able to delete Sall4 in a time- and tissue-specific fashion (figure 7). In this approach, the 
second exon of Sall4 was flanked by loxP sites (floxed) to allow its controlled genomic 
deletion upon expression of Cre recombinase. This would leave only 39 amino acids of 
coding sequence prior to exon two behind. Possible splicing of exon one into exon three upon 
deletion of exon two would generate a protein lacking the N-terminal zinc finger required for 
histone deacetylase binding as well as the glutamine repeat and two of the three double zinc 
finger motifs suggesting that such a protein would be non-functional. The positive selection 
marker was surrounded by Flippase Recombination Targets, FRT sites, to allow deletion by 
flippase (FlpE).  
Subsequent to the establishment of 159 stable transfected R1 ESC clones through G418 
selection, a southern blot identified six clones that had inserted the neomycin resistance  
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Figure 07: Targeting strategy for Sall4loxP. 
A) Exon two carries the coding sequence for the glutamine repeat as well as the first two double zinc finger motifs. 
Floxing the second exon was chosen as a strategy to interfere with Sall4 function . Homologous recombination distal to 
either loxP site resulted in the insertion of a loxP site plus positive selection marker 5´and a loxP site 3´to the exon. FlpE-
mediated excision of PGK-Neo generated the allele termed Sall4-loxP.
B) Screening for homologous recombination was possible by digestion of genomic DNA with XbaI and subsequent 
southern blotting and probing with a probe 5´external to the 5´arm (grey box).
C) Successful deletion of the Neomycin resistance cassette as well as further genotyping utilized the primers 1F and 1R.
D) Deletion of Sall4 exon 2 can be assayed by primers 1F, 1R and 2R, the highest band at 500 basepairs is indicative of 
successful deletion.
E) Mice carrying a floxed as well as a deleted allele for Sall4 are viable showing that Sall4-loxP functions as a wildtype 
allele.
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cassette into the Sall4 locus by means of homologous recombination (see figure 7B). In such a 
conditional knockout approach recombination 3´ to the neomycin selection cassette could 
occur either proximal (within exon two) or distal (in the 3´ arm) to the second loxP site. Only 
a recombination event distal to the loxP site would integrate it into the chromosome, a 
prerequisite for subsequent Cre mediated recombination. A PCR strategy was used to test the 
identified clones for the presence of the 3´loxP site. The primers S4loxP2-F and S4loxP2-R 
anneal to either side of the second loxP site and generated an amplicon of 230 base pairs on 
wild type DNA or one increased to 270 base pairs by the insertion of additional sequence. The 
amplicons were analyzed by gel electrophoresis. Of the six clones tested only one (#A12) had 
recombined distally and thus integrated both loxP sites.  
Cells of this clone were injected in blastocysts and taken through the breeding scheme 
indicated in table 2 using the mouse line hACTP-FlpE expressing FlpE in the germline 
(Rodriguez et al., 2000). Deletion was assayed by PCR. The presence of a second band in 
addition to the wildtype band is indicative of excision of the selection marker (figure 7C). 
 
2.6. The Floxed Sall4 Allele is Functional. 
In order to be able to use the floxed Sall4 mouse line, I tested if the inserted loxP sites 
interfere with the normal function of Sall4 as well as if the second exon of Sall4 could be 
efficiently excised by Cre recombinase. Two breedings provided proof for the genetic 
functionality of the floxed Sall4 allele. 
First, heterozygous floxed mice were mated to the Deleter-Cre line as it had been done 
for the other alleles (see table 2). This efficiently deleted exon 2 of Sall4 from the genome 
(figure 7D) of mice heterozygous for the generic Sall4 allele and Deleter-Cre. Excision was 
shown by the presence of a 500 base pair PCR amplicon with primers S4loxP1-F and 
S4loxP1-R on genomic DNA. It shows that the loxP sites were recognized by Cre 
recombinase and sequence between was deleted efficiently. This breeding also generated a 
second null allele similar to Sall4-GFP. The new allele was termed Sall4-deleted.  
Secondly, to address whether the floxed Sall4 locus was still able to produce Sall4 
protein, mice heterozygous for the floxed allele were intercrossed and genotyped. Offspring 
homozygous, heterozygous and wild type for Sall4 was seen in the expected ratio. This argues 
either that Sall4 loss of function does not affect viability or that the introduction of loxP sites 
into intron one and two does not affect transcription and processing of the mRNA. The Sall4 
loxP mutation was subsequently maintained in a homozygous strain. To validate that Sall4-
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loxP does not interfere with viability, Sall4-loxP homozygous mice were bred to a mouse 
heterozygous for Sall4-deleted. Genotyping pups at weaning age (figure 7E) revealed the 
expected 50% of animals that carried a null allele over a floxed allele. This serves as a proof 
that Sall4-loxP does not cause a major phenotype and also no other lethal mutations are 
present in the Sall4-loxP strain. 
 
2.7. Breeding and Strain Maintenance 
Sall2-lacZ as well as Sall4-loxP alleles are homozygous viable and are therefore kept 
homozygous. Sall1-lacZ, Sall3-lacZ and Sall4-GFP are maintained heterozygous, bred to 
wildtype mice each generation and offspring is genotyped.  
In order to be able to analyze compound knockouts of Sall1 or Sall3 together with Sall2, 
these mutations were bred on a Sall2 null background through two generations. Sall2 null 
mice were used as controls for further analysis of the Sall1 and Sall3 alleles since loss of Sall2 
shows no phenotype in the genetic and environmental background tested. Crossing of Sall1-
lacZ animals with Sall3-lacZ lines also generated mice double heterozygous for Sall1 and 
Sall3. These lines were intercrossed both on a Sall2 wildtype as well as on a Sall2-lacZ 
background. 
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3. Sall4 is Required for Periimplantation Development 
In contrast to the overlapping expression of Sall transcription factors in the brain, early 
expression in the inner cell mass derivatives of extraembryonic endo- and mesoderm is unique 
to Sall4. Thus the effect of a deletion of Sall4 can not be masked by redundancy with other 
Sall genes. If Sall activity is required for early stages of development, an early phenotype 
would be expected. 
3.1. No Homozygous Embryos were Found at e10.5 
To analyze the effects of a loss of Sall4 on murine development, heterozygous Sall4-
GFP mice were interbred. Genotyping the offspring revealed that Sall4 knockout mice were 
not born alive. Subsequently, the onset of pregnancy was determined by vaginal plug check. 
To find out whether Sall4 deficient embryos successfully undergo implantation, gastrulation 
and turning, 55 embryos were collected 10.5 days post coitum. At this age, genotyping of a 
normally developed embryo can be achieved by PCR analysis. Embryonic tissue was 
carefully separated from maternal tissue and DNA was purified. Wildtype and heterozygous 
embryos were found at the expected ratio but no embryos homozygous for Sall4-GFP could 
be detected. Consistent with this, a high number of small, empty implantation sites were 
observed. Genotyping of absorbed embryos or empty implantation sites is not possible by 
PCR due to the mixing of maternal, heterozygous tissue with the embryonic tissue of interest. 
Thus, amplicons indicative for both alleles would always be detected. It was therefore 
speculated that these empty implantation sites were due to embryos homozygous for Sall4-
GFP. To support this assumption, embryos were collected at e3.5, prior to implantation into 
the uterus, and genotyped by PCR. Roughly one quarter of the blastocysts collected from an 
interbreeding of Sall4-GFP heterozygous animals was genotyped to be Sall4 deficient. It was 
conducted that termination of development is occurring later than e3.5 and significantly 
before e10.5. 
 
3.2. Generation and Testing of an Antibody Raised Against Murine 
Sall4 
The presence of empty implantation sites suggests that Sall4 deficiency does indeed lead 
to early embryonic lethality as it was hypothesized from comparative expression studies.  
Sall4
actin
Figure 08: Testing of peptide antibodies generated against Sall4;  Quantitanive differences in GFP 
intensity of e3.5 blastocysts enable separation of genotypes 
A) Testing of sera obtained from SG-2671 till SG-2674.  Equal amounts of protein extract from ES cells was loaded on an 
acrylamide gel, run, blotted and each lane was incubated independently in preimmune serum and third boost serum 
(1:1000). Animals SG-2673 and SG-2674 were injected with the C-terminal peptide and do not show immunoreactivity. 
SG-2671 and SG-2672, immunized against the N-terminal peptide show robust immunoreactivity against Sall4.
B) Nine blastocysts in nomarski optics (left) and GFP bioluminescence (right). Blastocysts are sorted according to GFP 
intensity into strong (left column), medium (center column) and no GFP signal (right column).
C) Subsequent to sorting, RNA was purified from 15 individual blastocysts and analyzed for presence of Sall4 transcript. 
Equal amounts of RNA were successfully purified, reverse transcribed and can be used for PCR as seen by the strong band 
obtained in all samples with primers specific for actin RNA. The eight blastocysts quantified to show strong GFP expres-
sion did indeed not contain Sall4 mRNA;
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More detailed analysis of Sall4 protein distribution was required to interpret the observed 
defects. GFP expression in the knockin of H2b::EGFP into the Sall4 locus gives a good 
indication of Sall4 expression in heterozygous animals but protein stability and translational 
control of the mRNA transcript are not addressed. High levels of Sall4 expression had been 
observed by in situ hybridization in developing oocytes. This opened possibility that maternal 
contribution of protein could affect development in a Sall4 knockout blastocyst. To address 
Sall4 protein presence, an antibody recognizing Sall4 was required.  
The decision to generate antibodies against mouse Sall4 was taken. Peptides identical to 
the N- and C-terminus of Sall4 were synthesized commercially and used to immunize two 
rabbits each. Affinity of antibodies present in the serum was analyzed by western blots after 
the third bleed. While the C-terminal peptide did not result in an antibody recognizing murine 
Sall4, both rabbits immunized with the N-terminal peptide show robust immunoreactivity 
against full length endogenous protein (figure 8A). Antibodies were affinity purified after the 
5th boost and tested in immunohistochemistry. Optimal dilution was determined to be 1:1000 
in immunofluorescence and immunohistochemistry as well as 1:5000 for western blotting. 
 
3.3. Precise Expression Analysis for Sall4 
It had already been established by in situ hybridization that Sall4 transcript is present in 
mature oocytes and e6.5 implantation sites until mid gestation. Protein expression studies thus 
spanned all embryonic stages until e10.5 (figure 9). Protein could be visualized from cleavage 
stage embryos continuously until e8.5 embryos where levels start to decrease. In oocytes as 
well as in all other cell types examined, Sall4 is localized in the nucleus. High magnification 
of fluorescent immunostainings shows localization in distinct spots within the nucleus. 
Expression can still be detected at two cell stage and is likely due to maternal contribution of 
protein and mRNA (figure 9A). In cleavage stage embryos, expression of Sall4 is again seen 
at 16 cell stage and can subsequently be visualized in all blastomeres. Expression of a paternal 
Sall4-GFP allele also starts at morula stage, e2.5, in all blastomeres, arguing for an onset of 
zygotic Sall4 expression at the 16 cell stage. Blastocysts at e3.5 start to show higher level of 
expression in the inner cell mass while the trophoblast still expresses considerable amounts of 
Sall4. After expanding blastocysts in culture for 24 hours, Sall4 is expressed stronger in the 
inner cell mass stem cells than in the surrounding trophectoderm but expression is still visible 
in all cells. 
 
Figure 09: Sall4 expression at periimplantation stages
Analysis of Sall4 expression by immunofluorescence (A-D), immunohistochemistry (E-H) and in situ hybridization (I-L). 
Maternal Sall4 protein is still detectable at the two cell stage (A) prior to zygotic transcription. The first zygotic transcrip-
tion is visible between 8 and 16 cell stage (B), will be ubiquitously expressed in early blastocysts (C) and localize mainly 
to the inner cell mass in expanded blastocysts (D). At early postimplantation stages e6.5 (E), e7.5 (F), specific expression 
in the inner cell mass (ICM) including embryo proper (EP), extraembryonic mesoderm (EM) and exrtaembryonic enco-
derm (visceral: VE, parietal:PE) reaches completion (GC: giant cells of the trophoblast; EE: extraembryonic ectoderm). Data 
obtained by antibody staining were confirmed using in situ hybridization. Sall4 transcript is exclusively found in the inner 
cell mass of a blastocyst ouwtgrowth in culture (I), an embryo e6.5 (J) and e11.5 (K).  H and L show expression in maturing 
oocytes at P3 (H, top) and eight weeks of age (H, bottom and L); 
M) differentiation of wildtype ESCs by withdrawl of LIF and addition of retinoic acid results in a decrease of Sall4 and Oct4 
present. Tubulin was used as a loading control.
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Post implantation at e6.5, expression is seen in embryo proper and primitive endoderm 
exclusively. All these tissues are ICM derivates. The primitive or extraembryonic endoderm 
surrounds the epiblast cells and forms an epithelium all around the blastocoel separating 
apolar epiblast cells from the lumen of the blastula. Sall4 protein abundance is similar in all 
ICM cell types. At e7.5, all three embryonic germlayers can easily be recognized to express 
Sall4. Extraembryonically, Sall4 immunoreactivity is visible in allantois and chorion of the 
extraembryonic mesoderm as well as in visceral and parietal primitive endoderm. 
 Cells of the trophectoderm lineage comprise two cell types, polar (extraembryonic 
ectoderm, EE) and mural trophectoderm (giant cells, GC). In the presence of FGF4 (fibroblast 
growth factor 4) secreted from the ICM, trophoblast cells remain proliferative as polar 
trophectoderm. Without the stimulus of this growth factor trophoblast cells will undergo 
endoreplication and form postmitotic, polyploid giant cells (Tanaka et al., 1998). Both cell 
types do not express Sall4 protein at detectable levels. The expression in the embryo is 
regulated down upon onset of differentiation at e8.5 but expression is still detected in embryo 
proper, extraembryonic mesoderm as well as in visceral and parietal primitive endoderm. At 
this stage, all membranes surrounding the embryo are fully developed and show strong 
immunoreactivity while the developing placenta still shows only very faint expression. In 
figure 9 I-L in situ hybridization is visualizing transcripts enzymatically (I, J) or 
radiographically (K, L). Expression of transcript and protein fully overlaps and confirms the 
data obtained from immunostaining. In figure 9I, a blastocyst outgrowth (BO) is shown 
expressing Sall4 in the ICM exclusively. A BO is a blastocyst attached and grown on a 
surface for five days (see also below). 
Sall paralogous proteins show strong correlations of expression of in stem cell pools of 
ventricular zones of the brain and in early embryos. I next wanted to know if Sall4 expression 
is linked to an undifferentiated state of pluripotency. If such a connection can be made, 
expression levels of Sall4 should drop quantitatively upon induction of differentiation in ES 
cell culture. The transcription factors nanog and Oct4 had previously been shown to be 
required for stem cell identity. Protein abundance of these stem cell factors is known to drop 
in differentiation assays of embryonic stem cells (Boyer et al., 2005). 
ES cells were plated at very low density on feeder free 10cm culture dishes in ESC 
medium and kept in culture for seven days. Medium was exchanged every day. Each day, 
colonies of one more plate were deprived of ESC medium and medium was replaced by 
differentiation medium containing all-trans retinoic acid at 100 nMol/liter. Removal of LIF 
from ES cell medium together with the addition of retinoic acid induces differentiation of 
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ESCs (Gribnau et al., 2005). Protein levels of Sall4 and Oct4 were analyzed by western blot. 
Equal protein loading was assured by reprobing the membrane against tubulin. 
Figure 9M shows strong immunoreactivity against Sall4 and Oct4 protein in an ES cell 
lysate. Both protein levels decrease upon LIF withdrawal to a similar extend as well as with 
comparable kinetics. Reduction of Sall4 expression could thus be linked to differentiation in 
embryonic stem cells. Whether loss of Sall4 is sufficient to inhibit ESC self renewal was then 
analyzed in vivo as well as ex vivo utilizing the previously generated Sall4-GFP allele. 
 
3.4. In Vivo Analysis of Embryos Deleted of Sall4  
Sorting Embryos at Blastocyst Stage 
Since no Sall4-GFP homozygous embryos could be found at e10.5 and initial analysis 
revealed presence of blastocysts homozygous for Sall4-GFP, I wanted to establish their 
developmental potential prior to e10.5. Heterozygous Sall4-GFP animals were interbred and 
cleavage stage embryos, morulas and blastulas of superovulated females were collected at e 
0.5 to e3.5 by flushing oviduct and uteri. Presence of Sall4 knockout embryos was established 
by different methods. 
During the handling of embryos it was observed that three distinct classes of GFP 
intensity are present in blastulas. While 50% of the observed blastulas repeatedly showed 
weak signal, 25% showed no fluorescence and another quarter appeared bright green. 
Intensity of GFP signal thus seems to depend on the number of Sall4-GFP alleles inherited. 
The observed ratio is in accordance with expected Mendelian allele distribution in an 
interbreeding of animals heterozygous for Sall4-GFP. 
To verify that Sall4 knockout animals were present and developed comparably to 
wildtype until e3.5, blastocysts were genotyped with a PCR reaction using genomic DNA of 
blastocysts as template. Indeed, knockout animals were still present. Subsequently, I sorted 
embryos according to the intensity of the detected GFP signal and prepared RNA from single 
blastocysts. Reverse transcription and PCR showed that in embryos with strong GFP-
fluorescence, no Sall4 transcript can be amplified as presented in figure 8C. Actin mRNA 
could be detected at equally high levels in all embryos serving as control for successful RNA 
preparation and in vitro reverse transcription on single blastocysts. I therefore concluded that 
loss of Sall4 does not affect development prior to implantation after e3.5. In addition this 
result clearly proofs, that no maternal mRNA is contributing to Sall4 protein in blastocysts 
homozygous for Sall4-GFP. 
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Secondly, immunostaining against Sall4 revealed that in one fourth of the embryos no 
Sall4 protein could be detected. While Sall4 protein is detected in 16 cell wildtype littermates, 
no protein can be detected in Sall4-GFP embryos at this stage (figure 10 A-D) and thereafter. 
At e3.5 when GFP signal allows reliable sorting of animals, Sall4 protein was detected in all 
wildtype and heterozygous embryos while no Sall4-GFP homozygous animals show 
detectable staining (figure 10E-H).  
Sorting embryos by fluorescence intensity prior to genotyping revealed that the GFP 
signal is indicative of the genotype. For further studies, from then on blastocysts were 
routinely sorted as described. No inconsistencies in the phenotype were observed in the 
analysis. Thus sorting embryos based on GFP intensity is a precise method to identify Sall4 
knockouts. 
No Sall4 protein can be detected at 16 cell stage in a knockout. A phenotype due to the 
loss of Sall4 should thus manifest until the expanded blastocyst stage if Sall4 is required at 
preimplantation development. I asked whether these embryos show any effect due to the 
absence of Sall4 in expanded blastocyst stage by immunofluorescent staining. 
 
Immunohistochemical Analysis of Expanded Blastocysts. 
Blastocysts were collected at e3.5, sorted and kept in culture for 24 hours. In this period 
they will undergo one more round of cell division resulting in a total of around 128 cells and 
also hatch from the protective zona pellucida. Further internalization of fluid by the 
trophoblast results in an increased volume of blastocoel surrounded by a thin layer of mural 
trophectoderm. These blastocysts roughly resemble e4.0 blastocysts at the time of 
implantation in utero.  
Three cell lineages can be found in an e3.5 blastocyst, trophoblast and the ICM 
containing embryonic stem cells or ES cells as well as primitive (extraembryonic) endoderm. 
Markers indicative of the different cell types present at this stage were used to screen for 
phenotypic aberrations in embryos depleted of Sall4. Counterstaining with DAPI revealed the 
morphology of blastocysts. This method also shows that overall cell number of expanded 
blastocysts does not differ from wildtype. 
Oct4 protein is expressed in all cells of the early blastocyst but restricts to the inner cell 
mass after 24 hours of culture (Nichols et al., 1998). Staining Blastocysts with Oct4 antibody 
revealed no differences between Sall4 knockout and control. This suggests that loss of Sall4 
does neither prevent inner cell mass specification nor Oct4 transcription. Active translation of 
Oct4 also indicated viability of inner cell mass cells. 
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As opposed to Oct4, Nanog is expressed only in the epiblast but excluded from the 
primitive endoderm in the inner cell mass (Mitsui et al., 2003; Yamaguchi et al., 2005). 
Immunostaining Sall4 negative blastocysts for Nanog expression also revealed no differences. 
The trophoblast lineage was successfully established in Sall4 knockout animals as seen 
by the morphology of the blastocyst (figure 8B). Only if cells form an epithelial sheet 
surrounding the inner cell mass, polarize successfully and form tight junctions can they pump 
in fluid to form the blastocoelic cavity. In accordance to this, TROMA, an antibody 
recognizing cytoskeleton of the trophoblast lineage (Nichols et al., 1998), labels the 
trophoblast also of Sall4 deficient blastocysts without recognizable differences to wildtype 
blastocysts. In the inner cell mass, no TROMA epitopes can be recognized. 
Another molecule expressed in the trophoblast is the homeobox transcription factor 
Cdx2 (Strumpf et al., 2005). It is the first known marker for the trophoblast lineage in mouse 
and starts to be differentially expressed already in compacting morulas. Immunostaining 
Sall4-deleted expanded blastocysts with an antibody against Cdx2 revealed that - like in the 
wildtype - Cdx2 is localized to trophoblastic nuclei and excluded from the ICM. Overall 
expression levels observed in the knockout were reproducibly higher than in wildtype 
littermates.  
 In conclusion, blastocysts deleted of Sall4 do not show gross phenotypic effects, are 
seen at the expected ratio and are not developmentally delayed. All cell lineages are present 
based on the analysis of molecular markers suggesting that Sall4 is not required for the 
establishment of early lineages in the mouse blastocyst. 
One possibility is that maternal protein is still present until blastocyst stage and might 
prevent an earlier onset of a Sall4 deletion phenotype. To answer that question, a conditional 
knockout of Sall4 specifically in maturing oocytes was generated using a Gdf9-Cre line (Lan 
et al., 2004). Oocytes from these females do not accumulate Sall4 protein. I intended to 
compare development of blastocysts from such a breeding to blastocysts from a GFP 
interbreeding. However, females with Sall4 deleted oocytes were completely sterile. Even 
after hormonal stimulation, plugged females had not ovulated. Sectioning ovaries revealed the 
absence of preanthral follicles showing that Sall4 deleted oocytes fail to mature underlining 
the importance of Sall genes for development. 
 
 
 
 
Figure 10: Analysis of expanded blastocysts deleted of Sall4. 
A-H) No Sall4 protein can be detected in cleavge stage till blastcyst stage Sall4 knockout embryos. While Sall4 protein 
can be detected in wildtype blastomeres (A, B), no signal is detected in immunostainings with an anti-Sall4 antibody on 
morulas or blastulas at 16 cell stage (C, D), early blastula (E, F), or expanded blastula (G, H). Nevertheless, blastocysts reach 
full size at e3.5 plus 24 hours in culture and show no delay compared to littermates.
I-N) Comparative immunostainings on littermates wildtype or deleted of Sall4. Blastocysts G-N were collected at e3.5 
and kept in culture for 24 hours to allow full development to occur. No significant change of expression domains was 
detected for Cdx2, TROMA, Nanog or Oct4. In both genotypes, Cdx2 and TROMA positive cells are observed in the 
trophoblast while the inner cell mass labels for Nanog and Oct4. Expression levels of Cdx2 in the trophoblast were always 
ehanced in the knockout (L). 
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Histological Analysis at e6.5 and e7.5 
Determining the developmental potential post implantation is complicated by the fact 
that even wildtype embryos can not easily be genotyped prior to e 7.5. It was known from the 
analysis at e10.5 that no embryos form in the knockout and thus no tissue could be retrieved 
for genotyping. To overcome this problem and to show that Sall4 knockouts are absent post 
implantation rather than the negative result of a failure to identify knockout animals, 
blastocysts were collected at e3.5 from superovulated females. After sorting the embryos 
according to their GFP intensity, batches of 7-15 blastocysts for each genotype were 
transferred into separate pseudopregnant females 2.5 days post coitum. Litters were harvested 
at e6.5 and e7.5 and processed for paraffin sectioning. Periodic Acid-Schiff Reagent (PAS) 
staining several implantation sites for each genotype revealed a dramatic difference between 
knockout and control litters. While in control transfers all or almost all implantation sites 
carried an embryo of expected morphology, no such embryo was seen in any of the knockout 
litters analyzed. Instead, at e6.5 the implantation site was empty containing only scattered 
cells. Close Examination of the edges of the implantation site cavities revealed the presence of 
few very big cells with huge nuclei, characteristic of trophoblast giant cells (figure 11A, E: 
asterisk). This suggested that knockout blastocysts hatched successfully from the zona 
pellucida, implanted in the uterine wall and embryonic giant cells responded to the 
implantation adequately. At e7.5, hardly any embryonic cells could be identified from 
implanted knockout embryos. 
 
Lineage Marker Analysis on Implantation Sites 
To determine which embryonic cell types are still present in e6.5 implantation sites, in 
situ hybridization was used. H19 is a non-coding RNA expressed at high levels in all 
embryonic (as opposed to maternal) cell types but the embryo proper (Avilion et al., 2003; 
Mitsui et al., 2003). Figure 11C illustrates H19 expression in trophoblast and extraembryonic 
endoderm in the wildtype control. In implantation sites of Sall4 knockout animals, H19 
staining is still seen surrounding the cavity. This is presumable due to the presence of primary 
giant cells and serves as a further proof that implantation occurred. 
Oct4 expression is mutually exclusive with H19 and found in all cells of the embryo 
proper at this stage (Avilion et al., 2003; Mitsui et al., 2003). In situ hybridization for Oct4 
revealed that no cells of embryo proper identity are present in the case of a Sall4 knockout at 
e6.5 (F).  
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Figure 11: No inner cell mass (ICM) derivatives can be identified in Sall4 knockout embryos post 
implantation.  
PAS staining (A, E, I, M) on reimplanted, pregenotyped embryos wildtype and deleted of Sall4 shows, that implantaion 
sites appear empty in foster mothers pregnant with Sall4-/- embryos. While residual cells (giant cells: asterisk) can be 
seen at e 6.5 (E),  embryonic cells are rarely observed in e7.5 implantation sites (M). Reimplanted control embryos grow 
normally arguing that the sorting procedure does not  disturb the development of the embryos.
In situ hybridization was used to label individual cell lineages expected at e6.5 and 7.5 to test which cell lines are affected 
in the knockout. No cells of the embryo proper (EP) expressing Oct4 were observed in the knockouts (F) while strong 
H19 staining (G)  is visible in giant cells (F); Cited is expressed in secondary giant cells (+) and cells of the visceral primi-
tive endoderm (VE) at e6.5 (D,H) and e7.5 (L, P). An overabundancy of secondary giant cells in knockouts is observed. 
Neither visceral (VE) nor parietal (PE) endoderm is present in Sall4 deleted implantation sites at e7.5 as shown with in 
situ probes against Villin, Sparc and Cited. extraembryonic ectoderm (EE); 
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To distinguish between the two H19 expressing cell lineages, trophoblast and primitive 
endoderm, I performed in situ hybridization with markers indicative of primitive endoderm. 
While Hnf-4 (Taraviras et al., 1994) and Villin (Maunoury et al., 1988) are expressed in the 
visceral primitive endoderm located on the surface of the ICM cone, Sparc is expressed in the 
parietal endoderm giving rise to Reichert´s membrane (Mason et al., 1986). None of these 
markers could be detected in implantation sites at e7.5. It was thus concluded that all the 
staining observed with H19 originates from cells of the trophectoderm lineage. In the 
implantation sites analyzed, signal could not only be detected in the surrounding primary 
giant cells but also in the center of the implantation site. Cited is expressed by cells of the 
visceral primitive endoderm as well as by secondary giant cells (Rodriguez et al., 2004). In a 
knockout for Sall4, expression of Cited can be detected in multiple cells around the 
implantation site. If primitive endoderm is absent in Sall4 knockouts, expression must be due 
to secondary giant cells. The overabundance of Cited positive cells may be explained by 
differentiation of polar trophectoderm. The trophoblast differentiates into polyploid giant cells 
in the absence of Fgf4 secreted from the ICM (Tanaka et al., 1998). If indeed no primitive 
endoderm or embryo supplying Fgf4 can be found in knockout implantation sites it would be 
expected that the staining for H19 observed in the center originates from giant cells.  
As seen in PAS staining, giant cells are present in the center of a Sall4 knockout 
implantation site while they are never found in such location in control animals. This analysis 
demonstrated that, in vivo, loss of Sall4 leads to periimplantational lethality in mice. It also 
establishes that only trophoblast cells can be found at implantation sites of Sall4 knockout 
embryos while all cell types originating from the inner cell mass are missing. To study the 
fate of ICM cells, I used an ex vivo system allowing the developmental observation of Sall4 
knockout embryos. 
 
3.5. Ex vivo Analysis 
Outgrowth of Blastocysts in Culture 
In utero, blastocysts undergo implantation at around e4.0 unto e4.5. From then on up 
until e5.5 the blastocyst will hardly grow in size making identification hard. To circumvent 
this problem, blastocysts were harvested at e3.5 and cultured in ESC medium for up to ten 
days. In such conditions, blastocysts hatch from the surrounding zona pellucida and adhere to 
the culture dish at around day two in culture. Given the planar surface of the dish, the three 
dimensional structure of the developing embryo is altered. The trophectoderm flattens while 
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ICM cells grow on top in a shape similar to the in vivo situation. These cells might 
subsequently form embryoid bodies consisting of a primitive endoderm and an embryonic cell 
layer as well as a proamnion like cavity comparable to e6.5 (Wiley and Pedersen, 1977). 
Gastrulation does not occur. In other cases, the inner cell mass grows in a more 
undifferentiated fashion. 
Blastocysts of an interbreeding of Sall4-GFP heterozygous animals were sorted at e3.5 
and 24 of each of the three genotypic classes were placed in separate wells of a 24 well dish 
containing ES cell medium. Starting with day two in culture, the development was monitored 
daily. Figure 12A shows examples of such blastocyst outgrowth (BO) experiments. Control 
embryos behaved as expected and their ICM grew constantly. In contrast, ICMs of knockout 
blastocysts did not gain size after approximately four to six days. No embryoid bodies or large 
aggregations of cells were ever observed. Instead, the inner cell mass terminated growth, 
disintegrated and spherical multi-cellular aggregates detached from the underlying 
trophectoderm (asterisk). At this stage, the trophoblast has already undergone multiple rounds 
of endoreplication and formed the typical primary giant cells as judged by histological 
examination. The detaching aggregates of ICM derivative cells have lost the typical ESC 
appearance of small, round cells. Instead, cells appeared differentiated.  
This suggested that the cells of the trophoblast were not altered in their developmental 
potential ex vivo while the ICM cells lost the ability of self renewal and proliferation leading 
to a complete loss of the ICM. The observed effect of Sall4 deletion in blastocyst outgrowth 
supports the in vivo finding and suggests that Sall4 is required specifically in the ICM to 
maintain the identity or a pluripotent ES cell. 
 
Cell Types Present in Blastocyst Outgrowths 
Observation of blastocyst outgrowths suggested that the identities of ICM stem cells 
may not be maintained in the absence of Sall4. To prove this, markers for the different cell 
lines present in the blastocyst were used. BOs were fixed and processed for 
immunofluorescent staining or in situ hybridization. 
Apoptotic and necrotic cells can be identified in cell culture by fragmented nuclei in 
DAPI staining and large vacuoles. Judged by appearance in light microscopy, no cell death 
could be observed. To validate that apoptosis does indeed not account for the size reduction in 
the knockout outgrowth, apoptotic cells were identified with TUNEL staining. No differences 
were observed as presented in figure 12B. 
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Figure 12: Sall4 is required for the ouwtgrowth of blastocysts in culture.
To study the dynamics of implantation and to follow the progress of the phenotype due to loss of Sall4, blastocysts were 
collected e3.5 and cultivated in ESC meduim containing LIF. Under these conditions, the trophoblast will adhere to the 
surface of the culture dish and the inner cell mass will grow on top. Progress of blastocyst outgrowth (BO) was docu-
mented daily, representative examples are shown in A. No significant differences between wildtype and knockout are 
observed until day four in culture. Subsequently, Sall4-/- BOs will terminate growth and the ICM disassembles and 
fractionates until only giant cells remain after 7-12 days. 
B) Apoptag staining at day 6 indicates that the cell loss observed is not due to apoptosis since only very few cells stain 
positive both in wildtype and knockout (arrowhead).
C) Confocal immunofluorescence at day 8 illustrates observed changes. Pictures to the right are higher magnifications of 
a single optical section through the ICM.  Strong TROMA staining recognizing intermediary filaments in epithelial cells 
around the mutant ICM suggests that ESCs differentiate in ESC culture medium. Detouching aggregates observed in A 
appear to be trophoblastic cells (asterisk in A, C). Cells undergoing division are marked by immunostaining  against phos-
phorylated histone 3 and are present in wildtype and knockout  BOs. In knockouts however,  cell division is mainly seen 
in TROMA positive cells while almost no division is visible in GFP positive, TROMA negative cells.
A
B C
Sall4-/+
Sall4-/-
GFP, TROMA, phosphoH3
GFP, TROMA, phosphoH3
ApopTag
ApopTag
*
*6d 8d
*
10d
Results
39
  Results 
40 
To visualize trophectoderm, outgrowths were stained for TROMA immunoreactivity as 
seen in figure 12C, red channel. Giant cells stained strongly in knockout and control as 
expected but differences were seen in the inner cell mass. In wildtype, hardly any TROMA 
immunoreactivity is observed in and around the ICM since trophoblast cells settle on the 
surface of the slide. In contrast, cells surrounding the mutant ICM stain strongly for TROMA. 
In the overview of a knockout outgrowth in figure 12C one of the multicellular, spherical 
aggregates can be seen displaying TROMA immunoreactivity (asterisk). This suggests that 
cells at the surface of the inner cell mass are no longer ES cells since TROMA staining clearly 
shows presence of a cytoskeleton typical for epithelial cells. 
Purple staining in figure 12C is indicative of dividing cells as visualized by an antibody 
against phosphorylated histone 3. It shows that ICM cells in both wild type and knockout BOs 
are still dividing. Nevertheless, the rate of proliferation is clearly reduced in knockout ICMs, 
especially amongst the TROMA negative cells. This result suggests that detaching cellular 
aggregates immunoreactive for TROMA together with reduced proliferation are the reason for 
a loss of cells at the site of the ICM.  
Taken together, the analysis of cell lineage markers in blastocyst cultures further 
strengthens the hypothesis that Sall4 is required specifically in the inner cell mass. To test the 
fate of ICM cells directly, I wanted to observe ICM growth in the absence of primary 
trophoblast cells. 
 
Cell Culture After Immunosurgery 
Trophoblast cells can be removed specifically from ICM by immunosurgery (Solter and 
Knowles, 1975). To do this, the zona pellucida is removed, blastocysts are incubated with an 
anti-mouse antibody for ten minutes, washed in cell culture medium and incubated in 
complement. Since only cells decorated with antibody will be attacked by the complement, 
solely those cells originally exposed to it are killed. The trophoblast forms a tight epithelium 
preventing access of antibody to the inner cell mass and thus the only cells surviving this 
procedure are the ICM stem cells. As can be seen in figure 13, size and appearance of the 
inner cell mass subsequent to immunosurgery is comparable in wildtype and knockout. Living 
cells form a round aggregate and separate from dead debris. 
Cells were subsequently placed in culture medium and growth was monitored daily. The 
early inner cell mass is still plastic enough to contribute to trophoblast lineage if kept under 
suitable conditions. Several studies show independently that this potential is usually lost 
during 32 cell stage of a late expanding blastula (Handyside, 1978; Johnson and McConnell, 
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2004; Rossant and Lis, 1979). Other studies were able to identify growth of TSC colonies 
after immunosurgery even of e4.0 blastocysts (Hogan and Tilly, 1978). Estimation of cell 
numbers in blastocysts used for this study suggests that the trophoblast itself already consists 
of at least 32 cells (see figure 13), thus the blastocysts used for the experiments are consisting 
of well above 32 cells. Therefore, ICMs used in this experiment will usually generate ESCs 
and primitive endoderm. However growth of TSCs can not strictly be excluded. 
 
 
 
 
 
Obtained ICMs were cultured at two different conditions, in ES cell medium on 
gelatinized plates as well as in TS cell medium on culture dishes containing a monolayer of 
mouse embryonic fibroblasts. 
In ESC medium, growth of knockout ICM cells is arrested. Cells form stable planar or 
spherical aggregates while control ICMs undergo rapid cell cycle giving rise to huge, loose 
aggregates of ESC like cells as well as to primitive endoderm cells migrating on the surface of  
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the culture dish. Initially, primitive endoderm cells (PE) can be identified clearly also in 
knockout colonies. After eight days, trophoblast giant cells can be observed in knockout ICMs 
while no giant cells are ever observed in cultures of wildtype inner cell mass. This experiment 
shows that ES cell deleted of Sall4 lost the capacity to grow and self-renew in ES cell 
medium. Instead, differentiation into trophoblast giant cells occurred. 
To test the capacity of ICMs to generate primitive endoderm or trophoblast, I cultured 
ICMs in TSC medium on a feeder layer of mouse embryonic fibroblasts subsequent to 
immunosurgery. Feeder cells were treated with mitomycine C prior to seeding the ICM so that 
feeder cells were inhibited in their cell cycle. Under TSC medium conditions, ES cells do not 
grow while primitive endoderm and trophoblast stem cells can be cultured for many passages 
in TSC medium in the presence of mouse embryonic fibroblasts and FGF4 (Kunath et al., 
2005; Tanaka et al., 1998). 
Of the 24 ICMs of the control group, 21 had settled down and formed colonies of 
primitive endoderm after four days while only little growth was observed in Sall4 deleted 
ICMs. Nevertheless, the slow growth observed shows that cells originating from an inner cell 
mass that lost Sall4 are viable and in principal capable to proliferate in trophoblast stem cell 
medium. This supports the notion that loss of Sall4 does not lead to cell death. 
As shown in figure 14, epithelial cells reminiscent of TS cells grow on a feeder layer of 
mitomycine C treated fibroblasts in the knockout after seven days while cells in the wildtype 
appear more roundish in shape. TS cell medium supplies optimal conditions for the generation 
of primitive endoderm cell lines (Kunath et al., 2005). To identify the two types of cells 
undoubtedly, colonies for each genotype were cultivated seven days more, now in the absence 
of FGF4. Under these conditions, wildtype colonies disassociated and cells started migrating. 
Typical network like patterns of cell contacts allow identification of primitive endoderm cells 
in culture (XEN cells) (Kunath et al., 2005). Upon withdrawal of FGF4 in the knockout 
group, trophoblast giant cells differentiated in all wells, where growth had originally been 
observed. No giant cells could ever be observed in the control plates. Therefore it was 
concluded, that knockout ICM cells gave rise to trophoblast stem cells that differentiated into 
giant cells upon deprivation of FGF4. Due to the enormous size and polyploidity of giant 
cells, cell identity can be addressed by appearance. Differentiation into giant cells is the 
expected reaction of TSC in the absence of FGF4 and shows that TS cells derived from the 
inner cell mass of a Sall4 knockout blastocyst are competent to sense FGF4. 
Culture of ICMs in TSC medium proofs the competence of Sall4 knockout ICM derived 
cells to survive and grow though the competence to maintain ICM cell types is lost. Both cell  
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Figure 14: Cell culture of inner cell mass (ICM) after immunosurgery.
Based on the observation that Sall4-/- inner cell masses express TROMA in a blastocyst outgrowth, isolated ICMs were 
observed in culture. Growth was documented by photography. 
When kept in ESC medium, wildtype ICMs grow rapidly. ES cells (ESC) either proliferate as loose aggregations (top) of cells 
or differentiate into embryoid bodies (data not shown). The second lineage of the ICM, the primitive edoderm (PE) 
migrates and spreads on the culture dish surface (PE). Single PE cells typically form vacuoles and die. In Sall4 knockouts 
only very few cells and no ES cells are observed. Instead, Giant cells form from the inner cell mass (GC).
In trophoblast stem cell (TSC) medium supplied with FGF4, ESCs do not grow in either wildtype or mutant. While PE cells 
grow in the wildtype, no PE can be observed in Sall4-/- ICMs. TSCs grow from the inner cell mass culture of Sall4-/- 
blastocysts. These TSCs differentiate into giant cells upon withdrawl of FGF4. Thus Sall4-/- ICMs are competent of growth 
in an undifferentiated manner but can not maintain inner cell mass fates by self renewal.
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types usually generated by the ICM, ES cells and primitive endoderm cells, fail to grow 
suggesting that Sall4 is required to maintain inner cell mass identity. The formation of 
functional TS cells that are able to differentiate into giant cells illustrates that the trophoblast 
lineage is not severely affected by loss of Sall4. 
Taken together with the observation that giant cells form even in conditions favouring 
ES cell fate, it suggests that inner cell masses lost the capacity to maintain ES cell and XEN 
cell lineages. Instead, cells differentiate into trophoblast lineage. 
 
Deletion of Sall4 from ES Cell Lines 
Two cell types are present in the inner cell mass of an e4.0 blastocyst. Adjacent to the 
blastocoel, cells forming the primitive endoderm will assemble while cells surrounded by 
trophoblast and primitive endoderm give rise to the embryo itself as well as the 
extraembryonic mesoderm (Johnson and McConnell, 2004; Rossant, 2004). Both cell types 
are interdependent. This is also shown by the failure to form a wildtype blastocyst outgrowth 
observed for mouse knockout models that affect only one of the two cell lines (Cheng et al., 
1998; Nichols et al., 1998). In culture, primitive endoderm cells grow as XEN cells while the 
undifferentiated apolar cells inside the ICM are known as embryonic stem cells (ESC). Both 
cell types express high levels of Sall4 and so I wanted to know which cell type is responsible 
for the effects described in a Sall4 knockout situation.  
To study, which of the two cell types is primarily affected by a Sall4 deletion, or if both 
cell types require the protein, I wanted to delete Sall4 from an ES cell line in culture. In order 
to do that, an ES cell line had to be established, that was homozygous for Sall4-loxP. Mice 
homozygous for the floxed allele were bred to heterozygously floxed animals, blastocysts 
were collected and allowed to form a blastocyst outgrowth. At day four in culture, the inner 
cell mass was picked with a drawn glass capillary and dissociated in trypsin. Single cell 
suspensions for each clone was placed in one well of a 96 well plate and cultivated until ESC 
colonies formed. ESC lines were expanded and genotyped by southern blot. Figure 15A 
shows analysis of the established cell lines with a probe that recognizes the floxed exon of 
Sall4. Digestion with restriction enzymes BglII and XbaI results in a DNA fragment running 
with a size of 3.8kb in agarose gel electrophoresis. An additional XbaI site in the FRT 
sequence shortens the fragment to 2.4kb. A probe against the first part of Sall4 exon two was 
used to screen the derived ES cell lines. Of the six newly generated ESC lines, 4 clones were 
heterozygous for Sall4-floxed and two were homozygous. 
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Figure 15: Sall4 protein level modification in ESC culture 
A) Establishment of ESC lines carrying floxed Sall4 alleles. In order to genotype the resulting ESC lines, southern blot 
analysis was carried out. The Sall4 locus was marked with a probe recognizing the floxed exon two. DNA was digested 
with BglII and XbaI. The latter cuts in the FRT site next to the 5´loxP site and results in a shift of the DNA fragment contain-
ing Sall4 exon two from 3.8 kb to 2.4kb. Clones C and D are homozygously floxed, clones A, B, E and F are heterozygous.
B) Twelfe million cells of clones D and E (experiment 1) as well as A and C (experiment 2) were electroporated with a 
linearized vector carrying Cre and IRES-puroR under the CAGGS promotor. Selection in cell culture, picking of single 
clones and subsequent genotyping of the Sall4 locus showed that ESCs deleted of Sall4 can not be expanded in cell 
culture under conditions suitable for growth of ESCs while control clones as well as clones that did not delete Sall4 grew 
rapidly.
C) Overexpression of Sall4 in cell culture. ESCs heterozygous for Sall4 (Sall4+/Sall4-GFP) were electroporated with a 
vector carrying an HA-tagged Sall4 cDNA under the control of the  CAGGS promotor. Selection for stable transformants 
was possible through a bicistronic transcript for Sall4 and puroR. Western blot analysis shows overexpression of Sall4 
protein in clone 13 and 16 .
B
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To delete Sall4, one heterozygous as well as one homozygous cell line were expanded 
separately and 12 million cells each were electroporated with a vector coding for a bicistronic 
transcript of Cre recombinase and puromycin resistance under the control of the CAGGS 
promoter (Sunaga et al., 1997). 14 days of selection for puromycin resistance resulted in 
stably transfected clones that should express Cre recombinase. By the enzymatic activity of 
Cre, recombination between loxP sites should have occurred in all alleles flanked by the 
recombination sites. Homozygously floxed clones should then loose Sall4 during the selection 
procedure. Resulting clones were picked, expanded and genotyped to test for successful 
deletion. To genotype the clones, a PCR strategy was devised in which the 5´ primer was 
positioned overlapping with the 5´ loxP site and two 3´ primers were located distally to each 
loxP site. While a wildtype locus can not serve as a template for a PCR reaction with these 
primers, floxed loci can result in two sizes of amplicons, dependent on whether Cre-excision 
of Sall4 exon two had occurred. 
The heterozygous ESC line yielded 24 stable clones while no clones grew in the 
homozygous cell line. To verify this result the experiment was repeated with two 
independently established ES cell lines. In the second round, 56 clones were established in the 
control while the homozygous cell line gave rise to only two normal growing clones from 
which a cell line could be established as well as eleven independent, very small colonies that 
stopped growth and could not be expanded even after two additional weeks in culture. 
Genotyping revealed that the two normal growing clones of the homozygous cell line 
did not delete Sall4 while the small colonies that terminated growth were identified as Sall4 
null clones. Of the heterozygous clones, only one had failed to delete the floxed allele 
indicating that excision should occur in almost all cases and that the absence of deleted clones 
in the homozygous ES cell line is due to requirement of Sall4. 
The most likely explanation for the failure to delete Sall4 in puromycin resistant 
colonies is the deletion of the Cre recombinase sequence of the electroporated plasmid 
through the integration into the genome. The absence of growing, Sall4 deficient colonies in 
the homozygous Sall4-floxed ESC lines as opposed to 24 and 54 colonies in the control cell 
lines proofs the requirement of Sall4 for growth of ESC lines in culture. Small colonies can be 
explained by the fact that homozygous deletion of Sall4 may take several cell cycles and 
counter selection of that event will take place due to the requirement of Sall4. Complete loss 
of Sall4 protein might thus take a few days, sufficient to generate a small colony. 
Loss of the transcription factor Oct4 leads to differentiation of the inner cell mass into 
trophoblast, similar to the effects observed here. Loss of Oct4 in an ESC line can also not be 
  Results 
47 
tolerated. Overexpression of Oct4 in ES cells leads to differentiation into primitive endoderm 
(Niwa et al., 2000). To test if Sall4 can be over expressed in ES cells, a vector coding for an 
HA-tagged version of SALL4 under the control of the CAGGS-promoter was assembled and 
electroporated into a cell line heterozygous for Sall4-GFP. As seen in Figure 15C, clone 16, 
overexpression of about 3-4 fold Sall4 compared to normal ES cells is tolerated. No 
phenotypic differences of these cells were observed compared to wildtype ES cells. 
 
3.6. Sall4 is Required Cell Autonomously in vivo 
Requirement for Sall4 in Inner Cell Mass Cells  
The cell culture experiments indicated a requirement for Sall4 specifically in ES cells. 
Further experiments were designed to confirm this finding in vivo. To test if Sall4 requirement 
in ES cells is cell autonomous in vivo, studies on chimeric animals were performed. Morulas 
were collected at e2.5, sorted by GFP intensity and the zona pellucida was removed. In 
parallel, e2.5 morulas heterozygous for ROSA-lacZ (Soriano, 1999) were harvested and 
treated in the same way. Subsequently, each morula of a Sall4-GFP interbreeding was placed 
in small aggregation well together with one morula heterozygous for ROSA-lacZ. Under such 
conditions, blastomeres of both morulas attach, intermingle and form a chimeric morula in 
over night culture. In one third of the aggregation wells, chimeric blastocysts arose. In these 
blastocysts, GFP positive and negative cells had intermingled and each genotype had 
presumably given rise to all cell types. Immunostaining of such blastocysts revealed that the 
GFP positive cell line had indeed contributed to trophoblast and inner cell mass (figure 16A). 
The fact that Sall4-GFP homozygous cells are capable to contribute to the inner cell mass and 
do not sort exclusively to the trophoblast even in presence of competing wildtype cells 
indicates, that these cells are initially capable of ICM formation. This confirms earlier 
observations. 
To address the question if cells homozygous for Sall4 can contribute to the developing 
embryo, chimeric blastocysts of each genotype were transferred into pseudopregnant females. 
Embryos were collected at day 10, fixed and subjected to Bluo-Gal staining to identify the 
contribution of ROSA-lacZ cells in these embryos. As expected, aggregations of ROSA-lacZ 
morulas with cells heterozygous or wildtype for Sall4 resulted in chimeric animals as 
identified by speckled blue staining (figure 16B). However, embryos obtained from 
aggregations of Sall4 knockout morulas with ROSA-lacZ morulas, collected at e10.5 stained 
blue in all cells. Paraffin sectioning of embryos confirmed this result. Analysis of the 
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trophoblast in aggregations of knockout morulas with ROSA-lacZ revealed the presence of 
Sall4 deleted cells in the placenta. Thus it was concluded that Sall4 is required in a cell 
autonomous fashion in the embryo proper but not in the trophoblast.  
In mice, tissue specific gene deletion allows dissection of phenotypes. To do so, mice 
carrying floxed alleles are bred to a tissue specific Cre line resulting in excision of the loxP 
flanked sequence in all cells where Cre recombinase is expressed. A Sox2-Cre strain was 
shown to mediate efficient recombination in the inner cell mass (Hayashi et al., 2002). 
Deletion starts at e3.5, by e6.5 all cells of the embryo proper have lost the floxed allele. At 
embryonic day 7.5, the visceral primitive endoderm will also have deleted efficiently. I 
decided to make use of this Cre-line and genetically ablate Sall4 from the embryo proper 
without disturbing development by ex vivo manipulations. A mouse carrying a Sall4-GFP 
allele as well as one copy of the Cre transgene was crossed to mice homozygous for Sall4-
loxP and litters were taken at e8.5 to allow development post deletion. 25% of mice carried a 
Sox2-Cre transgene as well as a Sall4-GFP and a Sall4-loxP allele as expected. In these mice, 
Sox2-Cre should have deleted the floxed allele of Sall4 in all cells of the embryo proper 
between e3.5 and e6.5 while the primitive endoderm should delete only one day before 
harvest of the embryos In figure 16C, deletion is symbolized by darker tones of green. All 
trophoblast derived tissues will in this setup still be heterozygous for Sall4. Figure 16D 
compares the appearance of such an embryo with a Sall4 heterozygous littermate. A 
developmental arrest of the embryo is clearly visible. Control embryos had undergone 
gastrulation and neurulation and are visible through the yolk sack. In the knockout population, 
embryo proper tissue was found as an unorganized clump. Deletion of Sall4 mediated by a 
Sox2-Cre line takes until e6.5 in the embryo proper while visceral endoderm is still 
genetically wildtype at this stage. Embryos most severely affected do not even reach a state 
equivalent to e6.5. Since deletion in the primitive endoderm occurs only after e6.5, this 
experiment supports the finding that Sall4 is required in the embryo proper itself. Whether the 
requirement is cell autonomous can not be addressed in this experiment. 
 
Figure 16: Chimeric analysis of Sall4-/- embryos 
A) To test if Sall4 requirement is cell autonomous, morulas sorted for GFP intensity were aggregated with morulas 
heterozygous for ROSA-lacZ. Retransferred animals were collected at e10.5. Both morulas contribute to the inner cell 
mass stained for Oct4 (A, red staining). While aggregation of ROSA-lacZ with morulas wildtype or heterozygous for Sall4 
resulted in chimeric embryos at e10.5 as expected (B), aggregation with homozygous morulas resulted in embryos 
derived exclusively from ROSA-lacZ cells.
C) TheSox2-Cre line results in deletion of loxP flanked sequences first in the embryo proper (EP), from e7.5 on also in the 
primitive endoderm (PE). The extraembryonic ectoderm (EE) of the trophoblast does not delete.
D) Conditional excision of Sall4 leads to developmental arrest of the embryo proper.
E) ESCs expressing cytoplasmatic beta galactosidase were injected into sorted blastocysts. Such ESCs can only contribute 
to the epiblast as seen in the control experiment (F). No beta galactosidase staining could be observed in any of the 
retrieved implantation sites of injected knockout blastocysts at e6.5 (G). 
Green: Sall4-GFP, blue: ROSAlacZ, dark green:deletion of Sall4 by Sox2-Cre;
E F G
Sall4-/+ Sall4-/-
B
A
Sall4-loxP/deleted;
Sox2-Cre
Sall4-loxP/deleted;
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D
C
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Requirement of Sall4 in Primitive Endoderm  
To address directly whether Sall4 deficient cells can form a functional primitive 
endoderm in vivo, ROSA-lacZ ES cells were injected into blastocysts from a Sall4-GFP 
interbreeding after sorting the blastocysts by the intensity of the GFP signal. Injected ES cells 
can contribute to the embryo proper but do not contribute to the primitive endoderm or 
trophoblast (Tam and Rossant, 2003). Therefore, the defects due to Sall4 deletion in the 
epiblast may be rescued by the presence of ROSA-lacZ cells while the primitive endoderm 
and the trophoblast will only consist of cells originating of the blastocyst. As shown before, 
Sall4 is not required for trophoblast differentiation. Developmental potential of the chimeric 
animals resulting from this experiment will thus be determined by the integrity of the 
primitive endoderm. 
Blastocysts were transferred into pseudopregnant females 2.5dpc and allowed to 
develop until e6.5. Whole mount BluoGal staining was used to distinguish between Sall4-/- 
cells of the blastocyst and injected ROSA-lacZ cells. In Figure 16E-G, sections through e6.5 
embryos illustrate a contribution of ROSA-lacZ cells to the epiblast. Such contribution of 
wildtype ROSA-lacZ cells to the epiblast and not to any other cell lines was observed as 
expected in injections of control blastocysts. Injection into Sall4 knockouts did not rescue the 
phenotype, these ESCs could not even be located at e6.5, suggesting that they did not survive. 
This experiment argues that defects outside the embryo proper, most likely the primitive 
endoderm, contribute to the Sall4 phenotype.  
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4. Sall1, Sall2 and Sall3 Function in Neurogenesis 
In contrast to Sall4, expression for Sall1, Sall2 and Sall3 largely overlaps as has been 
presented earlier. Based on the finding that loss of Sall function leads to severe defects in 
early development, I wanted to investigate if additional, unpublished phenotypes might be 
visible upon loss of one or several members of the SALL protein family.  
 
4.1. Loss of Sall1 or Sall3 Results in Perinatal Lethality 
In order to obtain animals homozygous for Sall1-lacZ, heterozygous mice were 
intercrossed. Shortly after birth, litters were visually inspected to screen for phenotypes. 
Subsequently pups were genotyped to correlate any observations to the genotype. 
Litters from Sall1 intercrosses regularly contained pups that had no milk in their 
stomach. This could easily be observed due to the translucent nature of the body wall at this 
age. Genotyping of the pups of such litters showed that lack of milk correlated with 
homozygosity for the Sall1 knockout allele. Animals deleted of Sall1 die within the first six 
hours after birth appearing dehydrated but without showing any further obvious abnormalities 
that can be observed. Breathing and reflexes are normal. 
Loss of Sall3 results in perinetal lethality (Dr. G. Schütz, personal communication). 
Because of similar expression patterns with Sall1, Sall3 litters were specifically analyzed at 
P0 for their ability to suckle milk. Genotyping litters directly after birth could show the 
presence of knockout animals and again these mice had not suckled milk. Dehydration is a 
likely cause for lethality within six hours after birth (Hongo et al., 2000). Thus, the failure to 
suckle milk might contribute to the lethality both for Sall1 and Sall3 knockout animals. 
Previously, severe kidney defects ranging from absence of kidneys to severe hypomorphia 
upon loss of Sall1 have been described and will also lead to lethality (Nishinakamura et al., 
2001).  
 
4.2. Macroscopic Analysis 
Anatomical defects in mouth or oesophagus could result in the inability to suckle milk. 
Examination of pups showed no major defects. A recent report observed minor deformations 
in the palate in Sall3 knockouts (Parrish et al., 2004). Upon re-examination of Sall3 based on 
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this information still I could not confirm defects of the kind described. This might be due to 
genetic background effects.  
Sall1 and Sall3 are expressed predominantly in the central nervous system. Expression 
in the palate has not been observed. Therefore I hypothesized that a defect in the CNS might 
explain the lethality of mice homozygous for Sall1 or Sall3. This is a plausible hypothesis 
since several mouse models link neuronal defects to the failure to drink milk. 
 
4.3. Histological Analysis of the Olfactory Bulb in Mice Mutant for 
Sall1 and Sall2 
Rodent models for anosmia result in postnatal lethality due to the failure to suckle milk. 
Amongst them are mechanical ablation of the olfactory epithelium in rats (Risser and 
Slotnick, 1987) and genetic targeting of a cyclic nucleotide gated cation channel (Brunet et 
al., 1996). 
As described earlier, Sall1, Sall2 and Sall3 are all strongly expressed in the olfactory 
bulb. All receptor neurons in the olfactory epithelium project their axons onto the surface of 
the olfactory bulb. Mammalian olfactory epithelia harbour up to 1000 different types of 
receptor neurons, each expressing only one odorant receptor (Mori et al., 1999). For each kind 
of receptor, axons of all neurons expressing it converge at the surface of the olfactory bulb in 
so-called glomeruli. Dendrites of underlying mitral and tufted cells invade each glomerulus to 
form excitatory synaptic connections with the olfactory receptor neurons. In mice, each 
glomerulus receives converging axonal inputs of several thousand sensory neurons while only 
around 20 mitral and tufted cells innervate it (Royet et al., 1998). Axons of all mitral and 
tufted cells project the information through the lateral olfactory tracts (LOT) to the olfactory 
cortex of the brain. Mitral cells are organized in a dense layer (MCL) between glomeruli and 
the high number of GABAergic inhibitory interneurons in the center of the olfactory bulb. 
These form local circuits through dendrodendritic inhibitory connections to mitral and tufted 
cells. A rostral extension of the lateral ventricle extends into each olfactory bulb. 
To identify a possible defect in the olfactory bulb responsible for the inability of 
newborns to suckle milk, sagittal cryostat sections were prepared and nuclei were stained with 
nuclear fast red. In a wildtype mouse at P0 the mitral cell layer is clearly visible while this 
dense neuronal layer can not be observed in a Sall1 knockout (figure 17A). In contrast, mice 
mutant for Sall2 display a clearly identifiable MCL at e19.5. This was expected, as these mice 
show normal feeding behaviour. In the double mutant for Sall1 and Sall2, the defect becomes 
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even more pronounced. In order to study the maximal defect caused by loss of spalt genes in 
the olfactory bulb I decided to study the phenotype in a Sall2 deleted background. 
 
4.4. Comparison of the Effects of a Loss of Sall1, Sall2 and Sall3 on 
the Olfactory Bulb 
To analyze the contribution of Sall1 and Sall3, mice heterozygous for Sall1 and Sall3 as 
well as homozygous for Sall2 were intercrossed. Litters were taken at embryonic day 18.5 to 
exclude loss of pups. Figure 15B presents examples of observed phenotypes in different 
allelic combinations. Mice mutant for Sall2 exhibit normal interneuron- and mitral cell layer 
organization. In coronal sections, layers appear as concentric rings around the ventricle. As 
shown previously, no mitral cell layer (MCL) was detected in Sall1/Sall2 double mutants 
while no obvious effect on underlying granular neurons (GC) was observed. 
In double mutants for Sall2 and Sall3 only mild effects on MCL organization could be 
seen. In contrast, the outer plexiform layer (bar in figure 17B, OPL) contains almost no cells 
bringing the MCL closer to the surface of the olfactory bulb. 
Loss of all three Sall genes, Sall1, Sall2 and Sall3 results in almost complete absence of 
the olfactory bulbs. No internal lumen could be observed and all dense neuronal structures are 
missing including granular neurons. Due to the minimal rostro-caudal dimension, the only 
sections obtained rather resembled superficial tangential sections of the cortex. 
For further studies of the described histological defects with molecular markers I 
decided to focus on a comparison of Sall2 knockout mice to Sall1/Sall2 double knockouts for 
two reasons:  
First, breeding for triple knockout mice is time consuming and inefficient. The parental 
generation was obtained from interbreeding Sall1-/+, Sall2-/-, Sall3+/+ males with Sall1+/+, 
Sall2-/-, Sall3-/+ females and results theoretically in one female double heterozygous for 
Sall1 and Sall3 in eight pups born. To analyze e18.5 litters that should contain a triple 
knockout in one of 16 pups, such females bred to males of the same genotype had to be 
sacrificed. Expected accumulation of Sall deletion was found in a sub-mendelian frequency in 
both generations and mating efficiency was very low. 
Secondly, I wanted to study neurogenesis in the olfactory bulb using molecular markers. 
Olfactory bulb tissue is absent in a triple knockout and so I focused on the MCL in a 
Sall1/Sall2 double knockout situation. 
 
Wt Sall1-/- Sall2-/- Sall1-/-, Sall2-/-
A
Sall1+/+, Sall2-/-, Sall3+/+
Sall1+/+, Sall2-/-, Sall3-/-
Sall1-/-, Sall2-/-, Sall3+/+
Sall1-/-, Sall2-/-, Sall3-/-
Sall1+/+ Sall1-/-
Sall3+/+
Sall3-/-
B
Figure 17: Loss of mitral cells in a Sall1/Sall2 compound knockout. 
A) H&E staining of sagittal sections of olfactory bulbs e19.5 (wt and Sall1-/-) or e18.5 (Sall2 -/- and Sall1-/-, Sall2-/-) 
shows developmental defects caused by loss of Sall1 in the mitral cell layer (mcl). These changes are more pronounced 
in a Sall2 deleted background. 
B) Coronal sections of olfactory bulbs e18.5 stained with thionine to compare the effect of Sall1 or Sall3 loss or both in a 
Sall2 deleted background.  Loss of Sall1/2 results in absence of a visible mcl while loss of Sall2/3 causes  a thinning of 
mainly the outer plexiform layer (bar, opl) containing horizontal processes of mitral and tufted cells as well as cell nuclei 
of local circuit neurons. In a triple knockout of Sall1, Sall2 and Sall3, all OB structures are absent.  midline (m)
C) In situ hybridisation on a Sall1/2 double knockout in comparison with a wildtypic Sall2 knockout to molecularly label 
the mitral cell layer (Reelin) as well as local circuit inhibitory (GABAergic) neurons (Gad67). Some mitral or tufted cells are 
still found in a Sall1/2 knockout but they are no longer organized in a condensed, pallial layer. Thus, cells of the opl and 
gcl also appear less organized and the two layers are further apart. Lateral, the opl specific Gad67 staining is absent.
opl
mcl
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C
Sall1+/+, Sall2-/- Sall1-/-, Sall2-/-Sall1+/+, Sall2-/- Sall1-/-, Sall2-/-
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To verify the absence of mitral cells from the olfactory bulbs, in situ hybridization was 
performed. Reelin is specifically expressed in mitral and tufted cells (Bulfone et al., 1998) and 
was used to detect these cell types. The concentric ring observed in histological stains labels 
intensely for Reelin in all control animals (figure 17C). In contrast, staining was strongly 
reduced and dispersed in the mutant. Reelin positive cells are still present in the olfactory bulb 
of Sall1/Sall2 deleted mice and are probably tufted cells, typically present in a scattered 
distribution (Bulfone et al., 1998). To verify this result, Gad67, expressed in the most 
superficial periglomerular layer (PG) as well as the underlying granule cell (GC) layer (Long 
et al., 2003), was used as an in situ probe. These layers were not severely affected by loss of 
Sall1 and Sall2. They also did also not collapse as would be the case if mitral and tufted cells 
were missing completely.  
These results demonstrate that cells of the mitral cell layer are almost absent in the 
described mutant and their organization is severely impaired. It is still possible though that 
few mitral cells remain functional. To investigate this, further analysis was necessary. 
 
4.5. Remaining Mitral Cells do not Project to the Olfactory Cortex 
in a Sall1/Sall2 Double Knockout 
To further characterize the neurons in a Sall1/Sall2-/- olfactory bulb, the cellular 
extensions of neurons were studied. Rhodamine red coupled phalloidine was used to visualize 
f-actin in cytoplasmic extensions of neurons. Figure 18A shows a coronal view on the medial 
olfactory bulb region. GFP expression in the olfactory bulb outlines the mitral cell layer in a 
heterozygous mouse. Phalloidine indicates the presence of the nerve layer of the sensory 
neurons (NL), the glomeruli (dashed circles), dendrites of the mitral cells in the outer 
plexiform layer (OPL) as well as the axonal extensions of the mitral cells to the olfactory 
cortex running through the inner plexiform layer (IPL). 
While the nerve layer as well as rudimentary glomeruli can be observed in the knockout 
situation, dendrites and axons of the mitral cells are absent. In contrast, the glomerular focal 
points, in which axons of the olfactory epithelium converge, are still present. This is not 
surprising as it had been shown earlier, that axons of the olfactory epithelium sort 
independently of mitral cells and GABAergic interneurons (Bulfone et al., 1998). 
To follow the neuronal projections of sensory neurons in the olfactory epithelium (OE), 
grains of the lipophilic dye DiI were placed on the olfactory epithelium of mice collected and 
fixed at e19.5. Samples were stored at room temperature in 2% PFA for six weeks to allow  
AB
Sall1+/+, Sall2-/- Sall1-/-, Sall2-/-
Sall1+/+,
 Sall2-/-
Sall1+/+,
 Sall2-/-
phalloidine, EGFP phalloidine, EGFP
DiI DiI
Figure 18: Axonal projections in the Sall1-/-, Sall2-/- olfactory bulb. 
A) shows actin staining with rhodamine-coupled phalloidine to visualize cytoplasmic extensions like dendrites and 
axons. Together with EGFP expression from the Sall1 locus, the outer nerve layer (onl), glomeruli (dashed circle), outer 
plexiform layer (opl), mitral cell layer (mcl) and inner plexiform layer can be distinguished. Axons from the olfactory 
epithelium (oe) reach the glomeruli through the onl and connect in each glomerulus with dendrites of mitral cells under-
neath. lateral extensions of mitral cells in the opl as well as axons collectingin the ipl to reach the cortex are seen as red 
staining within the olfactory bulb. In the mutant, onl and glomeruli-like structures are still visible while no mitral cells or 
mitral cell extensions can be observed.
B) DiI labeling was used to follow projection paths in the olfactory bulb. DiI grains were either placed in the olfactory 
epithelium (oe) or on the lateral olfactory tracts (lot) to allow incorporation into cells or celular extensions present and 
subsequent lateral diffusion in the membrane. Forward labelling of neurons of the olfactory epithelium did not reveal 
changes between control and knockout while retrograde labelling of mitral cells by placement of DiI to the site, where 
axonal projections should be found (lot), shows that the remaining reelin positive cells do not project to the olfactory 
cortex. Thus it can be assumed that Sall1/Sall2 knockout mice are anosmic.
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incorporation of the dye into membranes of the olfactory epithelium and lateral diffusion 
into axonal projections. In accordance with the results obtained with phalloidine, DiI labelling 
and subsequent sectioning the olfactory bulb revealed no differences in the projectory 
behaviour of OE neurons. In both genotypes, olfactory receptor neurons had reached the 
olfactory bulb and formed focal points of axonal convergence visualized by DiI staining. 
Next, I tested the projections of mitral cells by placing DiI grains on the lateral olfactory 
tracts (LOT) to allow for retrograde diffusion into the olfactory bulbs. In control animals, 
axons in the IPL as well as dendrites of the MCL in the OPL strongly label while no signal is 
detected in Sall1/Sall2 double mutant animals (figure 18B). 
This observation shows that scattered cells expressing Reelin, thus presumably 
remaining mitral cells or tufted cells, do not project to higher cortical regions in mice mutant 
for Sall1 and Sall2 and are therefore not functional. Absence of responsive mitral cells leads 
to anosmia in mice (Mori et al., 1999). The defect described in the olfactory bulb is thus 
sufficient to explain the inability of newborn Sall1/Sall2 mutant mice to suckle milk and will 
therefore lead to the observed lethality. 
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4.6. Histological Analysis of the Neocortex in a Sall1/Sall2 Double 
Knockout. 
 The olfactory bulb is the most rostral extension of the forebrain and in continuum with 
the neocortex. To test if loss of Sall genes also affects neocortical neurogenesis, I collected 
embryos at different stages of development and compared the brain histology. Figure 19 
shows thionine staining of neurons in coronal sections of Sall2 and Sall1/Sall2 knockout 
littermates at embryonic days 16.5 to 19.5. Figure19A exemplifies the differences in the 
appearance of the brain in a Sall1/2 double knockout and a Sall2 littermate. The ventricles of 
the double knockout are always larger due to a less developed neocortex. Cells in the 
superficial, cortical layer of the neocortex appear compacted and display a more clearly 
defined boundary to the underlying regions. The corpus callosum (CC), the main connection 
between the two hemispheres, was less developed in all observed animals. 
To describe the extent of this defect during development, mice were collected at 
different stages of neurogenesis. Figure 19B summarizes examples showing a dorsal section 
of the neocortex in littermates at e16.5 to e19.5. At all stages, the cortical layers in the 
knockout are thinner and contain fewer cells (bars). The compact structure of the neocortex 
observed in the control animals starts disappearing with differentiation of neurons at e17.5 as 
opposed to the double knockout where even at e19.5 a higher compaction of the cortical 
layers is observed when compared to the wildtype. Neuronal stem cells and precursor cells are 
located within the ventricular and subventricular zone while differentiating neurons migrate 
radially towards the cortex and differentiate (Takahashi et al., 1999). The ventricular zone of 
the neocortex adjacent to the lateral ventricles does not show significant changes in radial 
dimension in this staining, thus a reduction of the number of stem cells can not be shown. In 
conclusion, neurogenesis and differentiation of precursors does occur in the absence of Sall1 
and Sall2, the two spalt orthologs most prominently expressed in the neocortex. However, 
neurogenesis is reduced as shown by the smaller number of post mitotic neurons present in 
the cortical layers. 
 
Figure 19: Neurogenesis of mice lacking Sall1 and Sall2 
Histological analysis of coronal sections through mouse brains. Shown are sections of one hemisphere of the neocortex 
from midline (m) on. For comparison, all sections were taken at the rostro-caudal height of the corpus calosum (cc) in the 
most caudal region of the lateral ventricle. Figure A shows the enlarged lateral ventricle of the mutant accompanied with 
a thinner cortex. In addition, the corpus callosum appeared thinner in the mutant.
In figure part B, only a small region of the dorsal part of the cortex is shown. The extent of the cortex is highlighted with 
bars. All sections compared were obtained from littermates. Thionine staining reacting with the nissl substance was used 
to label cell nuclei in blue.
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4.7. Birthdating of Neurons with BrdU 
Next, I wanted to quantify the described defects by labelling cells with BrdU. BrdU 
(bromo-deoxyuridine) is an analogon of deoxy-thymidine and will be incorporated in the 
DNA of cells in S-phase of cell cycle upon administration. To label embryonic cells that are 
currently undergoing DNA synthesis, timed pregnant dams were intravenously injected with 
BrdU dissolved in PBS.  
In cortical neurogenesis, neuronal stem cells reside in the ventricular zone and will 
incorporate BrdU. These progenitors typically divide eleven times during neurogenesis. Each 
round of division, some of the daughter cells will leave the ventricular zone, migrate into the 
cortex and initiate differentiation.  The number of cells remaining is above 50% in the 
beginning leading to an increase of the progenitor population and will drop below 50% later 
on. Neurogenesis occurs in two distinct steps. During the first rounds of cell cycle, neurons 
are generated that form the preplate (Takahashi et al., 1999) (see also figure 20A). Neurons 
generated later will subsequently migrate into the preplate and thus split it into a superficial 
marginal layer (ML) and the subplate (SP). Newly generated neurons will now always pass 
the last population and reside adjacent to the marginal layer or layer one, thereby generating 
new layers of neurons. By this, a correlation between the date of birth and the location of the 
neuron is established, with the neurons generated last residing most superficial. This process 
gives rise to a six layered cortex above the axonal tracts of the white matter. 
By injection of BrdU at day 14.5 and 15.5 of pregnancy, neurons born at that age will be 
labelled while incorporated BrdU in the progenitor population will be diluted out again by 
several rounds of cell division (McEvilly et al., 2002). Figure 20B illustrates the relative 
location of neurons at day 19.5. While neurons born at e14.5 predominantly reside in 
superficial layers of the cortex in the control animals, almost equal contribution to all cortical 
layers can be observed in a Sall1/2 double knockout. This effect is more pronounced when 
labelling neurons at e15.5. In the control, neurons almost exclusively reside in the most 
superficial layers while a contribution to deeper layers is observed in the mutant. Since the 
cell cycle in lateral regions of the neocortex is slightly ahead of the most dorsal part, the effect 
is best seen laterally. Black bars outline the dimension of the neocortex to enable the 
evaluation of migratory behaviour. 
This experiment indicates that at any specific point in time, identity and/or localization 
of the neurons born in the knockout is shifted and delayed compared to wild type littermates. 
Whether this is due to a general delay in generation of progenitor cells from the subventricular  
Sall1+/+, Sall2-/- Sall1-/-, Sall2-/-
BrdU e14.5
BrdU e15.5
A
B
Figure 20: Neocortical neurogenesis is delayed in mice mutant for Sall1 and Sall2. 
A) Neurogenic precursors residing at the walls of the lateral ventricles undergo eleven rounds of cell division to give raise 
to neurons of the neocortex. During each cell cycle, its nuclei migrate to and from the ventricular walls undergoing 
mitosis directly at the ventricle. A fraction of daughter cells will initiate differentiation after each round of division and 
migrate into the cortex. Subsequent to preplate formation, all six cortical layers will migrate in and settle between cells 
of the preplate splitting it into  subplate (SP) and marginal layer (ML). The neuronal layers in the cortex are differentiated 
in an inside-to-outside fashion with cells born first will settle in layer VI while subsequent cohorts of cells always migrate 
through the last layer defined and stop at the edge of the marginal layer. Neurogenesis is slightly more advanced in the 
lateral cortical zone (LCZ) compared to the most dorsal part (DCZ).
B) BrdU administration to dams pregnant for 14.5 and 15.5 days with subsequent analysis of the pups at e19.5. BrdU 
incorporates into cells undergoing DNA-synthesis and can be detected by immunohistochemistry. Labelled cells settle 
in earlier/deeper layers in mutant littermates compared to control animals. The effect is even more pronounced laterally 
and when taking the thinner cortex (bars) of mutant mice in account. 
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zone or to misspecification of neurons can not be answered in this experiment. Having shown 
earlier that Sall genes are expressed in the ventricular zone of the neocortex, not in the 
maturing neurons, it was tempting to speculate that the observed delay in neurogenesis could 
be explained by a reduction in the neuronal stem cell population. This would be in accordance 
with the histological observation that the cortex appears thinner in a knockout animal at all 
stages analyzed. 
 
4.8. Immunohistochemical Analysis of the Subventricular Zone 
To test for the rate of neurons generated in the subventricular zone, immunostainings 
against BrdU and phosphorylated histone 3 were performed on adjacent sections. Histone 3 is 
phosphorylated during mitosis and can be recognized with a specific antibody. In contrast, 
BrdU labels cells in S-phase. Figure 21 presents the results of such an experiment at e11.5 and 
e15.5. Dams were injected with BrdU 30 minutes prior to harvest of the embryos. At e11.5, 
no significant differences in the numbers of cells staining positive for phosphorylated histone 
3 or BrdU incorporation were observed.  
An alternative explanation for the reduced number of newly generated neurons can also 
be increased numbers of cells undergoing apoptosis. Apoptotic events were detected by 
immunostaining for cleaved caspase 3 without detecting any differences between knockout 
and control animals (figure 21). At e11.5, Sall4 is still strongly expressed in the neocortex and 
might mask the phenotype of a Sall1/Sall2 double knockout. Therefore, BrdU incorporation 
was also carried out at e15.5, when no expression of Sall4 is detectable. Figure 21B shows 
comparable sections of the lateral ventricle after pulse labelling with BrdU for 30 minutes. 
For the mutant, stained sections contain a reduced number of cells in S-phase. Counting 
revealed a reduction by approximately 25%. Also, the width of the stripe harbouring the 
stained nuclei seems reduced. Due to the shorter duration of mitosis relative to S-phase, fewer 
nuclei stain positive for phosphorylated histone than for BrdU at any given time. The 
difference in the numbers of cells in M-phase is thus less pronounced but present.  
Nuclei of progenitor cells undergo a phased migration to and away from the surface of the 
ventricles with mitosis occurring directly at the ventricular walls while nuclei in S-phase are 
found in the subventricular zone (Takahashi et al., 1999). Since BrdU was injected only 30 
minutes prior to fixation, no migration will occur after S-phase and location of nuclei 
currently undergoing DNA synthesis can be addressed. In mouse mutants with disturbed cell 
cycle duration, uncoupling of cell localization and cell cycle phase can be seen 
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Figure 21: Cell cycle and apoptosis in mice mutant for Sall1 and Sall2. 
Immunohistochemistry was used to determine differences in cell cycle and apoptosis between Sall1/2 double mutants 
and control animals. DNA synthesis (S-phase) was identified by injection of BrdU 30 minutes prior to collection of speci-
men.  Mitosis was visualized with an antibody against phosphorylated histone 3, apoptosis through detection of cleaved 
caspase 3. Cell cycle and apoptosis seemed normal at e11.5, when Sall4 is still expressed ubiquitously. It would be 
expected from a delay in cell cycle, that M- and S-phase are no longer localized to the compartments at and anway from 
the ventricular walls. This is not the case in Sall1/2 double mutants arguing for a normal duration of cell cycle both at 
e11.5 and e15.5. Apoptosis was not more frequent than in wildtype (A, arrowhead) not observed at e15.5 and can thus 
not account for smaller numbers of cortical neurons.
B) reduction both in number of staining cells as well as in width of the stripe of BrdU incorborating cells in mice deleted 
of Sall1 and Sall2
C) Quantification of neuronal progenitors in S-phase at e15.5 shown in B);
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 (Estivill-Torrus et al., 2002). In such a case, nuclei in M-phase would not be located 
exclusively at the ventricular wall and some S-phase nuclei will in turn be found at the 
ventricle. At e11.5 and e15.5, no ectopically positioned nuclei were seen. 
Taking the observed thinner cortex in account, the result that less cells label BrdU 
positive allows two explanations. Either the number of progenitor cells is reduced or they 
undergo cell cycle in a slower fashion. The latter is unlikely since no progenitors were found 
to uncouple cell cycle and nuclear position. This makes a delay in cell cycle unlikely and 
argues for a reduced number of cells in cell cycle. 
The time in embryogenesis and number of the cell cycle in the progenitor population has 
been tightly linked to the cortical fate of the resulting neuron (Takahashi et al., 1999). Here I 
show that mice mutant for Sall1 and Sall2 produce deeper neuronal layers compared to the 
wildtype at any given point in time and show reduced cell cycle activity. The differences in 
localization of neurons at e19.5 that were born e14.5 and e15.5 can be explained in two 
different ways. Either, a delay in neurogenesis without any effects on final cortical 
architecture upon completion of neurogenesis or a fate change in neuronal cohorts exiting the 
precursor zone. In both cases one might predict that late generated superficial layers lack cells 
at e19.5, either because they are not yet specified due to the delay or because neurons 
determine to the wrong the fate of neurons in a deeper layer.  
 
4.9. Analysis of the Specification of Cortical Layers I-VI 
Markers indicative for all cortical layers have been described previously (McEvilly et 
al., 2002). Genetic deletions are published leading to aberrations from the organization 
observed in wildtypic mice (Gupta et al., 2003). Tbr1 deficient mice fail to develop layer six 
and the preplate (Hevner et al., 2001), in the naturally occurred mutation of the reeler mouse, 
all layers are specified but Reelin, the protein disrupted by the mutation, prevents normal 
migratory behaviour (Rice and Curran, 2001). This results in a failure of early born cortical 
neurons to invade and split the preplate resulting in a so-called superplate. Subsequent cohorts 
of neurons will also fail to pass their predecessors resulting in an outside-in pattern of the 
cortex (Caviness and Sidman, 1973).  
To test for the presence and correct localization of cortical layers, in situ hybridization 
and immunostainings were utilized. Analysis was performed at e19.5, just before birth, to 
ensure full differentiation of the cortical layers.  
 
Figure 22: Molecular analysis of the effect of loss of Sall1 and Sall2 in neurogenesis.
In situ hybridization and immunostaining on littermates. Early generated layers show no or almost no change due to the 
loss of Sall alleles as visualized in staining for CSPG, Reelin and Wnt7b. In contrast, superficial layers are found closer to 
the surface (RORbeta) and thinner (TLE3).  Oligodendrocytes are unaffected in a Sall1/2 knockout, GFAP positive 
astrocyte are reduced in number. All images are coronal views, the midline is always left. CSPG appears red in immuno-
fluorescence, DAPI is blue. For GFAP signal is brown, counterstain green.
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Chondroitin sulphate proteoglycan (CSPG) is deposited in the extracellular matrix of the 
preplate and will be found in its derivatives, marginal layer and subplate (McEvilly et al., 
2002). Figure 22A shows that cortical plate neurons successfully invade the preplate, splitting 
it in two layers as observed at e16.5. The more intense signal of CSPG in the mutant is 
probably due to the reduced number of intercalating neurons. An especially thick marginal 
layer can also be observed histologically at e16.5 (figure 11B). Presence of the marginal layer 
is also shown by in situ hybridization to Reelin. The signal in the knockout is again more 
intense than in the wildtype. The marginal layer thus consists at least of the cell number 
observed in wildtype neocortex. 
The next layer that is specified is layer VI. It is marked by expression of Wnt7. Even 
though the cells in the knockout labelling positive for Wnt7b are more compacted, cell 
number appears approximately equal. As seen in wildtype, cells are positioned in the deepest 
portion of the cortical plate.  
TLE4 is expressed in the subplate as well as in layer V. No significant differences can be 
seen between control and double mutant, the width of the layer is comparable. 
Superficial to the expression of TLE4, RORβ is expressed in layer IV. While expression 
is similar in intensity and superficial relative to layer IV, expression reaches much closer to 
the surface indicating that layers positioned even later might be hypoplastic. This observation 
is underlined by TLE3, a marker for layers II to V. The Sall1/2 double mutant shows fewer 
cells staining positive for this marker. 
Late in embryonic development, neurogenesis switches to gliogenesis and progenitor 
cells give rise to oligodendrocytes and astrocytes (Kessaris et al., 2001). To test if glia cells 
are present, in situ hybridization against Olig2 was used to detect oligodendrocytes (Yokoo et 
al., 2004) and Immunostaining against GFAP revealed astrocyte presence. No significant 
differences were seen for oligodendrocytes originating from the ventral telencephalon (Qi et 
al., 2002) In contrast, astrocyte numbers were reduced (figure 22). 
Taken together, analysis of all neuronal layers and glia cells with molecular markers 
indicates, that layers deposited later are more severely affected by loss of Sall activity than 
layers forming early. The astrocyte population is generated via differentiation of neuronal 
progenitors (Hunter and Hatten, 1995). Reduced numbers of astrocytes thus support the 
finding that the neurogenic precursor population is reduced. This strengthens the hypothesis 
that Sall1/Sall2 deletion leads to a delay in neurogenesis. This delay occurs at the expense of 
late, more superficial cortical layers. Low numbers of astrocytes suggest that the progenitor 
pool is reduced in size and thus causes such retardation. Indications for a loss of progenitor 
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cells have already been obtained by BrdU labelling. In contrast to the observation in the reeler 
mouse and related phenotypes, cortical layers were found to be in the correct relative position 
to each other.  
 
4.10. Expression of the Inserted lacZ Marker from the Genomic 
Locus of Sall1, Sall2 and Sall3 
As described previously, Sall1, Sall2 and Sall3 are strongly expressed around the 
ventricular zones of the brain as well as in the olfactory bulb. Delayed neurogenesis might be 
explained by deletion of Sall genes normally expressed in neuronal progenitor and stem cell 
populations residing in the ventricular zone of the neocortex. In absence of good antibodies 
against these Sall proteins it was decided to study the expression of the markers replacing the 
coding sequence to gain additional information to the data obtained by in situ hybridization. 
EGFP and lacZ had been introduced into the second exon of Sall1. Both markers 
reported expression. As seen in figure 23, A-F, Bluo-Gal staining faithfully recapitulates the 
expression pattern observed by in situ hybridization in the adult central nervous system. A 
very high number of cell nuclei in the olfactory bulb show expression of both the inserted 
lacZ gene in a mouse heterozygous for Sall1-lacZ as well as expression of Sall1 mRNA in a 
wildtype mouse. In most other regions of the adult brain, expression is seen in a small fraction 
of cells giving rise to a speckled pattern. In the cerebellum, almost all nuclei located in the 
deep white matter of the cerebellum harbouring axon bundles stain. Only nuclei of glia cells 
are found in this region. The good correlation with the in situ is therefore especially 
conclusive here (figure 8C). Comparison of β-galactosidase and in situ data in the CNS and 
elsewhere strongly suggests that all cells expressing Sall1 also transcribe the bicistronic trans- 
cript of EGFP and lacZ inserted into exon two. Expression of these markers can thus be used 
to locate Sall1 expressing cells. 
 
Sall1
Sall2
olfactory bulb dentate gyrus cerebellum
olfactory bulb dentate gyrus cerebellum
Figure 23: Expression of beta galactosidase from the Sall1 and Sall2 locus compared to in situ 
hybridization of the original transcript.
In situ hybridization of Sall1 (A-C) and Sall2 (G-I) in sagittal sections of adult brains is compared to beta galactosidase 
staining. Examples shown are olfactory bulb, hippocampus and cerebellum.
Sall1 in situ hybridization resulted in a speckled pattern of expression throughout the brain as well as high expression 
in the olfactory bulb interneurons (A). This expression is entirely recapitulated by beta galactosidase.
In contrast, Sall2 expression is not faithfully reported by beta galactosidase. Expression of Sall2 mRNA in the olfactory 
bulb is indistinguishable from Sall1, while neurons in the hippocampus express only Sall2 (H). Expression in the cerebel-
lum is specled but localized different from Sall1. Bluo-Gal staining only reports the speckled pattern observed (K;L) while 
interneurons of the olfactory bulb (J) and hippocampus (K) do not express lacZ.  PC: purkinje cells;
A B C
D E F
G H I
J K L
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To generate a Sall2 knockout, the second exon had been replaced with a lacZ allele. 
Figure 23G-L illustrates, that β-galactosidase activity can not be visualized in all cells where 
Sall2 transcript is detected. While the speckled pattern seen in the in situ and also for Sall1 is 
reported by Sall2-lacZ, expression in the neurons of hippocampus and olfactory bulb is not 
recapitulated by the inserted cassette. In the hippocampus, expression does report as expected. 
It has to be concluded, that the genetically modified transcript does not fully recapitulate 
expression of Sall2 and can not be used to study expression in detail. While part of the 
ih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Citation&amp;list_uid
s=11687494 </url></related-urls></urls></record></Cite></EndNote>(Blau et al., 2001; 
Weissman et al., 2001) 
However, a definitive proof that some adulfor Sall2 studied by in situ hybridization is 
reminiscent of Sall1 expression both in olfactory bulb and the speckles seen throughout the 
brain (with exception of the cerebellum). Therefore, cells expressing Sall1 might also express 
Sall2. 
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Expression of Sall3-lacZ is very weak and can only be detected at embryonic stages in a 
whole mount staining with Bluo-Gal as shown in figure 24. While the expression observed is 
roughly reminiscent of transcription observed through in situ hybridization, staining was too 
weak to allow cellular expression analysis based on β-galactosidase as exemplified in a 
comparison of in situ and Bluo-Gal visualization in the olfactory bulb. Unlike Sall2-lacZ, β-
galactosidase is expressed in the olfactory bulb from the Sall3 locus (figure 24A, B, 
arrowhead). Nevertheless, barely any expression is visible on a cryostat section of an adult 
mouse heterozygous for Sall3-lacZ. Arrows point to expression in the limb (figure 24A) and 
spinal cord (B).  
Since only Sall1 showed strong β-galactosidase activity precisely reporting transcription 
of the endogenous genomic locus, further expression analysis was restricted to Sall1. 
Nevertheless, in situ data suggest a considerable overlap between Sall1, Sall2 and Sall3 
expression also on cellular level for example in the olfactory bulb. 
 
4.11. Precise Expression Pattern of Sall1 in the CNS 
In situ data for Sall1 had shown strong expression in the subventricular zones of the 
lateral ventricles. It had been reported previously that neuronal stem cells reside in this 
location giving rise to the interneurons in the olfactory bulb (Gritti et al., 2002). To test if 
Sall1 is expressed in the SVZ and the differentiating neurons migrating into the olfactory 
bulbs, β-galactosidase staining was performed on lateral sections of the brain seven days and 
eight weeks after birth. Blue labelling is seen around the ventricle, in the rostral migratory 
stream (RMS) as well as in the olfactory bulb itself at P7 (figure 25A). This indicates that 
Sall1 is indeed expressed in or around the undifferentiated neuronal progenitor cells migrating 
into the olfactory bulb to give rise to granular cells (GC) (Gritti et al., 2002). It an adult mouse 
only few cells that stain positive for Bluo-Gal are observed in the ventricular zone. As this 
was suggestive of an involvement of Sall1 in undifferentiated neuronal stem cells or the stem 
cell niche also in adult brains, I next wanted to identify the cell types expressing Sall1 in the 
different regions of the brain. 
Fluorescent coimmunostaining with an antibody against β-galactosidase or EGFP, both 
indicative of Sall1 expression, and markers for different cell types was performed. Consistent 
with in situ data, EGFP expression was detected in almost all cells of the ventricular and 
subventricular zone at e16.5 while cortical neurons (top half) do not express Sall1-lacZ. 
Cytoplasmic staining of GFP shows long extensions of the GFP positive cells. These radial  
Figure 25: Expression analysis of Sall1 at cellular resulution
Based on the assumption that the reporter cassette including an EGFP fusion as well as transcription of lacZ faithfully 
reports Sall1 transcription, expression was analyzed on cryostat sections of brains heterozgous for Sall1.
In part A, an overview is shown at postnatal day seven (P7) as well as in an adult brain. In addition to the speckled expres-
sion observed, in the whole CNS including the neocortex (nc), higher density of cells presumably expressing Sall1 can be 
found in the neurogenic regions of the dentate gyrus (dg) as well as the lateral ventricle (lv). The rostral migratory stream 
(rms) consists on newly generated neurons migrating from the walls of the lateral ventricle into the olfactory bulb (OB) 
and minimizes in adulthood. Expression is also present in the mitral cell layer (mcl) of the OB.
Within the young lateral ventricle, expression is seen in almost all cells of the subventricular zone including cells forming 
long radial extensions towards the cortical surface (B). Reduced expression in adult brain colocalizes in cells staining 
positive for glial fibrillary acidic protein (GFAP) in all regions analyzed (B,C). GFAP is a marker for the glial celltype of astro-
cytes. While immunostaining for lacZ and NeuN (neuronal nuclei) is exclusive in dentate gyrus and cerebellum, colabel-
ling in yellow can be observed only in the olfactory bulb interneurons.
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extensions are indicative of radial glia and migrating neuronal precursors (Coskun and 
Luskin, 2001). Radial glia serves as neuronal progenitor population during embryogenesis 
(Tamamaki et al., 2001). At this age, the SVZ still consists of several layers of neuronal 
precursors and undifferentiated neurons suggesting that the staining observed is indeed 
located in the precursor population. The high cell density makes interpretation of colabelling 
studies difficult. Therefore, cells positive for Sall1-lacZ were costained on coronal sections of 
an adult mouse with an antibody against glial fibrillary acidic protein (GFAP). GFAP is an 
intermediary filament expressed in astrocytes (Garcia et al., 2004), one type of glial cell. 
Several recent reports identified astrocytes as neuronal stem cells in mouse (Doetsch et al., 
1999; Garcia et al., 2004). As illustrated in figure 25B, cells with nuclei labelling positive for 
β-galactosidase also express GFAP showing that lacZ is expressed in astrocytes of mice 
heterozygous for Sall1-lacZ. 
New evidence suggests that GFAP positive neuronal stem cells are not restricted to the 
lateral ventricles but are also found in the olfactory bulb, dentate gyrus of the hippocampus 
and neocortex (Gritti et al., 2002; Song et al., 2002a; Song et al., 2002b). I thus analyzed these 
regions of the adult brain for their expression of Sall1 and GFAP. As presented in figure 25C, 
immunoreactivity is located in cells positive for GFAP in all regions. To test whether Sall1-
lacZ is also expressed in neurons, fluorescent colabellings with an antibody raised against 
neuronal nuclei (NeuN) were performed. Sall1-lacZ is expressed in neurons of the olfactory 
bulb (mitral cells and granular cells) but absent from all other neurons tested. Since neuronal 
progenitor cells are residing at the lateral ventricle while differentiating neurons are found in 
the cortex, the brain offers the possibility to illustrate that Sall1 is expressed in neuronal 
precursors and astrocytes, identified as neuronal stem cells. 
These studies confirmed that Sall1 is expressed in neuronal progenitors and stem cells 
during development as well as in adult mice. Absence of olfactory bulb neurons and delay in 
cortical neurogenesis in a Sall1/Sall2 double knockout is thus best explained by requirement 
of Sall1 and Sall2 in the neuronal progenitor population. 
 
 
Figure 26: Effects of a Sall1-3 triple knockout on brain architecture and comparison of Sall1 and 
Sall3 expression in forebrain and the developing olfactory bulb.
A-C) Comparative  thionine staining to study the effects of a Sall3 compared to a Sall1 and Sall3 deletion in a Sall2 
deficient background. Deletion of Sall3 does not lead to major effects in the neocortex. Even a triple knockout of Sall1-3 
still retains a neocortical structure similar to a Sall1-/-, Sall2-/- deletion. In conrast, deletion of Sall1-3 leads to almost 
complete absence of cortical structures from the ventral forebrain or paleocortex (arrow) where expression of Sall1, 
Sall2 and Sall3 overlap. Due to overall changes in brain morphology, sections look slightly different.
D-G) Sagittal sections through mouse telencephalon and olfactory bulb at e13.5 (D, F) and e15.5 (E, G). At e13.5, Sall1 is 
expressed in the ventricular and subventricular zone as well as mitral cell progenitors, at e15.5 expression in the mitral 
cell layer (mcl) is already apparent. In contrast, Sall3 is not expressed in the mitral cell progenitors, only in the ventricular 
and subventricular  zone at e13.5. Later expression is detected in the periglomerular layer, a region not transcribing Sall1 
while Sall3 is not detected in the Sall1 expressing mitral cell layer. While the ventricular zone gives rise to inhibitory 
local interneurons at e13.5, mitral cells are generated in the subventricular zone. (aob: accessory olfactory bulb)
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4.12. Synergistic Effects of Sall Proteins in Neurogenesis 
Considerable overlap of expression patterns amongst murine Sall genes was described 
for the central nervous system. In the developing neocortex, expression of Sall1 and Sall2 is 
most prominent during stages, in which neurogenesis takes place (e.g. e13.5). Sall3 transcript 
is considerably less abundant but present (figure 4). In contrast, Sall1, Sall2 and Sall3 are 
strongly expressed in the olfactory bulb all through embryogenesis (figure 3, 4). A deletion of 
Sall1 and Sall2 leads only to minor effects in the neocortex while in the olfactory bulb, 
functional mitral cells are completely absent. Can expression of Sall3 account for these 
differences? 
OB projection neurons (mitral and tufted cells) originate from the ventricular zone of the 
developing bulb, are not renewed postnatal and are already present at embryonic day 13 while 
interneurons (granular and periglomerular cells) are of subventricular origin and mostly 
generated late in embryonic development or after birth (see figure 25A), (bulfone1998). Sall1 
is expressed in (figure 26D-G) progenitors as well as interneurons and projection neurons at 
e13.5 as well as at e15.5. Sall3 transcript, also found in the ventricular and subventricular 
zone of the olfactory bulb, is absent from developing neurons of the mitral cell layer at e13.5 
and e15.5. Additional expression is observed in periglomerular cells at e15.5. 
In accordance with the notion of redundancy, deletion of Sall1 manifests in loss of 
mitral cells that express only Sall1. Loss of Sall3 results in loss of cells in the outer plexiform 
and periglomerular layer where only Sall3 is present and in mice deleted for Sall1, Sall2 and 
Sall3 all cell types are missing. This suggests that both, Sall1 or Sall3 alone, are sufficient for 
the formation of granular cell precursors and deletion of the genes leads to defects in cell 
types in which they are exclusively expressed. 
In the dorsal telencephalon, additional deletion of Sall3 does not result in a major 
enhancement of the phenotype observed in a Sall1/Sall2 knockout while the ventral portion of 
the telencephalon lacks almost all cortical structures (figure 26C, arrow). Sall3 is expressed at 
high levels in the ventral telencephalon at e13.5 and e15.5. Expression in the dorsal 
telencephalon is only seen at birth, a stage where neurogenesis in a wildtype mouse is almost 
completed. 
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5. Loss of Function of Sall1 and Sall3 Causes Oligodactyly 
As mentioned earlier, Sall1 and Sall3 are expressed in developing limb buds (Kiefer et 
al., 2003; Ott et al., 2001). Mutations of SALL factors in humans cause limb deformations. It 
has been suggested that these deformations may be explained by haploinsufficiency 
(Kohlhase et al., 2002b; Kohlhase et al., 1998), gain of function or dominant negative effects 
(Kiefer et al., 2003). Clean deletions of Sall coding sequence through knockout technology in 
mouse enabled me to study effects of Sall proteins on limb development in a well defined loss 
of function situation. 
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Intercrossing animals heterozygous for Sall1 and Sall3 generated nine classes of 
progeny at e18.5. Embryos were collected and processed for alcian blue alicarin red staining. 
Figure 27 illustrates a clear genetic dosage effect. Developmental malformation correlates 
with progressive loss of spalt-like alleles that are expressed in the limb bud. Observed defects 
included loss and fusion of skeletal elements. Oligodactyly can be seen upon loss of at least 
three of the four alleles provided by Sall1 and Sall3. Like for the human syndromes of TBS 
and DRRS, anterior phalanges were affected most by loss of Sall genes in mouse.  
For humans, polydactyly as well as oligodactyly has been described. Polydactyly could 
never be observed in this loss of function study arguing that at least some of the dominant 
mutations described for TBS and Okihiro/Radial Ray Syndrome are due to gain of function 
effects, not of haploinsufficient or dominant negative nature. This is consistent with the 
finding that truncations of sem-4 containing the first zinc finger act as gain of function 
proteins (Toker et al., 2003). 
Additional loss of Sall2 did not enhance the observed phenotype. Expression of Sall4 in 
early limb buds had been reported previously (Kohlhase et al., 2002a), whether Sall4 function 
is required for murine limb development was not addressed.  
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Discussion 
The spalt family of transcription factors is highly conserved in all functional domains 
not only between different species but also amongst the four known SALL paralogs of human 
and mouse. Previous work in several model organisms including Drosophila, C. elegans, fish, 
chicken and mouse has established a crucial role for Sall genes in development. Nevertheless, 
no systematic genetic approach in vertebrates has been undertaken till date to analyze the 
effects of a loss of Sall genes. Due to functional redundancy amongst the four Sall family 
members, such an approach is required. I chose a systematic genetic approach in mouse to 
gain new insights in the role of SALL transcription factors in vertebrate development. 
Generation of knockouts for all four murine Sall genes enabled a combinatorial genetic loss of 
function analysis of several developmental processes. 
 
1. Sall Transcription Factors are Expressed in Proliferative 
Cell Populations 
Some information on the expression of Sall genes in mouse could be retrieved from 
previous studies. Typically, expression was studied by whole mount in situ hybridization or 
northern blot analysis. Sall1 expression is described in brain, limb buds and kidney (Takasato 
et al., 2004). For Sall2, northern blot analysis (Kohlhase et al., 2000) showed high expression 
levels in adult brain, and low transcript abundance in lung, kidney and ovary. No expression 
was observed in adult heart, liver and testis. A study in 2003 (Sato et al., 2003) stated an 
overlap to Sall1 expression. 
Sall3 expression is described for neural tube as well as the midbrain-hindbrain 
boundary, the diecephalon and the ventral forebrain (Ott et al., 2001). Expression of Sall3 in 
the palate and subsequent loss of function analysis demonstrated a function of Sall3 in the 
palate (Parrish et al., 2004). 
Cloning of Sall4 was reported in 2002 (Kohlhase et al., 2002a) and expression analyzed 
by whole mount in situ hybridization. Transcript was detected in the embryo proper at e7.5, in 
the primitive streak, isthmus as well as in limb and tail buds at later stages. So far, no 
comparative analysis for all four Sall members has been undertaken to compare expression in 
space and time. In this study, systematic radioactive in situ hybridization was utilized to 
compare the expression of SALL factors in mammals. Sall genes code for highly conserved 
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transcription factors. The in situ hybridization protocol used included digestion of single 
stranded RNA post hybridization and thus prevented cross-hybridization to closely related 
transcripts.  
Sall1 and Sall3 expression is almost exclusively localized to the central nervous system 
(figures 3 and 4). Additional expression outside the CNS was observed in heart and kidney. 
Expression of Sall1 and Sall3 overlaps largely except for the neocortex where mainly Sall1 is 
transcribed at stages of neurogenesis. Later stages also show expression of Sall3 in 
neocortical regions. In the kidney, expression in the cortex is unique to Sall1 while 
epithelializing mesenchyme also expresses Sall2 and Sall3. Cells expressing transcripts of 
Sall1 and Sall3 within the CNS are found adjacent to ventricles. Strong expression in adult 
mice is restricted to the olfactory bulb. Utilizing the lacZ knockin into the Sall1 locus 
revealed that expression was seen in almost all cells of the ventricular and subventricular zone 
of the lateral ventricles in the neocortex at e16.5 and restricts to astrocytes along the 
ventricular walls, hippocampus as well as intermingled within neurons in adult mice. Thus it 
seemed as if Sall1 was expressed in cells capable to serve as neuronal progenitors. The only 
neuronal population found to express Sall1 are olfactory bulb interneurons. 
In contrast to that, transcripts for Sall2 and Sall4 are not restricted to the neuroectoderm. 
Rather, these genes are expressed in a fairly wide range of cell types in all germ layers. 
Detailed expression analysis revealed that Sall4 is expressed from the 16 cell stage on, 
restricts to the inner cell mass of the blastocyst at the time of implantation and remains 
localized to ICM derivatives until decline of protein levels around day 9.5 (figure 9G). 
Expression of Sall4 in later embryonic development is restricted to the liver (figure 4J), in 
adult mice, only Sall4 was found in maturing oocytes. 
Interestingly, the similarity of expression patterns correlates with protein homology 
amongst Sall genes in mouse and human (figure 3 and 4, compare to figure 1) Sall1 and Sall3 
are the closest related members judged by protein similarity and their strongly overlapping 
expression suggests that ORF and promoter region duplicated together during evolution. Both 
genes express mainly in the central nervous system. Sall2 and Sall4 express in all germ layers 
with Sall4 expressing in an earlier time window than Sall2. 
As we and others show, spalt-like transcription factors are in general developmentally 
expressed and only few adult tissues retain Sall transcription. A systematic expression 
analysis of all four Sall genes revealed that embryonic transcription is found in cells well 
described to act as self-renewing, proliferating stem- and progenitor cell populations. 
Totipotent germ cells and cleavage stage embryos (Johnson and McConnell, 2004; Nichols et 
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al., 1998) express Sall4, pluripotent epiblast cells express Sall2 and 4, cells of the CNS 
ventricular zones express all Sall genes, especially Sall1 and Sall3. Expression of Sall1 in the 
neocortex peaks at the time of maximal progenitor population e12.5-e14.5. Adult expression 
of Sall transcription factors is found in astrocytes serving as neuronal stem cells (Doetsch et 
al., 1999), interneurons of the olfactory bulb that underlie constant renewal (Kaplan et al., 
1985) as well as oocytes of the female germline. Upon differentiation of progenitor cell 
populations in the neocortex, Sall1 expression declines (figure 25B). In cell culture, induced 
differentiation of ES cells leads to a reduction of Sall4 expression (figure 9M). 
Specific localization of Sall gene products to progenitor compartments was not 
previously recognized and served to evaluate the various phenotypes described herein. It lead 
to the hypothesis that SALL function is specifically required for progenitor cells. In the 
Drosophila sensory organ precursors, loss of spalt expression is a prerequisite for 
differentiation (de Celis et al., 1999) suggesting a function of spalt genes in maintenance of an 
undifferentiated state. 
 
2. A Role for Sall Factors in Stem and Progenitor Cell 
Populations 
A stem cell, by definition, is an undifferentiated cell that can produce daughter cells 
capable to either remain a stem cell (self-renewal) or enter a differentiation pathway. The 
signals that induce self renewal can be intrinsic, external (the stem cell niche) or both (Tada 
and Tada, 2001). Often, differentiating cells will undergo several additional rounds of cell 
division. They can not produce a self-renewing stem cell any more, rather all daughters will 
ultimately be terminally differentiated. Hence, these cells are referred to as progenitor cells. 
Besides self-renewal, proliferation, differentiation and tissue regeneration capacity, some 
definitions for stem cells include that stem cells must be able to self renew indefinitely, at 
least for the lifetime of the organism. The capacity to generate multiple different cell types is 
not included in the term stem cell. Rather a distinction between totipotent (the fertilized egg), 
pluripotent (ES cells) multipotent (radial glia cells) or cell type specific stem cell (e.g. in the 
skin) is made. However, the developmental potential of non-totipotent stem cells is under 
debate (Raff, 2003).  
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Till date, ES cells are by far the best characterized stem cell population due to well 
established culture conditions and because protocols for ES cell derivation are relatively 
simple and remain unchanged to the present day (Rastan and Robertson, 1985; Smith, 2001)  
Intense studies during the last many years have lead to a well characterized system. 
Knockout analyses have supported such studies and identified Oct4, Sox2 and Nanog as core 
players in a transcriptional circuitry required to maintain the developmental pluripotency of 
stem cells. These three factors are believed to have distinct but related roles (Chambers, 2004) 
in embryonic stem cell populations.  
Deletion of Oct4 leads to differentiation of ICM into trophoblast within four days in 
cultures of blastocyst outgrowths and immunosurgically exposed inner cell masses. This 
could be shown by morphological changes and upregulation of TROMA (Nichols et al., 
1998). Subsequent studies of Oct4 in ES cell culture showed that deletion of Oct4 results in 
transdifferentiation of ES cells into trophoblast. In contrast to that, overexpression of Oct4 
leads to differentiation into primitive endoderm. However, this was only shown by increased 
levels of Gata4 expression measured by RT-PCR (Niwa et al., 2000). Oct4 is thus believed to 
play an important role in the separation of the inner cell mass lineages from the trophoblast. 
In a knockout of Sox2, implantation sites are empty at e6.0 and only H19 can be 
detected while the Oct4-expressing embryo proper is missing. Blastocyst outgrowth 
experiments revealed that the mutant ICM failed to grow. After immunosurgery, few giant 
cells were observed in ESC medium (Avilion et al., 2003) leading to the assumption that Sox2 
is required for ICM lineage maintenance. 
Nanog is only expressed in epiblast cells forming the embryo proper. Knockout ES cells 
differentiate into primitive endoderm (Mitsui et al., 2003) judged by the upregulation of 
multiple markers for primitive endoderm. Additionally it could be shown that ES cells 
ectopically expressing Nanog remain undifferentiated even in the absence of LIF (leukaemia 
inhibitory factor). LIF is required for ES cell culture to maintain cells in a pluripotent state. 
These observations placed Nanog directly into a cascade required to maintain pluripotency. 
Common to all three studies is a developmental arrest immediately after implantation as well 
as the presence of trophoblast tissue accompanied with an absence of cells expressing the 
respective transcription factor. The Oct4 phenotype establishes already at preimplantation 
stage. In an Oct4 and Sox2 knockout, giant cells replace ES cells upon immunosurgery. 
Similar effects are seen in the Sall4 knockout. How might they relate? 
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2.1. Sall4 is Required for Inner Cell Mass Fate 
Sall4 is expressed in preimplantation embryos and will remain expressed in inner cell 
mass and its derivatives until mid-gestation at decreasing levels. No other Sall genes are 
expressed that early and at such high levels (figures 3, 4 and 9). In absence of additional Sall 
factors, deletion of Sall4 causes dramatic effects. Implantation sites of Sall4 deficient 
blastocysts lack embryonic structures or cell types at e6.5 as it was observed for Sox2-/- and 
Nanog-/- embryos. Neither embryo proper nor primitive endoderm can be identified either 
histologically or by marker analysis such as in situ hybridization against Oct4. Implantation 
was verified by detection of H19 and Cited transcript expressed in primary and secondary 
giant cells (figure 11). Unlike all prior analyses of periimplantation lethality (Avilion et al., 
2003; Hanna et al., 2002; Mitsui et al., 2003; Nichols et al., 1998) in mouse, this study is able 
to receive positive confirmation for the genetic identity of the blastocysts leading to empty 
implantation sites due to the possibility of non-invasive genotyping of living e3.5 blastocysts 
prior to implantation (figure 8). Chimeric studies in vivo present evidence that Sall4 
requirement is cell autonomous in the epiblast (figure 16). The failure to rescue a Sall4 
deficient blastocyst by injection of labelled wildtype cells suggests that defects in primitive 
endoderm prevent survival of injected ES cells, since results of in vitro studies argue against a 
defect in the trophoblast (see also below). 
In vivo studies were supplemented by the observation of blastocyst development ex vivo 
to study the dynamics leading to complete termination of development at e6.5. Culture of 
blastocysts in ES cell medium supported the finding that ICM cell lines but not trophoblast is 
affected by loss of Sall4.  
Intense TROMA expression in a tight layer surrounding the ICM in a Sall4-/- blastocyst 
outgrowth suggests that ES cells can not maintain identity in culture. Instead of proliferation 
in a self-renewing fashion, cells differentiate and form a tight epithelium. Cultivated in ESC 
medium, wildtype ESCs maintain their identity and grow even on the surface of a blastocyst 
outgrowth (figure 12C) or in cell culture of ES cell lines. 
Immunosurgery was used to separate ICM cells from trophoblast cells to then follow the 
developmental potential of ES and primitive endoderm (XEN) cells upon deletion of Sall4. If 
lineage commitment is already established by transcription factor expression, cells will 
continue growth as ES cells and XEN cells. Indeed, in ICM cultures of control blastocysts 
cells grew as ES and XEN cells. In contrast to that, no such cells could be observed from 
Sall4-/- ICMs after a few days in culture.  
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The absence of growing ES and XEN cells that would be expected in ICM culture 
confirms observations in vivo where no ICM derivatives could be observed at e6.5. I conclude 
that Sall4 is required for maintenance of both cell types of the ICM, ES cells and primitive 
endoderm. Trophectoderm replaced cells of the inner cell mass. Whether TS cells or giant 
cells are formed from the ICM depends on presence of Fgf-4 like it does for cell culture of 
wildtype TS cells indicating normal responsiveness. 
The two cell types present in ICMs are interdependent. Thus, experiments were 
designed to distinguish effects in ES cells and primitive endoderm. Deletion of Sall4 by Cre 
recombinase mediated excision in two independently established ES cell lines showed that 
Sall4 is required specifically for ESCs in culture. Growth of ES cells in culture is cell 
autonomous. Therefore Sall4 is cell autonomously required for growth of ES cells in culture.  
Establishment of XEN cells and subsequent targeting with Cre remains to be done in 
order to ask if XEN cells also depend on the presence of Sall4 in a cell autonomous fashion. 
Absence of primitive endoderm cells in culture of ICMs however suggests that both ICM cell 
types require Sall4 cell autonomously. In vivo, morula aggregation confirmed that Sall4 is 
required cell autonomously in the epiblast.  
Taken together, this study was able to show that Sall4 is required for maintenance of 
embryo proper and primitive endoderm in a cell autonomous fashion both in vivo and in vitro.  
 
Cell lines of trophoblast and inner cell mass separate at the compacting morula stage 
(Rossant, 2004). The lineage separation is accompanied by differential expression of several 
transcription factors. Oct4, Sox2 and Nanog are expressed in the inner cell mass as discussed 
earlier. Cdx2 is the first known transcription factor to be specifically expressed in trophoblast 
cells. How the two separate lineages of ICM and trophoblast are established and different sets 
of transcription factors expressed is not known.  
One hypothesis is that the location position of the cells serves as the initial signal for 
lineage determination and will induce the transcriptional differences. By the eight cell stage, 
blastomeres start compaction and transform from an apolar to a highly polarized cell leading 
to the first proto-epithelium of development (Fleming and Johnson, 1988). This polarization 
occurs at all levels of organization: cytocortical, cytoplasmic and cytoskeletal (Johnson and 
McConnell, 2004). If subsequent cell division occurs in a radial axis relative to the morula, it 
will result in a distal, polarized cell as well as a proximal cell in the center of the 16 cell 
morula. The centric cell will derive exclusively from the basolateral side of the dividing polar 
cell and thus be apolar again. Further cell divisions generate a 32 cell compacted morula with 
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apolar ICM cells in the center as well as highly polarized cells on the surface giving rise to the 
trophoblast lineage. This lineage commitment is still plastic in an experimental setup. 
Removal of all outer cells will initiate an additional round of cell division with subsequent 
differentiation of superficial cells into trophoblast (Johnson and Ziomek, 1983). Thus the 
location of each cell might induce a transcriptional profile generating different cell identities 
in the mouse morula.  
Further support for this model comes from the observation that initial polarization and 
compaction is independent of protein synthesis (Kidder and McLachlin, 1985). Differential 
expression of transcription factors like Sox2, Oct4 and Nanog in the inner cell mass as well as 
Cdx2 in the trophoblast thus might be a consequence of cell localization and serve to reinforce 
differences to a developmental commitment. In accordance to a rudimentary ability of 
preimplantation embryos to establish the two cell lineages prior to transcription factor 
expression, no knockout of transcription factors described till date interferes with initial 
lineage separation. The most severe phenotype described has been found in Cdx2 knockouts. 
Cdx2-/- morulas can still transform into a blastula like structure, a process that requires 
polarization and epithelialization of trophoblast cells (Strumpf et al., 2005). Nevertheless, 
these blastulas fail to implant, demonstrating that no full trophoblast commitment can be 
reached. Deleting ICM specific factors like Oct4 (Nichols et al., 1998), Sox2 (Avilion et al., 
2003) and Nanog (Mitsui et al., 2003) allows developmental progression until and including 
implantation. 
This model of position-dependent lineage commitment has interesting implications for 
the interpretation of the results presented on Sall4. I show that ES cells and primitive 
endoderm cells fail to self-renew in a Sall4-/- blastocyst outgrowth experiment. Nevertheless, 
TROMA does not label all cells of the inner cell mass but rather is only detected on cells at 
the surface indicating that superficial cells are epithelialized. The presented model might 
explain the absence of TROMA staining in the center. While all ICM cells loose the ability to 
self-renew, differentiation and epithelialization of ES cells might require the exposure to the 
surface. Hence, only superficial cells in a Sall4-/- blastocyst outgrowth express TROMA 
while the whole ICM differentiates upon immunosurgery. As shown before, TROMA positive 
cells detach from a blastocyst outgrowth. This will ultimately lead to the complete loss of ES 
cells. Therefore, the interpretation that Sall4 is required for ICM maintenance is in accordance 
with the present understanding of cell lineage determination and maintenance in early 
embryos.  
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The definition stem cell includes the capacity to proliferate, self renew and differentiate. 
Growth of TS cells as well as subsequent differentiation into giant cells does not fulfil 
requirements for embryonic stem cells since both cell types are extraembryonic and not a 
natural progeny of ES cells. Therefore, ES cell fate can not be maintained in absence of Sall4 
function. 
 
2.2. Explanations for Appearance of Trophoblast in Sall4-/- ICMs 
As discussed earlier, giant cells appear upon culture of ICMs in ES cell medium while 
TS cell medium leads to the formation of trophoblast stem cells in a Sall4 knockout but not in 
wildtype. How can the appearance of trophoblast be explained? 
 
Two alternative explanations can account for the presence of trophoblast lineage in culture of 
ICM. A transdifferentiation model suggests fate change of ICM cells upon loss of Sall4. The 
maintenance model suggests that endogenous plasticity of ICM cells allows for TS cell 
growth from ICMs while ES and XEN lineage are not maintained. 
As discussed earlier, cell lineages of trophoblast and inner cell mass separate during 
morula compaction but final lineage commitment based on differential expression of 
transcription factors occurs at some point in the blastula in wildtype (Johnson and McConnell, 
2004). Several reports find plasticity until the 32 cell stage (Handyside, 1978; Rossant and 
Lis, 1979) while trophoblast formation was seen even from ICMs of blastocysts collected e3.5 
and cultured for 24 hours (Hogan and Tilly, 1978) by other groups. Inefficient killing of 
trophoblast cells by the immunosurgery procedure is unlikely as has been discussed in earlier 
studies utilizing immunosurgery (Hogan and Tilly, 1978). Blastocysts used in this study 
contained approximately 64 cells. The interpretation of the results obtained from cultivating 
ICMs depends on an assessment of the plasticity in the ICM. 
According to a transdifferentiation model, Sall4 is required for the identity of the inner 
cell mass and acts as a lineage switch between trophoblast and ICM. Sall4 is expressed at 
higher levels in the inner cell mass compared to the trophoblast lineage and will restrict to 
ICM derivates after implantation. In a Sall4 knockout, ICM lineage commitment can not be 
maintained and cells transdifferentiate into trophoblast upon surface exposure as they would 
do prior to the 32 cell stage. Loss of Oct4 is thought to have such an effect. However, to prove 
this model, it has to be formally shown that trophoblast cells arose from a population that was 
or should be fully committed to ICM fate. Whether lineages in a 64 cell blastocyst are already 
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committed is controversial (Hogan and Tilly, 1978; Rossant and Lis, 1979). Oct4 depletion 
from an established ES cell line lead to differentiation into trophoblast and thus fulfils these 
criteria. Also, differentiation occurs more rapidly than in case of Sall4.  
A maintenance model assumes that lineage commitment is not complete at the 64 cell 
blastocyst stage (Hogan and Tilly, 1978). ICM cells might still be able to give rise to 
trophoblast, even though under normal conditions ES cells and XEN cells will grow. 
Supportive to that is the notion that ICM will also give rise to totipotent germline, ultimately 
able to form trophoblast. If cells are not able any more to grow as ES or XEN cells, the 
remaining plasticity to generate trophoblast might divert some cells. Trophoblast is not 
affected by loss of Sall4 and will thus be able to grow.  
To distinguish between the two models, a transdifferentiation model versus a plasticity 
based model, it is crucial to assess the developmental potential of the cells undergoing the 
switch in cell types. To do so, one might make use of the floxed Sall4 ES cell line that has 
been described herein. Deletion of Sall4 in the presence of TS cell medium supplemented 
with FGF4 can challenge a transdifferentiation model because the plasticity of the floxed ES 
cell line is restricted. Murine ES cells never differentiate into trophoblast cells even under TS 
cell conditions. Subsequent to deletion of Sall4 by Cre transfection, presence of TS cells 
would thus argue for a transdifferentiation model. For Oct4, such a switch could be 
established. 
In conclusion, cell culture with Sall4 deficient blastocyst outgrowth, inner cell mass and 
ES cells served to establish that cells of the ICM depend on Sall4 expression to maintain their 
self-renewal capacity. Expression of TROMA in superficial cells of the inner cell mass 
together with absence of ES cells and XEN cells in culture of ICMs supports a model 
suggesting that Sall4 is required for commitment of ICM cells and only trophoblast cells can 
grow upon loss of Sall4. 
 
2.3. What Could be a Molecular Role for Sall4 in ES Cells? 
Chromatin co-immunoprecipitation with Oct4, Sox2 and Nanog transcription factors 
from human ES cells and subsequent microarray analysis (Boyer et al., 2005) identified 
binding sites of all three transcription factors in the promoter region of several other 
transcription factors. Amongst them, Oct4, Nanog and Sox2 each bind to their own promoter 
as well as to the promoter of the other two genes. It is assumed, that mutual regulation of 
these three transcription factors serves as a core regulatory circuitry to define stemness. 
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Recent studies come to the same conclusion for the murine orthologous for Oct4, Sox2 and 
Nanog (Robson, 2005). While a regulatory loop can maintain expression of these three stem 
cell factors, it would be expected that they also employ additional transcriptional regulators to 
maintain, proliferation, self-renewal and pluripotency. Interestingly, human Oct4, Sox2 and 
Nanog bind to the Sall1 promoter (Boyer et al., 2005), while all three mouse orthologs bind to 
the genomic locus of Sall4 (Robson, 2005). This suggests that Sall genes -Sall4 in mouse- are 
directly downstream of a core circuitry defining the properties of stem cells. 
Here I present data suggesting that ES cells loose the capacity to self renew in Sall4 
knockout embryos and ES cell lines. It is therefore tempting to speculate that Oct4, Sox2 and 
Nanog act in part through Sall4 to maintain stem cell identity and commitment. Down 
regulation of Sall4 protein levels as presented in a differentiation assay with ES cells might 
thus be an indirect effect caused by reduction in Oct4, Sox2 or Nanog expression. Based on 
present expression of Oct4 and Nanog in expanded Sall4-/- blastocysts it can be concluded 
that Sall4 is downstream of these two factors. An alternative explanation would be that Sall4 
also bound the promoter of Oct4, Sox2 and Nanog and is part of a transcriptional network 
controlling stemness. Loss of Sall4 might then not be sufficient to inactivate expression of 
Oct4 and Nanog. The ability to activate expression has been shown for spalt family 
transcription factors (Onai et al., 2004), though several studies suggest that Spalt proteins act 
as transcriptional repressors. 
What might be the molecular role of Sall genes in progenitors, more specifically Sall4 in 
ES cells? Drosophila spalt interacts genetically with polycomb complexes, important to 
maintain a transcriptionally silenced state (Landecker et al., 1994) arguing for a role of spalt 
related genes in general transcriptional silencing. Genetic deletion of members of the 
polycomb complex in mouse have been shown to lead to periimplantation lethality and 
growth defects in the epiblast (Donohoe et al., 1999; O'Carroll et al., 2001) Studies also 
establish protein interaction of vertebrate SALL factors to histone deacetylase as well as its 
localization to heterochromatin (Kiefer et al., 2002; Netzer et al., 2001). 
While the underlying process by which a stem cell chooses to self renew or differentiate 
must be molecular in nature, the pathways remain elusive. A critical and under-investigated 
area is chromatin organization and epigenetic control in ES cells (Smith, 2001). In part, 
historical reasons contribute because the field of stem cell research and epigenetic research 
developed independently. With increasing knowledge, both fields have started to converge 
recently (Tada and Tada, 2001).  
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Two important means of transcriptional silencing, histone acetylation and DNA 
methylation, could be functionally linked in the last years (Jones et al., 1998; Nan et al., 
1998). Especially DNA methylation during early embryonic development received much 
attention. DNA of somatic cells is methylated in a distinctive pattern that is stably inherited 
by the action of Dnmt1, a maintenance enzyme that methylates hemimethylated CpG 
dinucleotides in the nascent strand of DNA after DNA replication (Bestor, 1992). In contrast, 
developing gametes as well as early embryos undergo almost complete demethylation. It is 
achieved partially actively but also passively through tethering of Dnmt1 to the cytoplasm 
followed by a demethylation through cell division in preimplantation embryos. In both cases, 
gametogenesis as well as preimplantation development, erasure of methylation marks is 
believed to reset the genome and will be followed by de novo methylation (Li, 2002; Rideout 
et al., 2001). Mature gametes are again highly methylated (Rideout et al., 2001). In addition, 
especially the female pronucleus also contains relatively deacetylated histone as a means of 
transcriptional repression (Jackson-Grusby et al., 2001). After the second round of 
demethylation in embryogenesis, de novo methylation can be observed in the epiblast from 
implantation stage onwards (Li, 2002; Santos and Dean, 2004), while the trophoblast will 
remain demethylated. New methylation marks are believed to establish cell lineage restriction. 
ES cells in culture are generally hypomethylated even though these cells do possess a de novo 
methylation activity (Tada and Tada, 2001) and e.g. imprinted genes will remain methylated. 
Deletion of Dnmt1 does not affect ES cell growth. 
Linked to the methylation status of the genome, both X chromosomes are active in 
oocytes, female preimplantation embryos and female ES cell lines and serve as a model to 
understand chromatin organization during periimplantation stages. Two active X 
chromosomes are a disadvantage for propagation of ES cells and thereby one reason why 
most mouse ES cell lines are derived from male blastocysts (Rastan and Robertson, 1985). If 
stemness is a state of general transcriptional permissiveness (Smith, 2001) what ensures stable 
inheritance of that state in absence of common mechanisms for transcriptional silencing? 
Methylation is believed to be typically the last step in a silencing cascade functionally 
linked to histone deacetylation (Jones et al., 1998; Nan et al., 1998). Unlike methylation, 
inhibition of transcription through histone deacetylation plays an important role in ES cells 
(Rideout et al., 2001). 
As mentioned earlier, SALL proteins bind to histone deacetylase through their N-
terminal Zn-finger and localize to heterochromatin. One could envision a scenario whereby 
absence of Sall4 at a time where methylation marks are erased will lead to loss of 
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transcriptional repression in stem cells and thus the failure to maintain an undifferentiated 
state. In accordance to this, Sall4 is not required in early cleavage stages when methylation is 
still present but absence of Sall4 in demethylated embryos and ES cells is deleterious. Loss of 
Sall4 also leads to developmental arrest during oogenesis, the other period of global de- and 
remethylation. This model could explain the paradox that no phenotype was observed until 
expanded blastocysts but ES cells fail to grow in absence of Sall4. Post implantation, the 
repressed state of many loci in the epiblast will be re-established by DNA methylation and 
can be visualized with a specific antibody. In contrast, trophoblast cells do not methylate 
DNA until e7.5. Whether Sall4 is required for silencing specific promoters or involved in a 
general silencing complex remains to be established. 
 
To test if Sall4 is part of a general silencing-machinery essential for periimplantation 
embryos it would be interesting to purify Sall4 with its interaction partners from ES cells. 
Complementary to that, inducible deletion of Sall4 from an ES cell line can be achieved by 
stable expression of Cre fused to a modified estrogen binding domain (Metzger et al., 2005). 
Subsequent transcriptional profiling by microarray technology can address changes in the 
transcriptional landscape and would elucidate the molecular role of Sall4 in ES cell 
maintenance. These two complementary experiments will also address, if Sall4 is involved in 
a general mechanism of transcriptional silencing in ES cells. 
 
3. Sall Factors in Adult Stem Cells 
Adult stem cells are undifferentiated cells capable of proliferation, self-renewal, 
production of a large number of differentiated progeny and regeneration of tissues (Blau et al., 
2001). Especially the latter feature has caught interest recently. A general distinction is made 
between embryonic stem cells (ES cells) that can give rise to all cell types and tissues of the 
embryo including the germline (Bradley et al., 1984) and are therefore called pluripotent as 
opposed to adult stem cells residing in many or most tissues. Adult stem cells are generally 
believed to be more linage committed though this view has been challenged recently through 
a number of experiments (Blau et al., 2001; Weissman et al., 2001) 
However, a definitive proof that some adult stem cells retained pluripotency is 
challenging due to the technical difficulties of identification of cell fate before, during and 
after a possible switch. Also, results could not always be reproduced (Raff, 2003). The 
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interpretation of the presence of trophoblast cells upon culture of Sall4-/- ICMs discussed here 
suffers from similar ambiguities. 
If mesenchymal stem cells of adult rodent bone marrow, muscle or brain are cultured at 
low density for many passages, a population of cells might arise that shares many properties 
with ES cells (Jiang et al., 2002a; Jiang et al., 2002b) and are termed multipotent adult 
progenitor cells. Such cells will contribute to all mouse organs when injected into blastocysts. 
It remains to be seen whether these cells pre-exist at very low density or if they gradually 
acquire ES cell like properties due to culture conditions in the presence of LIF. Multipotent 
neuronal stem cells have been reported especially for the dentate gyrus as well as the lateral 
ventricles.  
Are SALL factors required for maintenance of adult stem cell populations? The genetic 
study of a requirement for Sall genes is complicated by lethality prior to adulthood in case of 
conventional knockout analysis.  
Expression analysis for Sall transcription factors suggested an intriguing possibility, 
namely a general function of SALL factors in stem and progenitor cell compartments. To test 
this hypothesis, the effect of a loss of Sall genes in domains of late expression was studied. 
 
3.1. Redundancy of Sall1, Sall2 and Sall3 in Olfactory Bulb 
Development 
Mammalian olfactory bulbs (OB) develop around a rostral extension of the lateral 
ventricles in the forebrain. Projections of the olfactory receptor neurons converge in glomeruli 
on the surface of the olfactory bulbs. Dendritic extensions of subcortical mitral and tufted 
cells reach the glomeruli and form synaptic connections with the axons of the sensory neurons 
of the olfactory epithelium (OE). Most of the neurons present in the olfactory bulbs are 
inhibitory interneurons in the granular cell layer. In rodents, these interneurons are constantly 
replaced. Less than 10% of the granular cells born in young adult rats survive 21 months 
(Kaplan et al., 1985). Sall1, Sall2 and Sall3 are expressed in the developing olfactory bulbs 
and remain expressed in adulthood. An analysis thus included all three genes since Sall4 is 
only expressed early in development and caused lethality prior to olfactory bulb development. 
In a comparative histological analysis of the olfactory bulb at e18.5 I show severe 
effects of Sall factor deletions on OB development: Sall2 deletion has no impact on the 
histology of the OB. Additional deletion of Sall1 results in a disturbance of the mitral cell 
layer (MCL) while additional deletion of Sall3 leads to cell loss in the outer plexiform layer. 
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In a triple knockout of Sall1-3, no specific olfactory bulb structures can be recognized. In situ 
hybridization against Reelin revealed only a scattered pattern as opposed to a dense ring 
structure in the olfactory bulbs of Sall1/Sall2 knockout mice. Scattered Reelin expression 
might be due to presence of tufted cells (Bulfone et al., 1998) or remaining mitral cells. 
Granular and periglomerular cells are less affected by loss of Sall1 as could be shown through 
in situ hybridization against Gad67. Retrograde DiI tracing of axonal projections of mitral and 
tufted cells showed an absence of projections to the olfactory cortex indicating anosmia in 
Sall1/Sall2 deficient mice. Previous studies (Belluscio et al., 1998; Bulfone et al., 1998; 
Hongo et al., 2000) show, that anosmic mice fail to find their mothers nipples and die due to 
the inability to suckle milk. Thus postnatal lethality in Sall1/Sall2, possibly also Sall2/Sall3 
knockout mice may be due to anosmia. It is likely that proliferation of progenitors at the time 
where mitral cells are born is reduced. BrdU labelling as well as immunohistochemistry for 
phosphorylated histone 3 at e12.5 will clarify this point. 
 
3.2. Loss of Sall1 & Sall2 Leads to Defects in Cortical Neurogenesis 
Can neurogenic defects be attributed to defects in the progenitor cell population? For the 
developing neocortex, it seems likely. The progenitor population is locally separated from 
maturing and mature neurons and Sall genes are expressed in the progenitor population, but 
absent from their progeny. In adult mice, Sall1 is expressed in astrocytes (figure 25B, C), 
shown to function as adult neuronal stem cells. 
Sall1 and Sall2 are the two orthologs of the Spalt family, prominently expressed in the 
subventricular zone of the developing neocortex between e12.5 and e19.5. The neocortex of 
double knockouts of Sall1 and Sall2 is hypomorphic as shown by histological analysis e16.5 
until e19.5. Overall, organization of the neocortex remained normal but the thickness and 
appearance of the cortex resembled that of a wildtype cortex approximately 24 hours earlier. 
BrdU labelling of cells undergoing DNA synthesis showed that serial differentiation of the 
cortical layers is also delayed to a similar extend. The observed delay could not be attributed 
to apoptosis but rather is due to 25% less cell divisions occurring in the ventricular zone of the 
lateral ventricles (figure 21C), the expression domain of Sall1 and Sall2. 
Delay in neurogenesis does not lead to a disturbance in cortical layering. Rather, all 
layers are present and located in the correct relative position (figure 22) to each other. In 
accordance with a neurogenic delay, superficial layers of the neocortex that develop late in 
embryogenesis are most severely affected by loss of spalt-like genes in the ventricular zone. 
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Two mechanisms could account for a reduced number of neuronal progenitors 
originating from the subventricular zone in the absence of Sall1 and Sall2. Either the cell 
cycle of neuronal progenitors is extended or the number of progenitor cells is reduced. For the 
Pax6 mouse mutant, a cell cycle delay has been shown. Nuclei of neuronal progenitors 
migrate to and away from the ventricular walls (Takahashi et al., 1999), (figure 20A). In a 
murine knockout of Pax6 extended cell cycle periods result in an uncoupling of nuclear 
migration and cell cycle (Estivill-Torrus et al., 2002). Upon BrdU administration for 30 
minutes, cell nuclei in S-phase are found also on the ventricular walls in a Pax6 mutant and 
mitotic nulclei are found away from the ventricle in turn. In the Sall mutants, no 
mislocalization of S-phase nuclei or mitotic nuclei was accompanied with the 25% reduction 
in cells incorporating BrdU suggesting that not cell cycle duration but rather population size 
may account for delayed neurogenesis.  
Whether daughter cells remain in the ventricular zone of the developing neocortex as 
progenitors or exit to the neocortex has to be tightly regulated to maintain a correct progenitor 
population. Over-expression of stabilized β-catenin leads to an increase in the number of cells 
re-entering the cell cycle after mitosis leading to an enlarged progenitor population and thus 
enlarged brains (Chenn and Walsh, 2002; Zechner et al., 2003). On the other hand, deletion of 
β-catenin from the brain leads to loss of progenitors resulting in a very thin neocortex 
(Zechner et al., 2003). Similar effects have also been described for Pax6 (Estivill-Torrus et al., 
2002). In case of the Sall1/Sall2 double knockout, a shift from re-entering towards exit of the 
cell cycle is therefore the most likely interpretation for the reduced numbers of cells found to 
be in S-phase. Sall1 and Sall2 might be required for the self-renewal of the stem/progenitor 
cell population in the neocortex.  
Neurogenesis does proceed in the Sall1 and Sall2 double knockout and brains reach 
almost full size at birth. This may be due to expression of Sall4 in the ventricular zone of the 
forebrain until approximately e12.5. Sall3 is expressed only very weakly in the neocortex of 
the telencephalon at e13.5. In accordance to that, defects in a Sall1/Sall2/Sall3 triple knockout 
are only mildly enhanced compared to the Sall1/Sall2 double mutant. In contrast, the 
paleocortex of the ventral forebrain expressing all three Sall genes is strongly affected by the 
additional deletion of Sall3 (figure 26C, arrow). Here, almost no cortical cells can be 
identified further strengthening the hypothesis that SALL transcription factors share 
redundant functions where coexpressed. 
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3.3. Could Progenitor Loss Account for Other Late Phenotypes? 
Oligodactyly might also be explained by progressive loss of proliferative cells. 
According to the progress zone model (Wolpert, 2002; Wolpert et al., 1979), limb elements 
are defined in a proximal to distal sequence. Successive loss of dividing progenitor cells in the 
limb bud would thus lead to cell loss in the most distal part. Anterior posterior patterning in 
the limb is achieved by a morphogen gradient (Shh) with anterior elements being established 
at lowest Shh concentration. If fewer cells are present in a primordium to be patterned by Shh, 
it could be envisioned that anterior elements, normally receiving lowest Shh levels, are most 
dramatically affected. However, direct interference with cell signalling in the limb bud could 
also explain the observed loss of digital and wrist elements. It would be interesting to quantify 
size and proliferative index of limb primordium at stages of distal patterning. 
Further, metanephric mesenchyme expresses Sall1 during the mesenchymal-epithelial 
transition (Nishinakamura et al., 2001), during a process that has been described as a stem cell 
phase in renal development (Bard J.  B.  L., 1996). As seen in figures 3 and 4, Sall2 and Sall3 
are also present during mesenchymal to epithelial transition. In a Sall1 knockout, 
mesenchyme is still competent to condense and undergo transition but kidneys are severely 
hypoplastic. The phenotype was interpreted as a failure of the ureteric bud to invade the 
mesenchyme (Nishinakamura et al., 2001). However, it is also consistent with the idea of a 
role for SALL transcription factors in progenitor population maintenance. The metanephric 
mesenchyme already consists of fewer cells at e11.5 and fails to grow upon induction, yet 
some nephrons do develop. Consistent with the notion of redundancy, kidneys are severely 
hypoplastic upon loss of Sall1, the only Sall member expressed in the cortex of the kidney. In 
mice deficient for Sall1, Sall2 and Sall3, renal tissue is completely absent, possibly due to 
complete loss of renal progenitors.  
The maturing oocyte can also be regarded as a totipotent stem cell, even able to 
reprogram somatic nuclei to totipotency upon nuclear transfer and is used in cloning (Wilmut 
et al., 1997). Female mice with an oocyte-specific deletion of the only expressed Sall gene, 
Sall4, are sterile. It will be interesting to see if the maturation block observed in an oocyte 
specific knockout for Sall4 is due to a differentiation process of the oocyte.  
 
The summarized observations do allow for an explanation according to a progenitor 
population based phenotype but do not prove it. To prove that Sall factors are required to 
maintain an undifferentiated state in adult stem cells, further experiments need to be carried 
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out that directly address identity of Sall expressing cells as well as their potential upon loss of 
Sall function. 
To formally show that Sall1 is expressed in the neuronal stem cell compartment, it 
would be required to genetically label Sall1 positive cells in adulthood and trace their fate. 
Expression of an inducible version of Cre recombinase (CreERT2, (Metzger et al., 2005) from 
the Sall1 locus could be employed. Upon activation of Cre in adult mice, excision of a 
transcriptional stop cassette in the 5´UTR of a ubiquitously expressed reporter will lead to 
irreversible labelling (Novak et al., 2000) of all cells expressing Sall1 as well as all progeny. 
In this setup one may ask if neurons that do not express Sall1 but the activated reporter can be 
identified in the adult mouse. While such a study could show presence of Sall1 in cells giving 
rise to newly generated neurons in adult mice, requirement of Sall1 would not be addressed. 
Disassociation of postnatal mouse brain and subsequent neuronal stem cell culture in mice 
null for Sall1, Sall2 and Sall3 would address if self renewal potential is reduced. 
Recently, a study showed the upregulation of Xenopus Sall4 during regeneration of 
limbs (Neff et al., 2005) fitting with the function I propose of SALL genes in vertebrates. 
While most mammalian tissues have lost the capacity of regeneration, it is maintained in the 
liver. Since only Sall4 is expressed in the liver, redundancy is not a concern in this system. An 
inducible Cre line has been reported for the adult liver (Schneider et al., 2003). Excision of 
the conditional Sall4 allele generated in this study can deplete the adult liver of Sall activity. 
Breedings to establish the required genotype are currently on the way. I intend to delete Sall4 
from the adult liver and then induce liver regeneration by surgical removal of liver tissue. In 
this setup I will be able to ask if regeneration of adult tissues requires the expression of Sall 
genes. 
 
4. Murine Compound Knockouts Partially Recapitulate 
Human Syndromes Caused by Mutations in Sall Genes. 
Townes-Brocks Syndrome (TBS) and Duane Radial Ray Syndrome (DRRS) are caused 
by autosomal dominant mutations in SALL1 and SALL4 respectively. 
Until date, no mouse model recapitulating the defects observed in humans suffering 
from mutations in SALL homologs could be established. Expression of a truncated version of 
SALL1 (Kiefer et al., 2003) while enhanced the phenotype of a Sall1 knockout mouse. 
Nevertheless, observed malformations do not all appear similar to TBS and are also not 
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penetrant even in homozygosity. The compound knockout strategy used in the presented study 
recapitulates anterior digit loss as well as neurogenic defects. Like for TBS, a hypoplastic 
corpus callosum was observed in Sall1/Sall2 double knockout animals. Further, Sall1/Sall2 
knockouts display hypoplasia of uterus and vas deferens (preliminary observations). 
Mutations in humans include insertions, deletions, nonsense mutations as well as 
frameshift mutations and result in highly variable phenotypes. In a clean genetic deletion of 
exon two as it was used for this study, phenotypes appear reproducible and invariable e.g. in 
CNS and limbs. Also, phenotypes are typically seen only upon deletion of several genes 
expressed in a specific tissue. This supports previous work stating that expression of truncated 
protein rather than loss of one allele is causal for the observed defects in TBS and DRRS. 
Since phalanx duplication was never observed and skeletal elements were lost upon SALL 
reduction, it can be argued that some mutations in SALL1 and SALL4 are gain of function 
mutations. The high variance in clinical manifestations of TBS and DRRS may thus be due to 
different functional effects of different molecular lesions. 
 
The identification of the progenitor pools as sites of Sall expression and action sheds 
new light on the underlying nature of TBS and DRRS as well as on the general function of 
Sall genes in vertebrate development. Interpretation of defects observed in Townes-Brocks 
Syndrome and Okihiro Syndrome should consider the finding that SALL transcription factors 
are required for mammalian progenitor populations. 
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Materials and Methods 
1. Materials 
1.1. Chemicals 
Acrylamide      Biorad 
L-Adenine      Sigma 
Agar, Bacto      Becton-Dickinson 
Agarose       Invitrogen 
Ampicillin       Sigma 
Ammonium Chloride      Merck 
Ammonium-Persulfate (APS)    Biorad 
Bovine Serum Albumin, Fraction V (BSA)  Sigma 
BrdU       Sigma 
Bromophenol blue      Sigma 
Calcium Chloride      Merck 
Carrier DNA (Herring testis)    Clontech 
Chloramphenicol      Sigma 
Dextran Sulfate      Amersham Pharmacia  
Dextrose      Merck 
DiI       Molecular Probes 
Dithiothreitol (DTT)      Biomol, Germany 
DMSO (Dimethylsulfoxide)     Sigma 
DPX        Agar Scientific 
EDTA        Merck 
Ethanol        Merck 
Ethidium Bromide      Sigma 
Eukitt mounting medium    Fluka 
Fetal Calf Serum      Invitrogen 
N,N-Dimethylformamide     Sigma 
Formalin       Electron Microscopy Sciences 
L-Glutamine       Invitrogen 
Glycine       Merck 
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HEPES        Invitrogen 
Isopropanol       Merck 
Kanamycin      Sigma 
Lithium Acetate     Sigma 
Lithium Chloride     Merck 
Magnesium Chloride      Merck 
MEM Non-essential amino acids    Invitrogen 
β-Mercaptoethanol      Sigma 
Methanol       Merck 
P32-dCTP      Amersham 
Paraformaldehyde (PFA)     Sigma 
Penicillin/Streptomycin     Invitrogen 
Peptone       Difco 
PEG4000      Sigma 
Potassium Chloride      Merck 
Protease Inhibitors Complete    Roche 
Puromycine       Sigma 
35S-UTP       Amersham 
Sodium Acetate      Merck 
Sodium Hydroxide      Merck 
Sodium Pyruvate     Invitrogen 
TEMED       Biorad 
Thionin powder      Sigma 
Triethanolamine      Sigma 
Triton X-100       Sigma 
Trypsin        Invitrogen 
Tween20      Gerbu 
Xylene        Sigma 
 
1.2. Equipment, Plastic Ware and other Materials 
Acid washed beads (0,5 mm)    Sigma 
Aquamount‚ Aqueous Mountant    LERNER Laboratories 
Bacterial Petri dishes      Greiner Bio-One 
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High-Density mouse BAC membranes   Research Genetics 
Cell counter chamber      (Neubauer improved) BRAND 
Cell culture dishes      NalgeNUNC International 
Cell incubator Hera cell     KendroLaboratoryProducts 
Centricon YM-10     Amicon 
Centrifuge 5417C      Eppendorf 
Centrifuge RC5C      Sorvall‚ Instruments 
Centrifuge RC-3B      Sorvall‚ Instruments 
Cryotome CM 3050S      Leica Microsystems 
Coverslips (24x60 mm)     Superior Marienfeld 
Electrophoresis chambers     PeqLab 
Electroporation system Gene Pulser II   BIO RAD 
Electro-SeparationSystem S&S BIOTRAP   Schleicher&Schuell Bioscience 
Filtration bottles STERICUP     MILLIPORE 
Fine forceps and scissors     ROBOZ 
Gene Pulser ‚ Electroporation cuvettes   BIO RAD 
Hybridiser incubator Techne HB-1D    TECHNE 
Hybridization bottles      TECHNE 
Hybridization Transfer Membrane NEN  Life Science Products 
Microlance hypodermic needles    Becton Dickinson 
Microscope Slides Super Frost ‚Plus 25x75mm  ROTH 
Microscope Axiovert 25     Zeiss 
Mini Protean 3 system     Bio-Rad 
Mini Trans-Blot Cell     Bio-Rad 
Nitrocellulose Membranes PROTRAN  Schleicher & Schuell 
Nylon Membranes Biotrans     ICN Biomedicals Inc. 
OCT Coumpound Embedding Medium   Tissue-Tek‚ 
Optical Microscope      Zeiss 
Paraffin Microtome RM2165     Leica Microsystems 
PCR thermal cycler PTC-200     Biozym 
PCR thermal reaction tubes     ABgene 
Plastic tubes (50 ml and 15 ml)    FALCON 
Power supply Power Pac 300     BioRad 
Reaction tubes (1.5 ml)     ROTH 
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Serological Pipets (25 ml; 10 ml; 5 ml; 2 ml)   FALCON 
Spectrophotometer Ultraspec 3000    Pharmacia Biotech 
Ultracentrifuge L8-M      BECKMAN 
 
1.3. Enzymes 
Proteinase K       MERCK 
Hot Star Taq DNA Polymerase    QIAGEN 
Restriction endonucleases     New England BIOLABS;Roche, 
Pwo DNA polymerase      Roche 
Expand High Fidelity system     Roche 
Klenow       New England Biolabs 
1.4. Molecular Weight Markers 
1kb DNA ladder      Invitrogen 
Broad Range protein ladder    Biorad 
 
1.5. Oligonucleotides 
Mouse Genotyping: 
Sall1tailF:  5’ act aag agc aag gat gcc cat gtc tg 3’ 
Sall1internR:  5’ gat gtt ggt gac acc gct cag agt gc 3’ 
Sall1gfpR:  5’ gtg cagatg aac ttc agg gtc agc 3’ 
Sall2internF:  5’ gtg aca gat gaa gat tcc cta gca gg 3’ 
Sall2lacZ-F:  5’ gtc gct acc att acc agt tgg tct gg 3’ 
Sall2tailR:  5’ agc caa cag cat gtg ctt ctt gag gg 3’ 
Sall3tailF:  5’ att ctg ggg cac acc cag cct gta gc 3’ 
Sall3internR:  5’ ccg cag atg tta cat ttg aag ggc cg 3’ 
Sall3KO-R:  5’ ggt caa agt aaa cga cat ggt cac gtg g 3’ 
Sall4tailR:  5’ tca gtagtg gcc ttg tct atg ttc tcc 3’ 
Sall4internF:  5’ cca agg ttt tcg gga cag ata gct cc 3’ 
Sall4gfpF:  5’ atg gac gag ctg tac aag  taa agc gg 3’ 
S4loxP1F:  5’ ctc cac caa ctc tag ctg cta atg gc 3’ 
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S4loxP1R:  5’ gtt aca gca ata cgg aga tac aca gc 3’ 
S4loxP2F:  5’ cct ctcacg tag ctg caa tga taa gc 3’ 
S4loxP2R:  5’ atg gcc ttt gca cat gtg ttc tgg ag 3’ 
S4onloxP1F:  5’ gct atc tag tgg gac gta gtg cca caa ac 3’ 
 
Cre1:   5’ gcc tgc att acc ggt cga tgc aac ga 3’ 
Cre2:   5’ gtg gca gat ggc gcg gca aca cca tt 3’ 
hCre1:   5’ gct gcg cat tgc cga aat tgc 3’ 
hCre2:   5’ ggc aga aca ggt agt tgt tgg 3’ 
FlpE1:   5’ cta atg ttg tgg gaa att gga gc 3’ 
FlpE2:   5’ ctc gag gat aac ttg ttt att gc 3’ 
lacZ-F:   5’ tac cca act taa tcg cct tgc agc ac 3’ 
lacZ-R:   5’ tca gac agc aaa cga ctg tcc tgg 3’ 
 
 
Southern Blot Probes 
Sall2-5´F:  5’ gct tca aga cag tgc ttg cat tct aca c 3’ 
Sall2-5´R:  5’ agc cca cag cac aca aga aga ggc 3’ 
Sall4-5´F:  5’ acg ttg cag tat ttg gac agg atc ag 3’ 
Sall4-5´R:  5’ ttc tca aca gta agt cta ggg gat gg 3’ 
 
RT-PCR  
Sall4-RTF:  5’ cga gca gcc tca gca gct acc gag 3’ 
Sall4-RTR:  5’ ttc aag tac agg atg gag tcc gtg cc 3’ 
Actin-RTF:  5’ ggc cca gag caa gag agg tat cc 3’ 
Actin-RTR:  5’ acg cac gat ttc cct ctc agc  3’ 
 
1.6. Antibodies 
Primary Antibodies: 
αphospho-Histone H3   rabbit   Upstate Biotech 
αCaspase    rabbit   Cell Signalling Technol. 
αTROMA    rat   gift from Dr. R. Kemler 
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αnanog     rabbit   CosmoBio 
αOct4     mouse   Santa Cruz Biotech. 
αCdx2     mouse    BioGenex 
αBrdU     rat   Abcam 
α−βgalactosidase   rabbit   Cappel 
αGFAP     rabbit   DAKO 
αNeuN     mouse   Chemicon 
αHA     biotinylated  Roche 
α−Tubuline    mouse   gift from Dr. M. Taipale 
CSPG     mouse   Sigma 
α mouse T cells    rabbit   Cedarlane 
 
Peptide Antibodies against SALL4 
N- and C-terminal peptides were synthesized commercially and coupled to KLH. The 
sequence for the N-terminal peptide is KQAKPQHINWEEGQGEC, the C-terminal peptide 
sequence is CAKHQFPHFLEENKIAVS. Each peptide was injected into two rabbits (Animal 
IDs N-terminus: SG-2671, 2672, Animal IDs C-terminus: SG-2673, 2674) using 
Freud’s adjuvant to induce antibody production against these epitopes. 
In a final bleed after the 5th boost, 76 and 80 ml of serum were obtained from SG-2671 
and SG-2672 respectively. A dilution series on SG-2671 showed that the signal to background 
ratio is best in a 1:5000 dilution for western blotting. Testing the sera for 
immunohistochemistry revealed good immunoreactivity in a 1:1000 dilution for serum of 
SG2671. After purification, a 1:1000 to 1:3000 dilution works best in immunohistochemical 
applications. All immunostainings shown subsequently were thus done diluting the antibody 
1:1000 in PBS. 
 
 
Secondary Antibodies: 
HRP-coupled αRabbit (western) Goat   Chemicon 
HRP-coupled αMouse (western) Goat   Chemicon 
All biotinylated antibodies were purchased from Vector Laboratories 
All fluorophore-labelled antibodies came from Jackson ImmunoResearch 
Standard guinea pig complement    Cedarlane 
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1.7. Plasmid Vectors 
Bacterial vectors: 
pBluescript SK+       Stratagene 
pSP73         Promega 
 
Mammalian vectors: 
FLPe cassette       Stewart, A.F. 
pKS-DTA        Tajbakhsh, S. 
Mouse BAC genomic clones      Research Genetics 
 
1.8. Commercial Kits 
ABC kit        Vectastain 
DAB Peroxidase Substrate System     Vector 
Geneclean Spin kit       Q-BIO gene 
Large Construct kit       Qiagen 
QIAquick Gel Extraction kit      Qiagen 
Maxiprep        Qiagen 
Prolong Antifade Kit       Molecular Probes 
 
1.9. Generally Used Solutions 
Acidic Tyrode  0.800 g/100 ml NaCl, 0.020 g/100 ml KCl, 0.024 CaCl2 • 2H2O,  
Solution  0.010 g/100 ml MgCl2 • 6H2O, 0.100 g/100 ml Glucose, 0.400  
g/100 ml Polyvinylpyrrolidone. Prepare at room temperature and  
adjust to pH 2.5 with HCl. 
BAC Church:   7 % SDS, 25 mM Na2HPO4 pH 7.2, 1 % BSA, 1 mM EDTA 
BAC Wash:  1 % SDS, 20mM Na2HPO4, 1mM EDTA 
Gel-loading Buffer: 0.25 % bromophenol blue, 15 % Ficoll, in TE 
PBS:    137 mM NaCl, 2.7 mM KCl, 6.5 mM Na2HPO4, 1.5 mM 
KH2PO4 
20xSSC:   3M NaCl, 0.3M Na3citrate•2H2O (pH to 7.0 with 1M HCl) 
50xTAE:  0.04 M Tris-Acetate, 0.001 M EDTA 
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LB:  1 % Bacto-tryptone, 0.5 % Bacto-yeast extract, 0.5 % NaCl 
Tail Buffer:  0.1 M EDTA, 0.1 M NaCl, 1 % SDS, 0.05 M Tris-HCl, pH 7.6, 
ProteinaseK, 0.5 mg/ml 
5xTBE:   45 mM Tris-borate, 1 mM EDTA 
TBF1:   30 mM Potassium acetate, 100 mM RbCl, 10 mM CaCl2, 
50 mM MnCl2, Glycerol to 15 % (v/v), pH 5.8 with acetic acid 
TBF2:    10 mM MOPS, 75 mM CaCl2, 10 mM RbCl, Glycerol 15 % 
(v/v), pH 6.5 with KOH 
TBS:   100 mM Tris-HCl pH 7.5, 150 mM NaCl 
TE    10 mM Tris-HCl (pH 8.0), 1 mM EDTA (pH 8.0) 
1.10. Cells 
Bacterial Strains 
E.coli XL-10 strain: Tetr, Δ(mcrA)183, Δ(mcrCB-hsdSMR-mrr)173, 
endA1, supE44, thi-1, recA1, gyrA96, relA1, lac Hte (F’ proAB, lacIqZ DM15 Tn10 
(Tetr) Amy Camr)a 
ES Cells 
ES cells used for gene targeting were from the IB10 and R1 line, both mycoplasma-free. 
IB10 was used for targeting of Sall2, both Sall4 alleles described were targeted in R1. 
 
2. Methods 
2.1. DNA - Plasmids 
Preparation of Plasmid DNA from Bacteria 
Mini preparation of plasmid DNA was performed according to standard protocols. For 
large scale preparation of plasmid DNA, the QIAGEN Plasmid Maxi Kit was used according 
to the manufacturer’s instructions.  
 
Purification of Supercoiled DNA by CsCl Gradient Centrifugation 
For purification of supercoiled plasmids, 4 g Caesium Chloride were dissolved in 3.8 ml 
of TE containing the DNA to be purified. 0.2 ml of Ethidium Bromide solution (10 mg/ml in 
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water) were added and the mixture was transferred to a 4 ml centrifuge tube (Beckman) for 
centrifugation in a Beckman vertical Vti65 rotor. After sealing, the tubes were spun O/N at 
60000 rpm and 25°C. One visible band at the center of the gradient was collected into a glass 
tube using a hypodermic needle. Ethidium Bromide was extracted from the DNA by a series 
of equal volumes of 1-Butanol extractions until no pink colour was detected. The DNA was 
centrifuged in a centricon filter device at 4000 rpm (SS34 - Sorvall) and 25°C and washed 3 
times with TE to remove CsCl. 
 
Spectrophotometric Determination of DNA and RNA Concentration  
Spectrophotometric measurements of DNA solutions were done at wavelengths of 260 
nm. An OD=1 at 260 nm corresponds to a concentration of 50 μg/ml for double-stranded 
DNA and 33 μg/ml for single-stranded oligonucleotides and 40 μg/ml for RNA.  
 
DNA Restriction and Klenow Treatment 
To a solution of DNA the appropriate 10xbuffer and restriction enzyme were added 
according to the manufacturer’s recommendations, mixed in a reaction tube and typically 
incubated O/N at the appropriate temperature. Klenow treatment was done in accordance with 
the NEB protocol. 
 
Electrophoresis of DNA 
Analysis and preparation of DNA were performed using agarose gels containing 0.5 
μg/ml Ethidium Bromide. 1xTAE-buffer was used as gel and electrophoresis buffer. DNA 
samples were loaded into the gels in 1xDNA loading buffer and run at 5 V/cm of gel. The 
DNA samples were generally run in parallel to a DNA molecular weight marker (1kb ladder). 
 
Isolation and Purification of DNA from Preparative Agarose Gels 
DNA was isolated from agarose using two different commercial kits according to the 
fragment size. For fragments up to 6 kb, the QIAquick® Gel extraction Kit (Qiagen) was used 
according to the manufacturer’s instructions. For fragments bigger than 6 kb, the Gene Clean 
Spin Kit was used according to the manufacturer’s instructions. For purification of large 
amounts of DNA from agarose gels, the S&S BIOTRAP Electro-Separation-System for 
elution and purification of charged molecules was used according to the manufacturer’s 
instructions. 
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DNA Ligation 
For ligation of purified DNA fragments into linearized plasmid vectors, an appropriate 
amount of each DNA species was incubated O/N in a total volume of 10 μl with 1 μl of 
10xbuffer and 1U DNA ligase. Ligation reactions were incubated O/N at 16°C. 
 
Preparation of Chemocompetent Escherichia coli XL-10 Cells 
5 ml of LB medium (+tetracycline) were inoculated with a single colony of E.coli XL-
10 and incubated with shaking (300 rpm) O/N at 37°C. 250 ml of LB medium were 
inoculated with 3-4 ml of the overnight culture and incubated with shaking at 37°C until an 
OD600 of 0.5 to 0.6. The cell suspension was incubated on ice for 5 minutes, poured into 50 
ml Falcon tubes and centrifuged at 3000 rpm (GSA - Sorvall) and 4°C for 10 minutes. The 
supernatant was discarded and the bacterial pellet was resuspended in 20 ml of TBF1 buffer 
(2/5 volume) and incubated on ice for 5 minutes. The cell suspension was centrifuged at 3000 
rpm (RC-3B) and 4°C for 5 minutes, the supernatant was discarded and the bacterial pellet 
was resuspended in 2 ml TBF2 buffer (1/25 initial volume). After 15 minutes of incubation on 
ice 200 μl aliquots were frozen in liquid nitrogen and stored at -80°C. 
 
Transformation of Chemocompetent Escherichia coli XL-10 Cells 
100μl of competent E.coli XL-10 cells were added to DNA in an eppendorf tube and 
incubated on ice for 30 minutes, the mixture was then heat shocked for 90 seconds at 42°C, 
followed by a 3 minutes incubation on ice. 1 ml of LB medium was added and the cell 
suspension was incubated for 30 minutes at 37°C. The transformation was then plated on the 
appropriate selective media and incubated at 37°C overnight. 
 
2.2. DNA - Genomic 
Preparation of Genomic DNA 
For genomic DNA preparation from mouse tails, each tail was incubated O/N in 800 μl 
of tail buffer at 56°C. The following day, 300 μl of 6M NaCl was added, mixed by shaking 
and centrifuged for 10 minutes at 14000 rpm (Eppendorf) at RT to pellet the tail debris. 800 
μl of the supernatant were transferred into a new reaction tube, mixed with 500 μl isopropanol 
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and centrifuged at 14000 rpm for 5 minutes to pellet the genomic DNA. Supernatant was 
aspirated and the recovered DNA was washed in 70 % ethanol and dissolved in 100 μl TE. 
For preparation of genomic DNA from ES cells, a confluent well from a 24 well plate 
was washed twice in PBS, incubated O/N at 37°C with 600 μl ES cell lysis buffer (10 mM 
Tris-HCl pH 8.0, 5 mM EDTA, 100 mM NaCl, 1 % SDS and 0.5 mg/ml Proteinase K). The 
next day DNA was precipitated in an eppendorf tube by addition of 500 μl isopropanol 
followed by mixing by shaking. The precipitated DNA was transferred to a new tube with a 
tip and washed O/N with 70% ethanol. After spinning down the DNA was resuspended in 100 
μl TE O/N at 37°C 
  
Polymerase Chain Reaction (PCR) 
For mouse genotyping, the standard genomic PCR reaction was performed with a hot 
start protocol that employs the HotStarTaq DNA polymerase. One reaction contained: 
16 μl H2 O 
2 μl 10xPCR buffer (QIAGEN) 
0.5 μl dNTP solution (10 mM each dATP, dCTP, dGTP, dTTP) 
0.2 μl each primer 50 mmol) 
0.5-1U HotStarTaq DNA polymerase 
5 ng DNA in 1μl 
The PCR reaction was initially denatured for 15 minutes at 94°C to activate the 
HotStarTaq DNA polymerase. PCR was typically performed with 36 cycles, each cycle 
consisting of 40 seconds denaturation at 95°C; 40 seconds annealing at the appropriate 
temperature for the oligonucleotides; 45 seconds of elongation at 72°C. The amplification 
products were assayed by gel electrophoresis. 
For cloning purposes either the Pwo polymerase or the High Fidelity Expand was used, 
essentially as described above with the omission of the 15 minutes hot start. 
 
Southern Blot Analysis 
Detection and localization of specific sequences within genomic or plasmid DNA was 
performed using the Southern blot technique. Typically the DNA (20mg of mouse genomic 
DNA or 1mg of plasmid DNA) was treated with one or more restriction enzymes. The 
resulting fragments were separated according to size by agarose gel electrophoresis (0.6 % gel 
cast in 0.5xTBE containing 0.5 μg/ml Ethidium Bromide was used for genomic DNA 
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samples). After electrophoresis was completed, the gel was photographed with a fluorescent 
ruler for subsequent assessment of band sizes. The DNA was denatured by incubating the gel 
in 0.5 N NaOH, 1.5 M NaCl for 30 minutes with agitation. The gel was then briefly rinsed in 
deionized water before the DNA was transferred to a nylon membrane by capillarity under 
neutral conditions (20XSSC). The membrane was incubated for two hours at 80°C to 
immobilize the attached DNA, followed by a pre-hybridization (2 hours minimum) in Church 
hybridization solution at 65°C. The membrane was then probed O/N at 65°C with a radio-
labelled probe in 30 ml of Church buffer. After hybridization, the membranes were washed in 
the following series of increasingly stringent washing buffers: 2xSSC, 1 % SDS; 0.5xSSC, 1 
%SDS; 0.1xSSC, 1 % SDS for 30 minutes each. Autoradiography was used to locate the 
positions of the bands complementary to the probe.  
 
Radiolabelling of DNA Probes for Southern Blot Analysis  
Labelling of DNA probes for southern blot analysis was performed by PCR. Using a 
previously amplified sequence (in general with a size of 300 bp) as a template in the 
following reaction, radioactive dCTP-P32 was incorporated of into the probe: 
8 μl H2O 
2 μl 10xPCR buffer 
3 μl dNTP solution (0.5 mM each dATP, dGTP, dTTP) 
5 μl P32-dCTP (50 μCi) 
0.5 μl each primer 
2.5 U HotStarTaq DNA polymerase (QIAGEN) 
5 ng Template DNA 
The PCR reaction was initially denatured for 15 minutes at 94°C to activate the 
HotStarTaq DNA polymerase. PCR was usually performed with 30 cycles, each cycle 
consisting of 20 seconds denaturation at 95°C, 30 seconds annealing at 50°C, and 30 seconds 
of extension at 72°C. A final cycle of 5 minutes at 95°C was performed to denature the 
labelled probe. The probe was incubated on ice for 4-5 minutes and then added into the 
hybridization solution. 
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2.3. Cell Culture Methods 
Culture Conditions 
Mouse embryonic stem (ES) cells were cultured in ES medium: glucose-rich (4500 
mg/liter) DMEM medium supplemented with 15 % Fetal Calf Serum (FCS), 1 % MEM 
nonessential amino acids, 1 % Penicillin-Streptomycin, 1 % Glutamine, 1 % Sodium Pyruvat 
and Leukaemia Inhibitory Factor (LIF). The ES cells were grown on a layer of mouse embryo 
fibroblasts (MEFs) at 37°C with 5 % CO2. Selection of ES cell clones that had integrated the 
replacement vectors was done by adding the antibiotic G418 (250 μg/ml) to the medium. 
Ongoing cultures of MEFs and ES cells were typically grown in 10-cm tissue culture dishes 
with 10 ml of medium. All ES-cell medium was changed daily. Puromycin was added to 
1μg/ml. 
 
TS cells medium: 
20% FCS (Invitrogen), 50 µg / ml Penicillin (Invitrogen), 50 µg / ml Streptomycin 
(Invitrogen), 1 mM Sodium pyruvate (Invirtogen), 100 µM ß-mercaptoethanol (SIGMA 
Aldrich), 2 mM L-glutamine (Invitrogen), in RPMI 1640 medium (Invitrogen); If required, 
Fgf-4 and heparin were added freshly before use: 10 µl of 1000x Fgf-4 (25 ng / ml / SIGMA) 
and 10 µl of 1000x heparin (1 µg / ml / SIGMA) into 10 ml of TS medium. 
 
Collecting embryos and for handling them outside the incubator: 
M2, a modified Krebs-Ringer solution with HEPES buffer substituted for some of the 
bicarbonate: 94.44 mM NaCl, 4.78 mM KCl, 1.71 mM CaCl2• 2H2O, 1.19 mM KH2PO4, 1.19 
mM MgSO4 • 7H2O, 4.15 mM NaHCO3, 20.85 mM HEPES, 23.28 mM Sodium lactate, 0.33 
mM Sodium pyruvate, 5.56 mM Glucose, 4 g/l BSA, 0.060 g/l Penicillin G • Potassium salt 
(final conc. 100 units / ml), 0.050 g/l Streptomycin sulfate (final conc. 50 mg / ml), 0.010 g/l 
Phenol red, 2x glass-distilled H2O. All reagents were bought from SIGMA Aldrich. 
 
Overnight culture of blastocysts: 
M16 is a modified Krebs-Ringer bicarbonate solution and is very similar to Whitten’s 
medium 94.66 mM NaCl, 4.78 mM KCl, 1.71 mM CaCl2• 2H2O, 1.19 mM KH2PO4, 1.19 mM 
MgSO4 • 7H2O, 25.00 mM NaHCO3, 23.28 mM Sodium lactate, 0.33 mM Sodium pyruvate, 
5.56 Glucose, 4 g/l BSA, 0.060 g/l Penicillin G • Potassium salt (final conc. 100 units / ml), 
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0.050 g/l Streptomycin sulfate (final conc. 50 mg / ml), 0.010 g/l Phenol red, 2x glass-distilled 
H2O. All reagents were bought from SIGMA Aldrich. 
 
Trypsinization of Cells 
ES cells and fibroblasts at sub-confluent density were passed into new tissue culture 
dishes at lower density. The medium was aspirated and the cells were washed once with PBS. 
The cells were subsequently covered with 0.5 % (w/v) trypsin and incubated at room 
temperature until they were visibly detached from the dish. The trypsinization reaction was 
stopped by addition of FCS containing medium. Cells were collected in a 50 ml tube and 
centrifuged (1500 rpm, 3 minutes) for large volumes. The pellet was resuspended in new 
medium. Small volumes were transferred onto the new plate directly. For Electroporation, the 
cells were counted using a Neubauer chamber and plated at appropriate numbers on new 
tissue culture dishes. 
 
Mitomycin C Treatment of Mouse Embryo Fibroblasts 
To mitotically inactivate feeder cells, confluent layers of MEFs in tissue culture dishes 
were treated with medium containing 10 mg/ml of Mitomycin C for 3 hours at 37°C with 5 % 
CO2. The dishes were washed three time with PBS and the cells collected by trypsinization. 
After centrifugation, the cells were resuspended in feeder medium (glucose-rich 
(4500mg/liter) DMEM medium supplemented with 15 FCS, 1 % MEM nonessential amino 
acids, 1% penicillin-streptomycin, 1% glutamine), counted and the appropriate number was 
transferred to tissues culture dishes to ensure the production of a uniform confluent mono 
layer of cells. 
 
Freezing and Thawing Cells 
Cells were trypsinised, counted and centrifuged for 3 minutes at 1500 rpm. The 
supernatant was discarded and the pellet was resuspended in new medium at a density of 
2.5x106 cells/ml. Aliquots of 1x106 cells were transferred into individual cryo vials and an 
equal volume of medium containing 20% DMSO was added to each vial (10% DMSO final 
concentration). The cell suspension was frozen, by storing the vials at -80°C. For long-term 
storage, vials were transferred into liquid nitrogen. For thawing, cells the vials were rapidly 
warmed at 37°C and the cell suspension was transferred into a centrifuge tube containing 
medium. The cells were centrifuged at 1500 rpm for 3minutes, resuspended in new medium 
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and transferred to tissue culture dishes. ES cells were transferred to tissue culture dishes 
containing a confluent layer of mitotically inactive MEFs. 
 
Electroporation of ES Cells 
An exponentially growing culture of ES cells at passage 4-6 was prepared for 
electroporation by changing medium approximately 3 hours before harvesting the cells. The 
cells were trypsinised and medium added to stop the trypsinization reaction. Cells were 
centrifuged for 4 minutes at 3000 rpm and RT, washed once and resuspended in PBS as a 
single cell suspension. The ES cell suspension was counted, and the cell suspension was 
centrifuged once more, washed and resuspended at a density of 1.5x107 cells/ml in Ca2+ /Mg2+ 
free PBS. For each electroporation, 0.8 ml (1.5x107 cells) of cell suspension was placed in a 
sterile cuvette and 30 μg of linearized DNA were added and mixed well. This mixture was 
incubated on ice for 5 minutes and a single pulse of 240 V, 500 mF was applied to the cuvette. 
After electroporation, the cells were incubated on ice for 5 minutes and plated onto 10-cm 
gelatinized tissue culture dishes. Each 0.8 ml sample from the electroporation was divided and 
equally distributed on twelve tissue culture dishes. The cells were allowed to recover for 48 
hours in non-selective medium. The G418 selection of ES clones that had integrated the 
replacement vectors started 48 hours after electroporation. 
 
Isolation of Individual ES Cell Colonies 
Selected individual ES cell colonies were isolated 9-10 days after electroporation. Sets 
of 96-well tissue culture dishes containing confluent mono-layers of MEFs in fresh medium 
were prepared in advance. Culture medium was replaced by PBS. A 20 μl Gilson pipette with 
the tip of a 10 μl micropipette was used to pick individual colonies under microscopic 
observation in 20 μl PBS. The colonies were placed into 96 well U-plates (NUNC) and 
incubated for 20 minutes at room temperature. Subsequently, 200 μl ESC medium was added, 
clones disrupted by repetitive pipetting and they were placed into the 96-well F dishes coated 
with MEFs and incubated at 37°C with 5 % CO2. 48 hours after isolation, the individual 
clones were visible giving rise to an exponentially growing set of evenly distributed ES cell 
colonies. The growth of all ES cell clones was monitored daily and when considered 
appropriate (~50% confluency for the highest number of clones) all clones in one dish were 
trypsinized and divided in the following way: Half of the ES cells of each clone were 
transferred to a new 96-well dish containing mitomycine C treated MEFs and these cells were 
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subsequently frozen; the remaining cells from each clone were transferred to gelatine coated 
24-well dishes for later preparation of genomic DNA. Homologous recombination was 
verified by southern blot. 
 
De Novo Isolation of ES Cell Lines from Blastocysts  
Embryos were flushed from the uterine horns with M2 and placed individually into 10 
mm well tissue culture dishes containing a preformed feeder layer of MEF and 0.5 ml of ES 
cell culture medium. 
Four to five days after explantation into culture, ICMs were dislodged from the 
underlying sheet of trophoblast cells using a finely drawn Pasteur pipette and transferred 
through two changes of Ca++/Mg++-free PBS.  
Incubation in a microdrop of trypsin lead to disassociations at 37˚C for 3-4 minutes. 
After complete mechanical separation of cells, they were transferred into a fresh 10-mm 
feeder cell tissue culture well. Individual cultures were monitored for ES cell growth. After 2-
5 days of culture primary colonies become visible. If clumps with ES cell morphology 
dominated the culture, clones were expanded. 
 
Immunosurgery  
Immunosurgery was performed according to Solter and Knowles, 1975. 
The zona pellucida was removed prior to immunosurgery with Tyrode’s Acid.  
 
ES Cell Injection into Blastocysts and Chimera Production 
Blastocyst injection was performed at the EMBL Transgenic Service. IB10 or R1 
targeted ES cells with a 129/OLA genetic background were injected into e3.5 mouse 
blastocysts of the C57/Black6 strain produced by natural matings. Always approximately 12 
cells are injected with an eppendorff microinjection apparatus in an inverted microscope 
under phase contrast. Two hours after injection, living blastocysts were implanted into 
pseudopregnant CD1 females (7-8 per oviduct arm) 2.5 days after mating to a sterile male to 
induce pseudopregnancy. 
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2.4. Tissue sectioning 
Tissue Preparation and Fixation 
Fixation of mouse tissues, organs and whole embryos was performed differently 
depending on whether the samples would be used for histology, Immunohistochemistry or in 
situ hybridization.  
For histological analysis of early embryos using paraffin sections, implantation sites 
were isolated and fixed 5 hours at 4°C in 2 % PFA. The tissue was subsequently washed in 
PBS for 10 minutes at 4°C and stored indefinitely in 70% ethanol at 4°C.  
For analysis of gene expression by in situ hybridization, organs from mice perfused in 
10 % formalin and embryos were properly dissected and stored indefinitely in 10% formalin.  
 
Cryosectioning  
After fixation, embryos and organs were incubated O/N at 4°C in RNAse-free 20 % 
Sucrose/PBS (w/v) solution O/N or until the tissue sank. OCT medium was placed in 
embedding moulds and the tissue sample was introduced in the medium. The moulds were 
placed in dry ice-cooled ethanol to freeze the medium. Typically, 18 μm sections were cut on 
a Leica Cryotome with a chamber temperature of -20°C. Tissue sections were transferred onto 
glass slides and air dried for a minimum of 2 hours and stored at -20°C for later processing. 
 
Paraffin Embedding, Mounting and Sectioning 
Specimen, preserved in 70% ethanol, were dehydrated in a series of 85%, 96% and three 
times 100% ethanol at least for 1 hour for each step at room temperature. The samples were 
cleared in two changes of xylene for 30 minutes each and incubated O/N in xylene at room 
temperature. Tissues were carried through a series of four changes in paraffin 1hour each at 
60°C and embedded in the proper orientation in embedding moulds. The moulds were stored 
at 4°C until sectioning. The microtome was set to cut 7 μm sections. 
 
2.5. Histochemistry and Immunohistochemistry 
PAS Staining 
Paraffin sections of implantation sites were incubated twice for 10min in xylene 
followed by rehydration in a series of 100%, 96% and 70% ethanol for three minutes each. 
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After washing in distilled H2O, the sections were incubated in Periodic acid 0.5% for 5 min. 
Sections were washed through a series of 3 fast changes of distilled H2O and incubated in 
Schiff’s Reagent (0.5% Basic fuchsin; 0.5% Sodium metabisulfite; 0.2% Activated charcoal, 
filtrated) for 20min. 
Sections were rinsed 7min under running tap water, stained 1min in Hematoxylene 
GILL-3 and rinsed again 7min under running tap water. Dehydration in an ascending ethanol 
series was followed by xylene incubation for clearance and mounting.  
 
Nuclear Fast Red Counterstaining 
Subsequent to β-galactosidase staining or to DAB-substrate to visualize HRP-coupled 
antibodies, the slides were washed in PBS for 15min at room temperature, rinsed in distilled 
water and counterstained with Nuclear Fast Red (Vector) for 5min. Sections were washed in 
distilled H2O for 10min and dehydrated through a ethanol series (twice 1min each in 70%, 
95% and 100%ethanol). Sections were cleared in xylene twice for 5 to 10 minutes and 
mounted in xylene based medium. 
 
β−galactosidase Staining 
Expression of the lacZ reporter gene present in the replacement vectors for the Sall1, 
Sall2 and Sall3 genes was visualized by staining whole embryos and frozen tissue sections for 
β-galactosidase activity. A β-galactosidase staining solution containing Bluo-Gal substrate 
(20mM K3; 20mM K4; 0.01% Na-deoxycholate; 2mM MgCl2; 0.02% (v/v) NP-40; 1mg/ml 
Bluo-Gal) was used. Staining was carried out at 37°C over night. 
 
Thionine Staining 
Staining solution was prepared by slow addition of 0.625g Thionin powder to a solution 
of 191ml water, 9ml NaOH-1M, 50ml acetic acid-1M at 60°C. Solution was boiled for 45 
minutes, filtrated and stored at 4°C for a maximum of 4 months. Staining was done 
subsequent to incubation in water and takes 5 minutes. Sections were dehydrated in an ethanol 
series directly after and mounted in xylene based medium. 
 
Immunofluorescence 
Imunofluorescent stainings were performed on 18 μm cryostat sections prepared as 
described. Sections were rinsed for 10 minutes in PBS. Blastocysts were fixed 5 minutes in 
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2% paraformaldehyde in PBS, permeabilized in 0.2% Triton X100 for 5 minutes and directly 
placed on a coated glass slide and allowed to dry in. For blocking, the tissue sections were 
incubated for 2 hours with 5 % (v/v) 2nd antibody species serum in TBS/0.4 % Triton X-100 
at room temperature. sections were washed twice with TBS/0.4% triton X-100 and incubated 
with the primary antibody at the appropriate dilution in TBS/0.4% triton X-100 O/N at 4°C. 
The slides were rinsed twice with TBS/0.4% triton X-100 and incubated with fluorescent-
labelled secondary antibody in TBS/0.4 % Triton X-100 for 1 hour at room temperature in the 
dark. The slides were washed twice in 1xTBS/0.4% triton X-100, counterstained in 1xDAPI 
for 5 minutes and mounted with 50μl of slow fade reagent (Prolong Antifade kit, Molecular 
Probes) according to the manufacturer’s indications. Slides were stored at 4°C in the dark. 
 
Immunohistochemistry 
Immunohistochemical stainings were performed on sections fixed in 4% 
paraformaldehyde in PBS for 2-12 hours. Paraffin sections were initially incubated in xylene 
for 3x5 minutes to dissolve the paraffin followed by rehydration in a series of 100%, 95% and 
70% ethanol (3 minutes each). After washing in PBS for 5 minutes, antigen was unmasked by 
boiling 1 hour in unmasking solution (Vector) and endogenous peroxidases were inactivated 
by incubation for 10 minutes in 3 % H2O2 in PBS followed by 5 minutes washing in PBS with 
agitation if DAB stainings were performed. 
The sections were incubated with blocking buffer (0.2 % Triton, 1 % Glycine, 3% BSA, 
5 % normal serum in PBS) in a wet chamber for 2 hours at room temperature. After blocking, 
the sections were incubated with primary antibody in blocking buffer in a wet chamber ON at 
4°C. The slides were washed for 3x20 minutes in wash buffer (0.4 % Triton, 1 % Glycine, 3 
% BSA in 1xTBS) with agitation. The sections were incubated with biotinylated secondary 
antibody (vector) in blocking buffer in a wet chamber for 1 hour at room temperature and then 
washed as after primary antibody. The staining procedure using the ABC reagent and DAB 
substrate was performed according to the manufacturer’s recommendations. The sections 
were counterstained with methyl green stain (1:8 dilution from 2 % stock 10 minutes) 
dehydrated 2x10 minutes in 1-Butanol, cleared in xylene and mounted with 60 μl Eukitt.  
 
Embryo Staining for Cartilage and Bone 
In order to reveal the skeletal structure and cartilage formation at e18.5, the following 
protocol was performed. Mice were sacrificed and placed in tap water for 24 hours. The skin 
was carefully peeled off with forceps by making a cut around the waist, neck, and base of the 
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limbs and pulling the skin back intact. Mice were eviscerated and fixed in 95%ethanol for 3-5 
days. Staining for cartilage was performed by placing the mice in Alcian Blue solution 
(0.015% w/v) (Sigma). Staining was performed for 24 hours. The mice were then rinsed twice 
in 95% ethanol and then let sit again in 95%ethanol for 24 hours. The mice were then placed 
in 2% KOH for a period of time that allows them to be cleared. Counterstaining for bone with 
Alizarin Red solution (0.005% w/v) (Sigma) stain was performed for 1-3 hours until an 
optimal level of staining was observed. The mice were cleared by placing them in 2% KOH of 
decreasing strengths. Initially a 2% KOH solution was used until the mice were almost clear. 
The clearing process was completed in the following ratios of 2% KOH to glycerol; 80:20, 
60:40, 40:60, 20:80. The mice were stored in 2% KOH, glycerol (20:80). 
 
2.6. In situ hybridization 
Generation of in Situ Probes by in Vitro Transcription  
The radioactive labelling of RNA probes was performed using the Riboprobe® 
Combination System-SP6/T7. An in vitro transcription labelling reaction was set up and 
incubated for 1 hour at 37°C:  
 
4 μl of 5xtranscription buffer  
2 μl of 100 mM DTT 
0.6 μl RNasin 
4 μl of A/G/C mix (2.5mM each nucleotide) 
1 μg of linearised template 
Nuclease free H2O to 14 μl 
5 μl 35S-UTP (100 μCi) 
1 μl of RNA polymerase 
 
The labelling reaction was followed by a treatment with DNaseI at 37°C for 15 minutes. 
This reaction was stopped by addition of 30 μl nuclease-free water and the labelled RNA was 
recovered using ProbeQuant™ G-50 Micro Columns according to the manufacturer’s 
protocol. A probe concentration of 5x106 cpm/ml was routinely used on the different tissue 
sections. The calculated amount of 35S-labeled probe for 1 ml Hybridization solution was 
initially mixed with 50 μl tRNA, 10 μl 1M DTT and nuclease-free H2O to 200 μl. This 
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mixture was incubated at 65°C for 5 minutes to denature annealed strands in the labelled 
probe and added to 800 μl Hybridization solution (50 ml l Hybridization solution: 25 ml 
formamide, 10 ml 50 % dextran sulphate, 3 ml 5 M NaCl, 1 ml 1xDenhardt’s solution, 0.5 ml 
1 M Tris-HCl pH 8.0, 0.1 ml 0.5 M EDTA pH 8.0, 0.4 ml nuclease free H2O). The 
hybridization mixture was stored at -20°C until the hybridization step for a maximum of 1 
week. 
 
Pre-treatment and Prehybridization of Tissue Sections 
18 μm frozen cryostat sections or 7μm paraffin sections were used for in situ 
hybridization. The tissue sections were initially treated with Proteinase K (10 mg/ml) in 
proteinase digestion buffer (0.1 M Tris-HCl pH 8.0, 50 mM EDTA pH 8.0) at 37°C for 30 
minutes. Slides were rinsed briefly in dH20 and incubated in 0.1 M triethanolamine (TEA) pH 
8.0 for 3 minutes at room temperature, and then acetylated in acetylation buffer (625 μl acetic 
anhydrid, 250 ml 0.1 M TEA) for 10 minutes at room temperature. Slides were then incubated 
in 2xSSC for 5 minutes and dehydrated through an ethanol series of 50%, 70%, 90% and 2 
times 100% ethanol for 3 minutes each step. The slides were drained for 5 minutes and dried 
under vacuum in an exciccator for a minimum of 2 hours until hybridization.  
 
Hybridization 
To hybridize the tissue sections with a 35S-labelled probe, an aliquot of the hybridization 
mixture was placed at 65°C for 10 minutes and then centrifuged for 10 minutes at 3000 rpm 
to eliminate any precipitates that may have formed. 65-75 μl of hybridization mixture was 
applied to each slide (50x22 mm) and the tissue sections were then covered with a coverslip 
and sealed by the application of liquid DPX mounting medium around the edges of the cover 
slip. For hybridization, the slides were incubated O/N on a slide-warming tray at 60°C. After 
hybridization, the slides were cooled and incubated four times 15 minutes with 4xSSC. The 
slides were subsequently treated with RNaseA in RNase buffer (RNaseA 20 μg/ml, 25 ml 5 M 
NaCl, 2.5 ml 1 M Tris-HCl pH 8.0, 500 μl 0.5 M EDTA pH 8.0, dH2O to 250 ml ) for 37 
minutes at 37°C. This was followed by a washing and gradual de-salting series of the 
following solutions: 2xSSC, 1 mM DTT for 5 minutes at RT; 1xSSC, 1 mM DTT for 5 
minutes at RT; 0.5xSSC, 1mM DTT for 5 minutes at RT; 0.1xSSC, 1mM DTT for 37 minutes 
at 65°C; 0.1xSSC, 1mM DTT for 3 minutes at RT. Slides were then dehydrated through an 
ethanol series of 50 % ethanol (with 0.08xSSC, 1mM DTT), 70 % ethanol (with 0.08xSSC, 
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1mM DTT), 95 % ethanol and 100% ethanol each step for 3 min. The slides were finally 
drained for 5 minutes and dried under vacuum in an exciccator for a minimum of 2 hours.  
Slides were dipped in liquid photographic emulsion in complete darkness, dried and stored at 
4°C for 1-4 weeks. Emulsion was developed in standard developer at room temperature for 3 
minutes, fixed, counterstained in Bisbenzimide, dehydrated, transferred into Xylene and 
mounted in Eukitt. 
Slides were photographed in an Axiophot microscope in dark field to visualize silver 
grains that formed around radioactively labelled probe and represent expression. The 
Histology was subsequently visualized by the blue fluorescence. Pictures were overlayed in 
Photoshop 6.0. 
 
2.7. Mouse Methods 
Mice were housed in a specific pathogen free environment (SPF) and under controlled 
light, temperature (21°C) and humidity (50 % relative humidity) conditions. Water and food 
were provided as needed. Mice were routinely weaned from their parents at the age of 3 
weeks with males and females being housed separately. Mice were tagged using six-digit 
number eartags and tail biopsies were taken for genotyping.  
For experiments with embryos, breedings were set up with one male and one female. Vaginal 
plug-checks were performed daily at 8am, starting the morning following the set up of the 
breeding. The presence of a plug was considered day e0.5 of pregnancy. For genotyping of 
embryos at day e12.5 or younger the yolk sacs were separated from the placenta and used for 
DNA extraction. With embryos older than e12.5 tissue samples for genomic DNA were 
normally taken from the tail. The day of birth was considered postnatal day zero (P0). 
 
BrdU Labelling of Cells Undergoing DNA Synthesis 
BrdU (Sigma) was dissolved in PBS at 8mg/ml, sterile filtrated and stored at -80°C. If 
labelling was desired, aliquots were thawed and pregnant dams received 0.4 ml of BrdU 
solution into the tail vein. For Immunostaining, sectiones were pretreated with 2M HCl for 20 
minutes at 37°C to denature DNA and expose the antigen. 
 
  Material and Methods 
118 
Collection of Preimplantation Embryos 
Superovulation was induced by an intraperitoneal injection of 5 units of PMSG 11am 
followed by 5 units of HCG 47 hours later. Mating was started immediately and plugs scored 
next morning. To collect preimplantation embryos, mothers were sacrificed e0.5-e3.5, 
oviducts and uteri dissected out and flushed in M2 medium. Blastocysts were collected using 
a fine drawn glass capillary, washed in M2 and processed further. 
To reimplant embryos, foster mothers were bred to vasectomized, sterile males to induce 
pseudopregnancy and embryos were transferred dorsally into anesthetized females at e2.5 of 
pseudopregnancy. 
 
2.8. Proteins 
Cell-extracts 
Extracts from cell-culture were done in RIPA buffer (50mM Tris-HCl pH 7.5, 150 mM 
NaCl, 1 % NP-40, 0.1 % SDS, 0.5 % Sodiumdeoxycholate, 0.05 % β-mercaptoethanol, 
protease and phosphatase inhibitors). 
Cells were trypsinized, the enzyme inactivated by addition of FCS, spun at 1500 rpm for 
3 minutes, the supernant removed and the pellet snap frozen in liquid nitrogen and lysed in 
RIPA buffer in an eppendorf tube by vortexing for two minutes. The extracts were sheared 
with a pipette tip and insoluble debris spun down at 14000 rpm. 
 
Protein Concentration Measurements 
Protein concentrations were determined by Bio-Rad Bradford protein assay according to 
the manufactures protocol. In all assays, BSA was used as a standard. 
 
SDS-PAGE  
All SDS-PAGE gels were run on the Mini Protean 3 system and the gels wereprepared 
as follows: 
Separation gel: 0.375 M Tris-HCl pH 8.8, 8-18 % acrylamide, 0.1 % SDS, 0.05 % APS 
and TEMED (3 μl in 5 ml) 
Stacking gel: 0.125 M Tris-HCl pH 6.8, 3.9 % acrylamide, 0.1 % SDS, 0.05 % APS and 
TEMED (5 μl in 5 ml) 
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Extracts were heated to 90°C for 4 min. in Laemmli buffer (5xLeammli buffer: 0.15 M 
Tris-HCl pH 6.8, 5 % SDS, 25 % glycerol, and 0.050 % Bromidephenolblue) with 3 % β-
mercapto-ethanol added freshly just before heating. The heated samples were spun at 14000 
rpm for 2 minutes before loading on the gels. Gels were run at 100-200V in running buffer 
(25 mM Tris, 192 mM Glycine) 
 
Western Blotting 
All blots were done using the Mini Trans-Blot Cell. In all cases nitrocellulose 
membranes were used. The mini-gels were blotted in a buffer containing 20 % Methanol 
(analytic grade), 0.1 % SDS, 8.3 mM Tris, and 64 mM Glycine at 80 volts for 60-90 minutes 
at 4°C.  
 
Probing 
Membranes were blocked in PBS, 0.075% Tween20 + 5 % milk for an hour at room 
temperature or overnight at 4°C. All primary antibodies were diluted in PBS, 0.075% + 5 % 
milk. In all cases incubations were for 2 hours at RT or overnight at 4°C. All washes were 
done in PBS, 0.075% Tween20. All secondary antibodies were used in 1:5000 dilution in 
PBS, 0.075% Tween20 (washing buffer) + 5 % milk for 1 hour at RT. Western blot were 
developed using ECL from Promega 
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